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ABSTRACT OF THE DISSERTATION
FCS Analysis of Pore Formation by the Human Protein Bax in Lipid Membranes
by
Olena Anatoliyivna Ivashyna
Abstract

Bax is a pro-apoptotic member of the BCL-2 protein family and its paramount function
during apoptosis is to form pores in the mitochondrial outer membrane (MOM). In a
simplified apoptosis model, upon apoptotic stimulation, Bax is activated via an
unresolved mechanism, translocates to the MOM, where it changes conformation, inserts
into the membrane as a monomer, and finally undergoes in-membrane oligomerization to
form a pore. Once the Bax pore is formed, cytochrome c and other mitochondria-resident
proteins escape into the cytoplasm where they activate the cascade of caspases, which
dismantle the cell. To date, the structure of the inactive cytoplasmic form of Bax is
known; however, the structure of the membrane-integrated, active form of Bax remains
unsolved. The absence of membrane structure for Bax leaves the mechanism of Bax pore
formation poorly understood. To investigate the mechanism of Bax pore formation, we
developed and used approaches to study fluorescently labeled Bax in solution and in lipid
membranes using single-molecule sensitivity fluorescence techniques based on
fluorescence correlation spectroscopy – FCS. These single-molecule fluorescence
techniques provide us with a non-invasive method to study the mechanism of Bax pore
formation reconstituted in giant unilamellar vesicles (GUVs). Our results show, that in
the environment of a GUV lipid membrane, Bax can form a complex distribution of
coexisting pore sizes ranging from 1 nm to 20 µm in diameter. Evidence is provided by

xi

directly examining oligomerization and mobility changes of Bax molecules in GUVs by
fluorescence cross-correlation spectroscopy (FCCS) and observing the large complexes
by confocal microscopy. We show that in the presence of Bcl-xL, an inhibitor of Bax pore
formation, membrane-bound Bax was primarily monomeric. We also show, that in the
large length-scale format of the GUV, Bax forms mega-pores – structures that reveal its
affinity for highly curved membranes. Analysis of the line tension in the rim of Bax
mega-pores indicates that Bax dramatically reduces line tension while stabilizing these
lipidic pores. Furthermore, our results demonstrate that Bax forms pores by increasing
membrane surface energy and by changing the curvature of lipid membranes, thus
manifesting an ability to sculpt lipid bilayers.
In addition to studying Bax in lipid membranes, we have investigated the in vitro
mechanism of Bax activation in detergent micelles, where, due to the formation of large
hydrodynamic volume protein-detergent micelles, Bax has been proposed to form homooligomers upon activation prior to membrane insertion, which is in contrast to the in vivo
studies which reported that Bax binds MOM as a monomer and then undergoes homooligomerization. Our studies using fluorescence intensity distribution analysis (FIDA)
have shown that Bax is a monomer before, during and after interaction with detergent
micelles; however, it does form large hydrodynamic volume complexes with detergent
micelles. The results of our FIDA study establish the connection between the in vitro and
in vivo mechanism of Bax activation, showing that, prior to the formation of an

oligomeric pore in a lipid membrane, Bax binds lipid membranes as a monomer.
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CHAPTER 1
“Apoptosis, Bcl-2 Protein Family, and Bax”

1

Apoptosis
In order to maintain homeostasis and survive, multicellular organisms developed
a mechanism to sacrifice certain cells for the good of others. For example, cells in the
xylem of plants must die to create a conduction pathway for water; so must do the cells in
the finger webs of a human embryo as well as the neuron cells which failed to create the
proper cellular connection1, 2. Therefore, to selectively kill cells, multicellular organisms
developed a mechanism – apoptosis – which is a morphologically defined form of a
programmed cell death3-6. The distinctive morphological features of apoptosis include
nuclear fragmentation, membrane blebbing and the formation of apoptotic bodies. All
multicellular organisms employ apoptosis; however, the biochemical details of apoptosis
vary among species. For example, vertebrates, during the mitochondrial pathway of
apoptosis, rely on the release of cytochrome c from mitochondria to ensure the activation
of caspases – the family of proteases responsible for cellular demise – while in C. elegans
only four proteins are involved in apoptosis without the engagement of cytochrome c7.
Furthermore, some single-celled organism who form surface biofilms, or live in colonies
(such as yeast), also have been shown to have a mechanism to eliminate single cells in
the colony to ensure the survival of others8, 9. Thus the need to eliminate old, virusinfected or otherwise unwanted cells is universal among the various forms of life.
Apoptosis plays an important role in mammalian development, especially in the
nervous system where deficiencies in the execution of the apoptotic program lead to
severe neurological disorders. Apoptosis also plays an important role in maintaining
homeostasis, for example, in the immune system where it eliminates unwanted B and T
cells. Disregulation of apoptosis during the maintenance of homeostasis leads to cancer,

2

as illustrated by B-cell lymphomas. While disregulation or inhibition of apoptosis at
different stages in the life of vertebrates is detrimental, activation of apoptosis, for
example, in the cells of the central nervous system upon trauma, or in cardiomyocytes
deprived of oxygen upon myocardial infarction, also has a deleterious effect onto the life
expectancy of an organism10, 11. It is estimated that up to 50% of the cells lost in a heart
attack or stroke might be saved by pharmacologic inhibition of apoptosis. The latter can
be accomplished only when we understand the molecular and biophysical mechanisms of
programmed cell death.

Bcl-2 protein family and apoptosis
Apoptosis can occur via two distinct pathways: the extrinsic and intrinsic
pathways7,

12-15

(Fig. 1-1). The extrinsic pathway, also known as the death-receptor

pathway, occurs via activation of the death receptors at the cell surface, leading to the
activation of effector caspase 8, which in turn activates the executioner caspases that
dismantle the cell. The intrinsic pathway of apoptosis, also known as the mitochondrial
pathway, occurs when the cell senses internal damage or is deprived of growth factors.
The mitochondrial pathway of apoptosis is controlled by the Bcl-2 protein family, where
upon activation, proteins Bax or Bak permeabilize the mitochondrial outer membrane
(MOM) resulting in the release of cytochrome c and other mitochondria-resident proteins
into the cytoplasm. In the cytoplasm cytochrome c activates the formation of an
apoptosome, leading to cell death. The two pathways of apoptosis are connected though
caspase 8. Caspase 8 can cleave Bid to produce tBid which activates Bax and Bak to
permeabilize the MOM and release cytochrome c, thus killing a cell.

3

Figure 1-1. The two pathways of apoptosis.

Sub-groups of the Bcl-2 protein family
In humans, twenty-three genes comprise the Bcl-2 protein family and they
generate both pro- and anti-apoptotic proteins13, 16-21. These two functional protein groups
are further divided into three structural groups based on the number of conserved Bcl-2
homology domains (BH1-4) (Fig. 1-2). The first group are the anti-apoptotic
multidomain proteins which display sequence conservation through BH1-4 domains, and
they include Bcl-2, Bcl-xL, Mcl1, etc. The other two groups of the Bcl-2 protein family
are the pro-apoptotic multidomain proteins (Bax, Bak) and the pro-apoptotic BH3-only
proteins (Bid, Bim, Bad, Noxa, Puma, etc.). Interactions between these three groups of
the Bcl-2 protein family inform the programmed cell-death decision by altering the
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Figure 1-2. The Bcl-2 protein family.

permeability state of the MOM. Alteration of the permeability state of the MOM is done
by Bax and Bak, which together22 or independently23, can form oligomeric pores in the
MOM. The rest of the Bcl-2 family proteins positively and negatively regulate pore
formation by Bax and Bak. It has been proposed that the anti-apoptotic proteins such as
Bcl-2 and Bcl-xL inhibit pore formation by Bax and Bak by directly binding these
proteins in the MOM. However, it has been shown that Bcl-xL can prevent Bax pore
formation and apoptosis by an independent mechanism where Bcl-xL does not need to
hetero-oligomerize with Bax or Bak24, 25, though the molecular details of this mechanism
have yet to be determined.
The BH3-only proteins, also known as the sentinels of death, transmit the death
signal sensed internally inside the cell to Bax and Bak26. However, two opposing
hypothesis for these proteins function have been proposed. The first hypothesis states that
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all BH3-only proteins can bind directly only to the anti-apoptotic proteins which keep
Bax and Bak in check. Binding of the BH3-only proteins to the anti-apoptotic proteins
releases Bax and Bak to form pores12-14,

20, 27-29

. The second hypothesis proposes that

there are two types of the BH3-only proteins: direct activators and derepressor/sensitizers7, 21, 30-34. The direct activator proteins, which include only Bid, Bim
and Puma, activate Bax and Bak by directly binding these proteins, while derepressor/sensitizer proteins, which include the rest of the BH3-only proteins, initiate
apoptosis by binding the anti-apoptotic proteins, preventing them from interacting with
the activator BH3-proteins as well as Bax and Bak. However, Puma have been
characterized by some groups as a direct activator while by others as a derepressor/sensitizer21, 31.
One of the interesting questions about the Bcl-2 protein family in vertebrates is
why the family needs to have so many members (over twenty), while in other
multicellular organisms, for example, C. elegans there are only two homologues of the
Bcl-2 protein family (Egl-1 and Ced-9)35. A possible answer to this question comes from
the tissue-specific expression of the Bcl-2 proteins in vertebrates. For example Bax and
Bak are expressed in most tissues while the BH3-only proteins have tissue-specific
expression patterns. Additionally, BH3-only proteins receive apoptotic signals from
various sources. For example, protein Bim is sequestered to the cytoskeletal structures via
association with dynein light chain LC8, and is released form this interaction upon the
induction of apoptosis. Free Bim translocates to the mitochondria where it serves as a
direct activator of Bax and Bak36, 37. Another example is the cytoplasmic protein Bid,
which upon cleavage by caspases 8 translocates to the MOM where it serves as a direct
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activator of Bax and Bak38-40. Puma, another BH3-only protein, is a cytoplasmic protein
which is known to interact with p53, a tumor-suppressor protein involved in the
regulation of the cell cycle41. Upon interaction with p53, Puma influences the activation
of Bax and Bak. Therefore, it has been proposed that the reason for the expansion of the
number of protein in the Bcl-2 family is the based on three points: (i) a need for
redundancy; (ii) a need for functional specialization due to the higher number of tissues
in vertebrates compare to invertebrates; (iii) and a need for compensatory regulation35.

Discovery of the Bcl-2 protein family: retrospective history
The Bcl-2 family of proteins was discovered during a quest to understand the
molecular origins of cancer. In the 1940s in the US, an increase in the incidents of cancer
was observed and this increase continues. As a result massive research effort has been
undertaken to understand the origins of cancer. In 1970s the first viral oncogene, src, was
discovered42. In 1989 Bishop and Varmus were awarded the Nobel Prize in Medicine for
the discovery of viral oncogenes, and in particular the src oncogene. The discovery of src
showed that there is a connection between the DNA content of a cell and cancer, and thus
opened new avenues of research. As a result it has been shown that a number of nonhereditary cancers are associated with chromosomal translocations43-45. For example, it
has been shown that translocation from chromosome 14 to chromosome 18, t(14:18), is
commonly detected in poorly differentiated lymphocytic lymphomas44. However, the
state of technology at the time did not allow sequencing of these translocations. In 1980 it
became possible to sequence chromosomal DNA at the translocation points and in 1985
three unrelated research groups published independently their results on cloning the gene
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located at the t(14:18)46-49. This gene was called bcl-2, abbreviating the name of cancer
cells from which it was cloned – B cell lymphoma. The translocation t(14:18) has
coupled the immunoglobulin heavy chain locus from chromosome 14 to the bcl-2 gene
on chromosome 18, thus leading to over-expression of this gene. However, it was unclear
how the over-expression of a gene can cause cancer.
In 1988 Vaux et al has shown that the over-expression of the Bcl-2 protein results
in reduced cell death and the locking of cells in the G0 state50. This observation became
the first proof that bcl-2 was an oncogene which promoted cancer not due to the mutation
in the gene, but due to the over-expression of the normal gene. After that point the quest
for detailed understanding of the Bcl-2 protein function began. As a result it has been
discovered that Bcl-2 is involved in the control of apoptosis. Additionally, it was found
that there are a number of proteins which share sequence homology with the Bcl-2
protein, which consequently became the members of the Bcl-2 protein family. These
proteins include Bax51, Bcl-xL52, Bcl-w53, Mcl154, Bik55, Bid40, Bim56 and others.
In 1993 protein Bax was discovered by coimmunoprecipitation with Bcl-xL51 and
later on it has been shown that to prevent apoptosis, Bcl-2 has to hetero-dimerize with
Bax57, 58. It has also been shown that during apoptosis the release of cytochrome c is
required to initiate the mitochondrial pathway of apoptosis and that Bax and Bak are
involved in this process59.
The biochemical function of the Bcl-2 protein family was revealed after the
structure for Bcl-xL was solved60. This structure showed a remarkable similarity in fold
with the pore-forming subunits of collicin A and diphtheria toxin61,

62

. Later on the

structures of Bid63, Bax64 and Bcl-265 have been determined and they showed the same
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resemblance in protein fold to Bcl-xL and collicin A. Thus, based on this similarity in
protein fold, it has been proposed and later proved that proteins of the Bcl-2 family can
form pores in lipid membranes66-72.
Since the over-expression of the anti-apoptotic proteins has been implicated in
causing cancer, an attempt has been made to develop pharmacologic inhibitors of the
anti-apototic proteins73. As a result, anti-cancer drugs such as ABT-747 and ABT-263
have been developed74-77. These drugs have been engineered to bind the hydrophobic
pocket on the surface of Bcl-2 and Bcl-xL, where normally the BH3 proteins would bind,
thus allowing the BH3 proteins to activate Bax and Bak resulting in the cell death.
Another avenue for the development of anti-cancer drugs would be to develop
small molecules able to activate the pro-apoptotic members of the Bcl-2 family, such as
Bax and Bak. In addition, development of small molecules which can inhibit the
activation of Bax and Bak would be tremendously beneficial in the prevention of
apoptosis in the central nervous system after trauma or apoptosis of cardiomyocytes after
myocardial infarction. However, all of the above scenarios of activation and inhibition of
Bax and Bak are still on hold, since the mechanism of the activation of Bax and Bak is
not clear. This demonstrates the need for more basic research to be applied to the problem
of understanding the molecular mechanism of action of the proteins of the Bcl-2 family,
and in particular of the protein Bax.
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Structure and function of protein Bax
Bax is a 21 kDa protein (192 amino acids). According to the solution NMR
structure, Bax consists of nine α-helices with 61 % α-helical content64 (Fig. 1-3). This
structure represents the conformation of inactive solution Bax. In contrast to inactive
Bax, active Bax is bound to a lipid membrane and has a different protein conformation
(Fig. 1-4). It has been shown by cysteine scanning of Bax that in the active membrane
bound conformation of Bax has three helices inserted into the lipid membrane78. These
are helices 5, 6 and 9 (Fig. 1-4, shown in blue and yellow). To achieve such conformation
the molecule of Bax needs to be “flexible”. The flexibility in changing from one protein
conformation to another is possible due to the presence of multiple glycines in the loops
connecting the helices of Bax (Fig. 1-5). Glycines constitute 11 % of all amino acids in
Bax and 60 % of them are found in the connecting loops.
In order to permeabilize the MOM, Bax needs to translocate from the cytosole to
the MOM and undergo a conformational change which is associated with its activation
and can be detected by the conformation specific antibodies. In particular, 6A7 antibody
against the N-terminus of Bax is used as a “gold standard” for showing the activation of
Bax79,

80

. However, the molecular mechanism of Bax activation is a matter of active

debate21, 28, 81. In fact, it has been recognized as a “holy grail of apoptosis research”7.
It has been shown in in vitro assays that Bax can be directly activated by a
number of BH3 peptides82, and by the full-length BH3-only proteins21,

41, 83-86

. In

addition, it has been shown that Bax can be directly activated by heat87, by the direct
interaction with p5388, by elevated pH89 and by incubation with detergents79, 80, 90, 91.
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Figure 1-3. Structure of the human Bax protein, alpha isoform64. See Appendix I for
protein sequence.

Figure 1-4. Schematic of the protein conformation of Bax in a lipid membrane.

Figure 1-5. Position of glycine and proline amino acids in the Bax protein
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Currently, two structural models of Bax activation are being proposed. The first
model suggests that the homo- and hetero-oligomerization of Bax with other Bcl-2 family
members occurs via a hydrophobic groove on the surface of Bax (formed by domain
BH1-3) which in the inactive protein conformation is occupied by the C-terminus of Bax.
This model of Bax activation is not supported by the structural studies on Bax, i.e.
currently there is no solved structure of Bax where this hydrophobic groove is occluded
by the BH3 domain. However, this hypothesis of C-terminus displacement by the BH3
peptides was proposed based on the structural studies with the anti-apoptotic proteins92
which share a similar fold with Bax. The second model of Bax activation by the BH3
peptides has been proposed by Gavathiotis et al, who has shown that the stapled BH3
peptide of Bim binds to Bax at a binding site formed by helices 1 and 6 of Bax93. This
site is on the opposite side of the Bax protein from the hydrophobic groove occupied by
the C-terminus. However, it is possible that in vivo both of these binding sites on Bax are
used in the homo- and heterotypic interactions.
The importance of various residues and sequences of residues in Bax has been
explored in a large number of studies. As a result, it has been shown that the removal of
the BH3 domain in Bax renders it inactive in vivo94 and that BH3 domain is important
for hetero-and homo-oligomerization among proteins of the Bcl-2 family95, 96. It was also
shown that the N-terminal end of Bax contains the mitochondrial-targeting sequence97, 98
and that the C-terminus of Bax, together with helices 5 and 6, is involved in membrane
binding70, 78, 99, while the rest of the helices of Bax play an important role in the activation
of Bax by the BH3-only proteins and in the homo-oligomerization of Bax93,

100, 101

.

Therefore, when considering a strategy for the fluorescent labeling of Bax for FCS
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studies discussed in Chapter 7, we did not label Bax with GFP (however, it has been
done102) but instead we labeled Bax with small fluorescent dyes (~0.5 kDa) via
genetically engineered cysteine. A similar fluorophore labeling strategy of Bax has been
used by Lovell et al, where Bax was used in a FRET study84.

Bax pore formation mechanism
According to a simplified apoptosis model, Bax is found in the cytoplasm of nondying cells and upon the initiation of the mitochondrial pathway of apoptosis Bax is
activated. Then it translocates from the cytoplasm to the mitochondrial outer membrane,
where it inserts into the membrane as a monomer and then undergoes selfassembly/oligomerization to form a pore through which cytochrome c and other
mitochondria-resident proteins can escape into the cytoplasm103-105 (Fig. 1-6).

Figure 1-6. Schematic of the mechanism of Bax binding, conformational change,
integration, and pore formation in a lipid membrane.

The formation of Bax pores in MOM has not been observed by high resolution
electron microscopy. Instead it was shown that Bax was accumulated at the fission site of
mitochondria during apoptosis106. In addition, it has been shown that disruption of
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mitochondrial fission results in the inhibition of apoptosis thus establishing a connection
between the function of Bax and that of the proteins involved in mitochondrial fission107110

. However, the electrophysiology measurements of membrane conductance in isolated

mitochondria from apoptotic cells revealed the existence of a mitochondrial apoptosisinduced channel (MAC). The exact protein composition of a MAC is not clear but it is
clear that Bax is its major component111, 112. It has been shown that MAC activity is not
present in Bax-/-, Bak-/- cells, but is present in cells expressing one or both of these
proteins112. Additionally, it has been shown that the conductivity of a MAC in proteoliposomes formed from mitochondrial membranes is similar to the conduction properties
of the channels formed by the recombinant activated Bax, however, the two do not match
exactly. On the other hand, in vitro Bax has been shown to form pores in artificial lipid
membranes, and its ability to release cytochrome c and other macromolecules from
liposomes via the formation of a pore is clearly documented39, 68, 83, 104, 105, 113. Therefore,
the existence of a MAC in mitochondria during apoptosis and the ability of recombinant
Bax to form pores in artificial lipid bilayers indicate that the permeabilization of the
OMM during apoptosis must occur via the formation of a Bax-containing pore. Dispite
this indication the opponents of this hypothesis do exist.
Studies of the kinetics of liposome poration by Bax revealed that Bax forms pores
of various diameters starting with a dimer pore of 1 nm in diameter, continuing to a
tetramer pore of 4 nm in diameter104 (this pore is wide enough for cytochrome c to go
though), and continuing to larger pores up to 100 nm in diameter83,

113, 114

. This

heterogeneity in the sizes of pores formed by Bax was assumed to be a controversy,
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however, later on it has been shown that the size of a Bax-containing pore in MOM
changes with time111, thus unifying all previous results.
In Chapter 6 of this dissertation we present data showing that Bax is able to form
even larger pores with diameter of 5-20 µm. We named these pores as Bax mega-pores
and they are wide enough to allow multiple mitochondria to diffuse through them. In all
of the observed Bax mega-pores Bax was concentrated at the rim of the pore, however, in
GUVs, where the mega-pore was observed to close, no trace of large visible aggregates
of Bax was left on the membrane surface of a GUV. This observation indicates that Bax
is accumulated at the pore edge, but it does not form tight contacts with neighboring
monomers of Bax thus allowing for fast disassembly of the pore. This brings us to the
discussion about the type of the pore formed by Bax.
The pore forming proteins and peptides can form two types of pores in lipid
membranes – barrel-stave and toroidal pores115 (Fig. 1-7). The interior of the barrel-stave
pore is outlined by protein components, while the interior of the toroidal pore has lipid
headgroups outlining the pore interior. Because of its unique structure toroidal pore is
occasionally called a lipidic pore since the two leaflets of the lipid bilayer are connected

Figure 1-7. Schematic of a cross section for a barrel-stave and for a toroidal pore.

15

at the pore site. The example of a peptide forming barrel-stave pore is alamethicin116,
while magainin peptide serves as an example of a peptide forming toroidal pores117.
In case of Bax both models of the pore has been proposed and still are being
proposed118-121. However, overwhelming number of arguments suggest that Bax forms a
toroidal type of pore. The first argument is that Bax accelerates the rate of lipid mixing
between the two leaflets of a lipid bilayer85, 119. Normally such lipid mixing or transfer
has an extremely low rate and can be accelerated only when the two leaflets are
connected, for example through a lipidic pore. The second argument comes from the
neutron scattering experiments where lipid bilayers treated with pore-forming helix 5 of
Bax shows formation of a lipidic pore structure121. As a control in these experiments
alamethicin was used to show the neutron scattering pattern for a bona fide barrel-stave
pore forming peptide. The third argument is based on the experiments where the addition
of positive intrinsic curvature promoting lipids (such as lyso-lipids), which energetically
favor being in the rim of a lipidic pore, accelerated Bax pore formation, while addition of
lipids with negative intrinsic curvature (such as DOPE or cholesterol) inhibited the pore
formation by Bax67, 86. In addition to this argument, it has been shown that activated Bax
can crosslink liposomes to form cuboidal structures – sponge-like structures (unpublished
data).
The above-mentioned review of the pore-formation mechanism of Bax together
with the enigma of Bax activation, also discussed above, clearly indicates that the
mechanism of Bax pore formation is poorly understood and needs to be studied in greater
detail. The experiments discussed in this dissertation attempt to answer some of the
questions about the mechanism of Bax action.
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CHAPTER 2
“In vitro Systems to Study Protein Bax”
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Introduction
Due to the complexity of cellular systems and due to the size limitations of mitochondria,
which represent the “battle ground” for the proteins of the Bcl-2 family, it has been
recognized that model in vitro systems which mimic mitochondria can provide crucial
information about the function of Bax and the other Bcl-2 family proteins. In this chapter
four model in vitro systems used to study Bax are discussed (Fig. 2-1). These in vitro
systems are introduced in the order of simplicity of preparation, starting with detergent
micelles, continuing to large unilamellar vesicles (100-200 nm in diameter), and giant
unilamellar vesicles (5-100 µm in diameter), and finishing with supported lipid bilayers.
In addition, previous use of these in vitro systems and the utility of these systems to the
study of the mechanism of Bax pore formation in lipid membranes are discussed.

Figure 2-1. In vitro systems used to study Bax pore formation. Adopted with permission
from Mariana Ruiz Villarreal.
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Detergent micelles
After the discovery of the various members of the Bcl-2 family, a number of
studies have been done to determine the cellular localization of these proteins prior to and
during apoptosis. These studies have shown that, for example, the Bcl-2 protein is found
primarily in the membrane compartment of cells1-3, while Bax and Bcl-xL changed
localization from cytosolic to membrane during the induction of apoptosis4. In these
studies, detergents were used to extract Bax and other Bcl-2 family proteins from the
membrane compartment, and it has been discovered that certain detergents can promote
homo- and hetero-dimerization of the Bcl-2 family proteins4, 5. In particular, it has been
found that certain detergents can lead to the conformational change in Bax which is
associated with its activation5. As a result, Antonsson et al. tested a number of detergents
for their ability to activate Bax, allowing it to form pores in liposomes6. The results of
this study have shown that Bax can be activated by incubation with detergents such as noctylglucoside, dodecylmaltoside, Nonidet P-40 and Triton X-100 but not with CHAPS.
This discovery has led to a number of studies where Bax was activated by incubation
with detergents, primarily n-octylglucoside7-13. However, before we discuss the important
results of the studies of Bax in detergent micelles, it is important to discuss the basic
properties of detergent micelles and detergent molecules comprising these micelles.
Detergents are amphipathic molecules which self-assemble into micelles in
aqueous solution (Fig. 2-2)14, 15. The critical concentration at which detergent molecules
start to self-assemble into micelles is known as critical micelles concentration (CMC).
The size and shape of detergent micelles together with the CMC depend on the chemical
structure of detergent molecules (Table 2-1). In addition, based on their chemical
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Figure 2-2. a. Schematic of a detergent molecule consisting of a hydrophobic tail and a
hydrophilic headgroup. b. Schematic cross-section of a spherical detergent micelle16.

structure detergents are subdivided into two major groups: non-ionic and ionic detergents
(Table 2-1). In addition to showing that a range of detergents can activate Bax to form
pores in lipid membranes, Antonsson et al. has also shown using analytical gel filtration
that Bax, when incubated with these activating detergent micelles, eluted together with a
high molecular weight marker with the molecular weight larger than the combined weight
of one Bax monomer and one detergent micelle6. Based on this observation together with
the knowledge that Bax oligomerizes in the MOM during apoptosis17, it was proposed
that detergents promote homo-oligomerization of Bax and these homo-oligomers
represent active Bax. As a result Bax activated by incubation with detergent micelles was
named oligomeric Bax, OG-Bax13, 18. In addition to these biochemical studies, Suzuki et
al. while determining the solution structure of inactive Bax, attempted to determine the
structure of Bax in an n-octylglucoside micelle19, showing that Bax does form large
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Table 2-1. Characteristics of various detergents.
Name

MW

CMC, M
at 25 °C

Aggregation
number

Dodecylmaltoside 510

0.15 mM

98

n-octylglucoside

292

20-25 mM

84

CHAPS

615

6 mM

10

cholic acid

430

14 mM

10

Triton X-100

625

0.2-0.9 mM

100-155

Tween 20

1228

0.06 mM

288

7-10 mM

Non-ionic detergents

Ionic detergents
Sodium lauryl
sulfate, SDS

62
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Structure

molecular weight complexes in the presence of n-octylglucoside micelles. These noctylglucoside/Bax complexes had very large hydrodynamic volume, preventing the
NMR based determination of the structure of active Bax.
In Chapter 4 of this dissertation, similar studies were undertaken with the
fluorescently labeled truncated form of Bax, BaxΔC, with the purpose of determining the
number of Bax monomers in the OG-Bax complex11. These studies show that indeed
BaxΔC, incubated with detergent micelles, forms large macromolecular complexes, but
with only one BaxΔC monomer present per complex. This result shows that Bax is able
to change the structure of detergent micelles and indicates that the molecular mechanism
of Bax activation by detergents is not well understood.
Cholic acid is a naturally occurring bile salt able to activate Bax5, 11 but without
the occurrence of large molecular weight Bax complexes. The latter fact makes cholic
acid an interesting candidate for the study of Bax activation.
Detergent micelles were recognized initially as in vitro platforms providing a
hydrophobic environment for the study of Bax activation. However, it turned out that
when present in detergent micelles, Bax has a transformative effect on the detergent
micelle structure. For this reason the activation effect of detergents on Bax have been
employed widely. However, it is conceivable that in the future, detergents such as cholic
acid can be used to determine the protein conformation of active Bax.
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Large unilamellar vesicles
Large unilamellar vesicles (LUVs) are widely used as a well characterized, easily
manipulated in vitro system to study the mechanism of Bax pore formation (Fig. 2-3).
LUVs have been used in a wide variety of in vitro Bax-related studies: (i) the
stoichiometry of Bax pore formation20; (ii) the kinetics of Bax pore formation in various
conditions such as presence of activating detergents, or activating proteins (such as cBid
and Bim), or low pH
23

6, 7, 9, 13, 20-22

; (iii) the kinetics of Bax binding to lipid membranes10,

; (iv) the morphological changes of lipid membranes upon Bax binding 24; (v) the effect

of curvature-producing and charged lipids on Bax pore formation7, (vi) the interaction of
Bax with other Bcl-2 family proteins 7, 22, 23, 25; (vii) the ability of Bax to promote mixing
of lipids between the internal and external LUV leaflets26; (viii) the conformational
changes in Bax structure upon membrane binding27 etc.
The LUVs used in the majority of the aforementioned studies are 200 nm in
diameter (similar to the smallest cross-section diameter of mitochondria28) and are most
commonly composed of a lipid mixture containing combinations of either of following
lipids: DOPC, POPC, DOPE, DOPA, DOPG or cardiolipin – lipids which are commonly
found in the contact sites of mitochondria29. The contact sites in mitochondria are the
sites where the outer and inner mitochondrial membranes are in contact. The two most
common methods of LUV preparation are the freeze-thaw method30 and the reversephase method10, 11, 31-33 (See Appendix II for a detailed protocol).
The utility of LUVs to study the mechanism of Bax pore formation is clear,
however this in vitro system has a number of important limitations: (i) lipid composition
of LUVs cannot be 100% identical to the lipid composition of the MOM; (ii) LUVs lack
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other mitochondrial proteins present in the MOM during Bax insertion and pore
formation which may affect the ability of Bax to form pores; (iii) due to their size, LUVs
cannot be used to study the in-membrane diffusion of Bax monomers and the oligomeric
Bax pores (GUVs can be used for this purpose).

Figure 2-3. Transmission electron microscopy
micrograph of LUVs. Scale bar is 200 nm.
Adopted from Soman et al.34

Giant unilamellar vesicles
Giant unilamellar vesicles (GUVs) are another example of a model in vitro system
used to study the mechanism of Bax pore formation (Fig. 2-4). GUVs have been used
successfully to study Bax pore using a patch clamp technique18, or to study the dye
release from a GUV though a single Bax pore using fluorescence microscopy9. Due to
their size, 5-100 µm in diameter, GUVs can be observed by light microscopy, unlike
LUVs, and they can be used to study protein diffusion and oligomerization in a lipid
membrane using FCS35-39 as well as to study the morphological changes in GUVs upon
protein binding40-42. The use of GUVs to study the diffusion and homo-oligomerization of
Bax in lipid membranes using FCS is discussed in Chapter 5.

34

Figure 2-4. Giant unilamellar vesicles: confocal microscopy images.
a. Confocal 3D reconstruction of a field of GUVs (view from the top). One large GUV
dominates the field. b. Multilamellar giant vesicle. c. Cross-section image of a field of
GUVs. d. Multilamellar GUVs prepared from a lipid mixture of DOPC and cardiolipin
(80:20 mol %). Scale bar in each image is 20 µm. All GUVs were prepared by the
electroformation method43.
GUVs can be prepared by three methods: “gentle hydration” method44, 45, reversephase method46, and by the electroformation method43,

47-50

. In the “gentle hydration”

method, as the name implies, GUVs are formed by the hydration of dried lipid film
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deposited on a glass or Teflon surface. In this method, GUVs are formed by the swelling
of the lipid film into lipid vesicles. It generally takes up to12 hours to produce GUVs by
this method while the electroformation and the reverse-phase methods take up to 2 hours
(depending on the lipid composition). In the reverse-phase method, GUVs are made by
mixing lipids dissolved in a mixture of diethyl ether and chloroform with aqueous buffer
solution forming an emulsion of water in ether/chloroform which is transformed into
GUVs after the slow evaporation of ether and chloroform. In the electroformation
method, lipids are dried on the surface of two parallel platinum wires43 or on the surface
of two parallel ITO-coated cover glass plates48, which are then transferred into an
aqueous solution (usually 300 mM sucrose) and connected to an AC generator (See
Appendix III for detailed protocol). The AC generator generates an alternating electric
field between the two electrodes (in this case platinum wires or ITO-coated glass plates)
resulting in the swelling of lipid bilayers from the substrate in the form of GUVs.
The electroformation method of GUV preparation is used most commonly due to
the relative simplicity of the preparation protocol51, and it was used to prepare the GUVs
described in Chapters 5 though 7. However, this method has a number of drawbacks,
such as the difficulty of forming GUVs in solutions containing physiologic salt
concentrations51, the inability to prepare GUVs with heterogeneous lipid distribution
between the two lipid leaflets (which would be desirable, since most cellular membranes
have asymmetric lipid distribution among the two leaflets), and the artifacts associated
with the heterogeneous lipid distribution among the GUVs in the same preparation (Fig.
2-5). In GUVs prepared from a mixture of more than three lipids, it is common to see
heterogeneous lipid distribute among the GUVs as shown by arrow and asterisk on
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Figure 2-5. Heterogeneity of lipid distribution among the GUV prepared by the
electroformation method. GUVs with prominent heterogeneity of lipid distribution are
indicated with an arrow and an asterisk. Scale Bar 20 µm.
Figure 2-5, where lipidic dyes DiO and DiD are unevenly redistribute among the GUVs.
Another example of heterogeneous lipid distribution is illustrated by the simultaneous
formation of unilamellar and multilamellar giant vesicles, electroformed from a lipid
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mixture of DOPC:cardiolipin (80:20 mol %) (Fig. 2-4d). This effect will be discussed in
greater detail in Chapter 5 of this dissertation.

Lipid bilayers
Lipid bilayers are another example of an in vitro system which can be used to
study the mechanism of Bax pore formation. Based on the preparation method, lipid
bilayers can be divided into supported lipid bilayers (SLBs), which are prepared on a
mica surface, and free-standing lipid bilayers which are mostly used in electrophysiology.
SLBs can be further subdivided into dry and hydrated lipid bilayers. All three types of
lipid bilayers have been used to study the mechanism of Bax pore formation. For
example, hydrated SLBs have been used to study by AFM the effect of full length Bax
protein and the pore-forming helices of Bax (helices 5 and 6) on hydrated SLB52, 53 while
dry SLBs were used in neutron-scattering experiments to determine whether the poreforming helix of Bax (helix 5) forms toroidal or barrel-staved type pores54. The result of
the latter study showed that helix 5 of Bax forms toroidal pores in lipid membranes. Use
of free-standing lipid bilayers in the electrophysiology experiments allowed conductance
measurements to be performed on Bax pores. It was shown that Bax pores are non
selective and can have a variety of diameters18, 21, 55, 56. In addition, using free standing
lipid bilayers, Basanez et al. have shown that upon insertion into the lipid bilayer, Bax
reduces the line tension in the bilayer55, which was further confirmed by Garcia-Saez et
al. in a study using AFM on a hydrated SLB exposed to the pore forming helix 5 of
Bax57. These line tension studies together with the measurements presented in Chapter 6
of this dissertation suggest the ability of Bax to stabilize a lipid edge, and provide further
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support for the hypothesis that Bax forms lipid stabilized toroidal pores in lipid
membranes.
We have also attempted to use hydrated SLBs to study the diffusion and
oligomerization of Bax in lipid membranes using FCS (Fig. 2-6). However, because of
the hindrance of lipid diffusion in SLBs due to mica-lipid bilayer interaction we reasoned
that free-standing bilayers where lipid diffusion in not hindered by the interaction with
mica would provide a better model system for studies of the in-membrane diffusion of
Bax. Therefore, we have used GUVs as a source of free-standing lipid bilayers in the
FCS studies on Bax (Chapter 5).

BaxΔC

lipidic dye DiD

overlay

Figure 2-6. Bax binding to a supported lipid bilayer. Lipid bilayer was prepared from
a lipid mixture of DOPC:Sphingomeyelin:Cholesterol = 2:2:1 mol%. BaxΔC labeled with
Bodipy FL was used in these experiments. Scale bar is 5µm.

Previous studies of Bax in lipid bilayers have shown that this model in vitro
system is instrumental in the study of the mechanism of Bax pore formation. However,
the limited number of studies utilizing this system to study Bax shows that this model
system is under-exploited. One of the potential uses of this model system can be
combining it with the use of total internal reflection (TIRF) microscopy. Use of hydrated
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SLBs in combination with single-molecule TIRF microscopy can be employed to study
the sequence of interactions among the Bax and other Bcl-2 family proteins leading to or
preventing pore formation by Bax.

Other in vitro systems
A description of model in vitro systems used to study Bax would not be complete
without mentioning a less commonly used model such as lipid monolayers and lipid
bicelles. Lipid monolayers have been used to study binding and incorporation of Bax and
tBid58 (Fig. 2-7 a) where it has been shown that upon binding tBid increases pressure in
lipid monolayers 12 times higher than the pressure produced by Bax, indicating that tBid
has higher binding affinity to lipid membranes than Bax. The results of this study have
been recently corroborated by the kinetic measurements of the fluorescent Bax and tBid
insertion into lipid membranes23.
Lipid bicelles present another possible model in vitro system for studying the
structure of active Bax. Lipid bicelles are discoidal lipid aggregates formed from longchain phospholipids and either detergents or short-chain phospholipids(Fig. 2-7 b).
Bicelles are

Figure 2-7. Schematic representation of a lipid monolayer and a bicelle.
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most commonly used in NMR to study the structure-function relationship of membrane
associated and membrane-integrated proteins59,
determine the structure of Bax in lipid membranes.
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. Therefore, they can be used to
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CHAPTER 3
“Techniques to Study Pore Formation in Lipid Membranes
by Protein Bax”
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This Chapter provides an overview of single-molecule sensitivity fluorescence
techniques and the description of liposome permeability assay, which was used to asses
the functionality of all proteins used in the experiments described in this dissertation.

Single-Molecule Sensitivity Fluorescence Techniques
Single-molecule sensitivity fluorescence techniques provide a powerful noninvasive tool to study biological processes in vivo and in vitro and have been used
extensively in a number of experiments described in this dissertation. The following
section provides a background on the physical basis of fluorescence and the background
of the three single-molecule sensitivity fluorescence techniques: fluorescence correlation
spectroscopy (FCS)1, fluorescence cross-correlation spectroscopy (FCCS)2, and
fluorescence intensity distribution analysis (FIDA)3.

Physical principles of fluorescence
Luminescence is a physical process of the emission of a photon by a molecule
during the transition between the electronic energy states4, 5. Depending on the nature of
the excited electronic energy states between which the transition occurs, luminescence is
divided into two categories – fluorescence and phosphorescence. Fluorescence occurs
during the transition from a singlet energy states to the ground state (for example,
S1→S0), while phosphorescence occurs during the transition from a triplet state to the
ground state (for example, T1→S0). The electron in a triplet state has the same spin
orientation as the electron in the ground state, and therefore, according to the principles
of quantum mechanics transitions between these energy states are forbidden; however,
they do occur but with lower probability. Based on the low probability of the T1→S0
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transition, the lifetime of an electron in the triplet state, T1, is longer than its life time in
the excited singlet state, S1, and therefore, the lifetime of a fluorescence process is
generally on the order of 10-9 seconds, while the lifetime of a phosphorescence is on the
order of 10-6 seconds.
The electronic energy states and the transitions among them can be summarized
by the Jablonski diagram (Fig. 3-1). On this diagram the excited electronic energy states
and the ground state are shown with thick horizontal lines, while the vibrational energy
states of each energy state are shown with thinner horizontal lines. According to this
diagram, in the absence of excitation the molecule is in the ground electronic energy
state, S0. Upon absorption of a photon with the energy of h A , the molecule is excited
into the higher electronic energy state S1 or S2. Transition between the energy states is
shown by vertical lines. Once in the S2 state, the molecule rapidly relaxes to the lowest
vibrational level of S1 via internal conversion mechanism. Next, molecule transitions to
the ground energy state by emitting a photon with the energy of h F or by transfering
energy via a non-radiative pathway (for example, collision with other molecules).
Alternatively, molecules in the S1 energy state can undergo an intersystem crossing to the
triplet state T1. Such transitions are forbidden by the principles of quantum mechanics but
do occur with a low probability. Once in the T1 state, a molecule undergoes T1→S0
transition by emitting a photon with energy h P or by the mechanism of non-radiative
energy transfer.
Excitation into higher vibrational energy states followed by the decay into various
vibrational ground states results in the lower energy of emitted fluorescence photons than
the energy of the adsorbed photon. The difference in the energy of adsorbed and emitted
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Figure 3-1. Jablonski diagram of the electronic energy states of a molecule.

Figure 3-2. Excitation and emission spectra for two fluorophores: Alexa Fluor 488
maleimide and Atto 655 maleimide. These excitation and emission spectra illustrate the
phenomenon of a Stokes’ shift.
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photons is translated into respectively shorter and longer wavelength of the adsorbed and
emitted photons which is also known as a Stokes’ shift, and is used to separate the
excitation photons from the emission photons in the FCS experiments with the use of
dichroic mirrors and filters (Fig. 3-2).

Fluorophores
Fluorophores, or fluorescent dyes, are molecules which can emit fluorescent light
when excited4-6. The major characteristics of fluorophores include excitation and
emission spectra, extinction coefficient, quantum yield, singlet-to-triplet quantum yield
and photobleaching. Excitation and emission spectra of a fluorophore define the
excitation wavelength of a laser and the combination of a dichroic mirror and filters in
the FCS experiment (Fig. 3-2). Extinction coefficient defines the efficiency of the
fluorophore molecules to absorb excitation light, while the quantum yield of a
fluorophore is defined as a ratio of the number of emitted photons per unit of time to the
number of absorbed photons. Alternatively, the quantum yield of a fluorophore is defined
as



kr
k r  k nr

(Eqn. 1)

where, k r is the rate of radiative energy transfer defined as the transition rate of singlet to
the ground state, and k nr is the rate of all non-radiative de-excitation processes.
Photobleaching of a fluorophore is a process of irreversible destruction of a
fluorophore. For each fluorophore type there is a characteristic number of photons
emitted before the dye undergoes photobleaching. For example, Alexa Fluor 488 is more
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photostable than carboxyfluorescein, while both of these fluorophores have identical
excitation and emission spectra. Photobleaching in the FCS experiment can be controlled
by the illumination levels7, 8.
For use in FCS experiments fluorophores should have high extinction coefficient,
high fluorescence quantum yield, low singlet-to-triplet quantum yield and low
photobleaching7, 8. However, the majority of biological molecules do not posses such
fluorescence properties (GFP would be an exception from this statement). Therefore, in
order to study the biological molecules, a number of synthetic fluorophores were
developed. These fluorophores are bright and photostable and have engineered reactive
groups which allow for their attachment to the biological molecules of interest. In case of
Bax we used maleimide reactive group which forms a covalent bond with an engineered
cysteine. Examples of chemical structure for some synthetic FCS-compatible
fluorophores used in the experiments presented in this dissertation are shown in Figure 33. Depending on the chemical structure fluorophores can be used in a variety of
applications. For example, small dyes like Alexa Fluor 488, Atto 655 and Bodipy FL can
be used to label proteins and nucleic acids, while lipophilic dyes like DiO and DiD are
used to visualize lipid membranes.
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Alexa Fluor 488 c5 maleimide

Atto 655

BODIPY® FL N-(2-aminoethyl)maleimide

DiO
DiD
Figure 3-3. Chemical structures for selected FCS-compatible fluorophores. All of these
fluorophores were used in the experiments described in Chapters 7 through 7.
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FCS and autocorrelation analysis
Fluorescence correlation spectroscopy (FCS)1 is a single-molecule sensitivity
technique uniquely suited for study of biological processes in the 3D space of solution1, 7,
9-14

, in the 2D space of a lipid membrane15-22, or in 1D space, in the case of the directed

flow of fluorophores8. It is based on detecting fluorescence intensity fluctuations within a
small observation volume (<1 fl) which is achieved by the use of a confocal microscope
(Fig. 3-4). Temporal analysis of these fluorescence intensity fluctuations allows
determination of the concentration and diffusion coefficients of the fluorophores passing
through the observation volume.

Development of FCS: historic prospective
The theoretical basis of FCS has been developed by Madge D., Elson E. and
Webb W.W. in 197223. However, due to technical limitations, it did not gain wide use
until two decades later; when in 1993, Rigler et al implemented FCS in the scheme of a
confocal microscope and showed a number of implementation of the technique in
biochemistry and biology9,

24-28

.

Since then, FCS has seen a renaissance in its

development based on the number of its various implementations such as fluorescence
cross-correlation spectroscopy2,

12, 29

, photon-counting histogram (PCH) also known as

fluorescence intensity distribution analysis (FIDA)3,

30-32

, high-order correlation FCS

(HO-FCS)33-36, image-correlation spectroscopy37-40, total internal reflection FCS (TIRFCS)41, stimulated emission depletion FCS (STED-FCS)42-44, FCS with UV fluorophores
(UV-FCS)26, 45, implementation of the FCS in vivo12, 14, 17, 18, 46-49, two-photon FCS50, 51,
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supercritical angle FCS52, multiple variation of scanning FCS17,

53-58

, FCS in lipid

membranes19-21, 32, 55, 56, 59-62 etc.

The auto-correlation function
In a generic FCS experiment, excitation light from a laser is focused into a small
volume (also known as observation volume) in a solution sample with the use of a
dichroic mirror and a high numerical aperture objective (Fig. 3-4 a). Here, for the sake of
simple explanation, we assume that the sample consists of a dilute solution of freely
diffusing non-interacting fluorophores (Fig. 3-4 b). Each time a fluorophore passes
through the observation volume, it is excited and emits fluorescence, a portion of which
is collected by the objective and directed through the dichroic mirror and a filter to a
pinhole positioned in front of the avalanche photo diode (APD) used as a highly sensitive
detector in the FCS setup. Pinhole does not allow photons generated outside the
observation volume to reach the APD, thus only the photons generated by the
fluorophores present in the observation volume are registered and give rise to the
fluorescence intensity fluctuations trace F (t ) (Fig. 3-4 c). From this intensity trace, the
autocorrelation function can be calculated as1, 8

G   

F (t )  F (t   )
F (t )

2

 1

F (t )  F (t   )
F (t )

(Eqn. 2)

2

where G is the autocorrelation function, F is the fluorescence intensity as a function of
time,  is the correlation time (also known as the “lag time”) and the angular brackets
refer to time averaging, while F (t )  F (t )  F (t ) and
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T

1
F (t )   F (t )dt .
T 0

Figure 3-4. Principles of FCS. a. Schematic of the FCS setup. b. schematic

representation of the FCS observation volume. c. Time trace of the fluorescence intensity
fluctuations is used to calculate the auto-correlation curve, which measures the selfsimilarity of the signal. d. Fitting of the experimental auto-correlation curve allows
determination of the parameters of interest such as diffusion coefficient and the number
of fluorescent particles in the observation volume. See next section for the description of
selected the fitting correlation functions.
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The auto-correlation function measures the self similarity of the fluorescence
signal with time by comparing the signal at time t with the signal at time t   (the
product carries out this comparison) and averaging over all times (Fig. 3-4 c). During the
short lag times  the fluorophore has not moved out from the observation volume and
signal intensity would not change much, thus resulting in high value of the autocorrelation function. For the longer lag times  the fluorophore would move out from the
observation volume resulting in a significance change in the signal intensity and low
values for autocorrelation function which decay to zero at long lag times.
The auto-correlation function is characterized by the two major parameters: the
diffusion time  D and the height of the curve, G (0) (Fig. 3-4 d). The diffusion time  D
represents the average time the fluorophore spends in the observation volume and is
connected to the diffusion coefficient, D , of the fluorophore

 D   xy 2 4 D

(Eqn. 3)

where  xy is the waist of the observation volume. The heights of the auto-correlation
curve, G (0) , is proportional to the average number of particles in the observation

volume. If we set   0 in the equation 2 and assume the fluorescence intensity to be
proportional to the number of particles N in the observation volume, then we find
G (0) 

F 2
F

2



N 2
N

2



1
N

(Eqn. 4)

because the number of particles in the observation volume follows a Poisson distribution.
The fluctuations of the fluorescence intensity in the observation volume arise not
only due to the Brownian diffusion of fluorophores through the volume, but also due to
photophysical

fluctuations,

internal

dynamics,
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rotation

of

fluorophores

and

photobleaching which lead to the variation in excitation probabilities. Additionally,
fluctuations in the excitation power or detection geometry can result in an unwanted
change of the fluorescence intensity and thus lead to the distortion of the auto-correlation
curve. Therefore, additional controls should be used to account for these possible sources
of fluorescence fluctuations.
Once the correlation curve is obtained, it is fitted with a mathematical function
which models the fluorescence intensity fluctuations in the observation volume according
to the characteristics of the system under study (for example, 3D versus 2D diffusion). IN
the fitting function some of the fitting parameters are the concentration of particles and
their diffusion coefficient.

Fitting correlation functions
In order to extract meaningful information about the system under study the
experimental auto-correlation function needs to be fitted to the fitting correlation function
which is derived from the fundamental physical principles. In the case of the Brownian
diffusion of a fluorophore in a 3D space the fitting correlation function is defines as

1

G3 D ( )  1 
N  D





1



1 
2
 D S





1 2

(Eqn. 5)

where N is the average number of fluorescent particles in the observation volume,
N  C 3 2 0 S , C is the concentration of fluorophores and  xy is the waist radius of the

laser focus. The structural parameter S   z  xy measures the aspect ratio of observation
volume which is assumed to have Gaussian shape. Detailed derivation of the Equation 5
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can be found in references 1 and 3. However, it is important to point out that this
equation was derived using the diffusion equation describing free Brownian diffusion:
C (r , t )
 D 2C (r , t )
t

(Eqn. 6)

where C (r , t ) is the concentration of the fluorophores at various positions r inside the
observation volume at a time point t .
Additionally, equation 5 should take into account the photodynamic state of a
fluorophore while it is present in the observation volume, since the timescale of these
photodynamic changes is comparable to the diffusion time of a fluorophore. For example,
the diffusion time  D of the Alexa Fluor 488 is aqueous solution is 30±5 µsec, while the
triplet time is 4.7±1.9 µsec (mean±s.d., n=3, measured with the Confocor 2 instrument).
Therefore, accounting for the triplet-state population (T ) of the fluorophore is done by an
additional factor:



G3 D T  1  T (1  T ) 1 exp
  G3 D ( )
  T 


(Eqn. 7)

where  T is the lifetime of the triplet state of the fluorophore and T is the fraction of
fluorophores in the triplet state.
In case of FCS measurement in a lipid membrane, a fitting correlation function
that models the 2D motion of fluorescently labeled particles in the plane perpendicular to
the laser beam path is:
1

G2 D ( )  1 
N  D
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Aeff  C   D
1





1

(Eqn. 8)

where Aeff is the lipid membrane area found in the observation volume, C is the
concentration of the fluorophores (in molecules per unit area), and  D is calculated using
equation 3. In many examples of the FCS measurements of lipid and protein diffusion in
lipid membranes, the diffusion time  D is on the order of milliseconds and is at least two
orders of magnitude longer that the triplet time of the fluorophore. Therefore, those cases
the contribution of the triplet state of the fluorophore is not considered.
In case of the active transport of molecules though the observation volume with
velocity v the fitting auto-correlation function is defined as8, 63:
1
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(Eqn. 9)

FCCS and cross-correlation analysis

FCS is a powerful technique which allows determination of the diffusion
coefficients and concentrations of fluorophores. However, in many biochemical and
biological processes this information is insufficient, since the fluorescently labeled
molecules of interest undergo chemical reactions such as association (or binding). If the
two molecules of interest associate and have similar diffusion coefficient (i.e. similar
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molecular weight), then FCS would not be able to differentiate between the hetero-dimer
and the individual monomer molecules. To solve this problem FCCS was developed2.
In FCCS experiments the two molecules of interest are labeled with spectrally
different fluorophores and excited with overlapping laser beams (Fig.3-5). Example of
the FCCS-compatible pair of fluorophores, Alexa Fluor 488 and Atto 655, is shown in
Figure 3-2 and 3-3.
In the FCCS experiment the fluorescence fluctuations are detected in two
channels with signals Fg (t ) and Fr (t ) (Fig. 3-5b). If the labeled species interact, they

will diffuse as one particle through the observation volume, resulting in simultaneous
fluorescence signal in both channels and positive cross-correlation (Fig. 3-5c). The
spectral cross-correlation curve is obtained from the cross-correlation analysis of the
fluorescence fluctuations in the two channels:

Grg ( ) 

Fr (t )  Fg (t   )
Fg (t ) Fr (t )

(Eqn. 7)

The degree of binding or percentage of cross-correlation ( %CC ) can be calculated by
comparing the amplitude G (0) from the auto- and cross-correlation curves:
%CC 

C rg
C rg  C g



Grg (0)
Gr (0)

%CC 
and

C rg
C rg  C r



Grg (0)
G g (0)

(Eqn. 8)

Here C rg , C r and C g correspond to the concentrations of bound species rg , and the
unbound form r and g respectively.
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Figure 3-5. Principles of FCCS. a. FCCS setup for measurement in solution and in a

lipid membrane of a GUV. b. Fluorescence intensity traces for the red and green
channels. c. Examples for the auto-correlation curves for the red and green channels and
the cross-correlation between the two channels (blue line).
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FCCS is prone to artifacts and care must be taken to avoid them. The two main
artifacts in FCCS measurements are spectral cross-talk, which leads to false-positive
cross-correlation, and imperfect overlap between the detection volumes, which leads to
decreased cross-correlation11,

12, 29

. Spectral cross-talk can be corrected by using

alternative excitation or alternative pair of fluorophores, while the imperfect overlap
between the detection volumes is more difficult to correct. One of the approaches used to
account for imperfect overlap between the detection volumes uses measurement of the
maximum possible cross-correlation for the instrument (for examples, by using doublelabeled DNA) and then correcting all consecutive measurements for the value of this
maximum signal.

Two-focus scanning FCCS

Two-focus scanning FCS was developed specifically for the FCS
measurement in the lipid membranes of GUVs which tend to undergo multiple
undulations (spatial fluctuations) during the time of the measurement (Fig. 3-6).
Presence of membrane undulations introduces additional fluctuations in the fluorescence
intensity signal which can be incorrectly interpreted as the presence of slowly diffusing
molecules64. In addition to the possible contribution of membrane undulations to the
auto-correlation curve, photobleaching is another problem encountered in FCS in lipid
membranes. In a lipid membrane molecules diffuse slower than in solution and thus
require longer FCS measurement time which increases the probability of photobleaching.
Use of scanning FCS reduces photobleaching during the measurement without shortening
the measurement time.
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a.

b.

Figure 3-6. Confocal microscopy image of the cross-section of a GUV which a.

undergoes large membrane undulations due to loss of tension which occurred due to the
permeabilization of the GUV by Bax; b. tensed GUV which does not have significant
membrane undulations.
Before continuing the description of the formalism of the two-focus scanning FCS, it is
important to mention the two approaches of performing FCS experiments in GUVs. FCS
in GUVs can be done in two spatial positions: at the top or bottom of GUV20, 47, 61, or in
the membrane segment in the equatorial section of a GUV16, 18, 19, 55 which is used in the
two-focus scanning FCS (Fig. 3-7a). In two-focus scanning FCS, the observation volume
is scanned perpendicularly through the equatorial section of a GUV along two lines
separated by distance d in alternating fashion. Intersection of each scanning line with the
GUV membrane creates a detection area on the GUV surface. Scanning of the
observation volume is up to 1000 times faster than the diffusion time of a protein or lipid
molecule in the lipid membrane, thus allowing sampling of the fluorescent protein or
lipid many time before it leaves the observation volume. In addition, scanning of the
observation volume through the GUV membrane reduces the photobleaching in the
detection each membrane detection area by reducing the residency time of the laser beam
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Figure. 3-7. Principles of two-focus scanning FCS. a. Schematic of the position of a laser

beam with respect to GUV in two types of FCS measurements. b. Confocal image of an
equatorial cross section of a GUV. c-f. Schematic of data analysis in two-focus scanning
FCS. g. Normalized auto- and cross correlation curve for Bax-G in a lipid membrane
measured by two-focus scanning FCS.
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in the detection areas. Once the scanning is done, a map of change in the fluorescence
intensity with time for each of the two detection areas is constructed (Fig. 3-7c) and
further processed by software to eliminate the contribution of membrane undulations to
the fluorescence intensity trace (Fig. 3-7d). Next, the fluorescence intensity trace for each
detection area is auto-correlated and fitted to


1
G ( )  1 
N  D
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(Eqn. 9)

while the cross-correlation of the fluorescence intensity traces of the detection areas is
fitted to
1
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(Eqn. 10)

The cross-correlation curve fitted to this equation shows a maximum at a characteristic
lag time, which is the time it takes a fluorophore to move from one detection area to the
other. Once the distance between the two detection areas is known, diffusion coefficient
D and the structure parameter S can be determined directly by fitting to equation 10. A
global fit of the two auto-correlation functions (one for each detection area) and the
cross-correlation function improves the accuracy. Example of

the auto- and cross-

correlation curves obtained by the two-focus scanning FCS is shown in Figure 3-7g.
Due to the alternating data collection between the two foci the resulting crosscorrelation curve is shifted by the delay time t d . If this delay time is comparable to the
diffusion time  D of the fluorophores, then the shift needs to be taken into account.
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However, in our two-focus FCS experiments on Bax in GUV membranes the delay time
was much smaller than the diffusion time and thus was not taken into account.

Two-color two-focus scanning FCCS

Two-color two-focus scanning FCCS is used to study the formation of inmembrane complexes by molecules labeled with two spectrally different fluorophores
(similar to the discussed above FCCS in solution). Data analysis for this technique
includes calculation of the auto- and cross-correlation functions for each spectral channel.
In case of perfect overlap between the detection volumes for each spectral channel
and negligible cross-talk, the concentrations of the unbound molecules C r and C g and of
molecules in a complex C rg is calculated from the amplitudes of the correlation functions
in following way
G r ( 0) 

1

Aeff C r  C rg 

rg
Gcross
(0) 

,

G g ( 0) 

C rg

1

Aeff C g  C rg 

Aeff C r  C rg C g  C rg 

(Eqn. 11)

Fluorescence intensity distribution analysis

Fluorescence intensity distribution analysis (FIDA) is an extension on the FCS
technique3. While FCS analyzes the temporal characteristics of the fluorescence
fluctuations allowing determinations of the concentration and diffusion properties of the
fluorophores, FIDA analyzes the instantaneous values of the fluorescence intensity
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fluctuations, thus providing information about the distribution of the aggregation states of
the fluorophores (Fig. 3-8).
FIDA and FCS share similar experimental setup which is based on confocal
microscope (3-4). In this setup fluorophores diffusing thought the observation volume
and emit photons, a portion of which is transmitted though the optics of the microscope to
the APD. It is estimated that up to 105 photons per second can be detected by the APD
from a fluorophore passing through the observation volume. The observation volume in
FCS is approximated to have Gaussian shape, while in FIDA the shape of the observation
volume can not be described by Gaussian and is more complex due to interference caused
by diaphragms and aberrations. The observation volume in FIDA is described by the

Figure 3-8. FIDA and FCS use the same signal of the fluorescence intensity fluctuations.

FIDA utilizes the values for the instantaneous brightness of the fluctuations while FCS
utilizes the temporal distribution of the fluorescence fluctuations. On the figure n
represents the number of photon counts.
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three-dimensional spatial brightness function B(r ) , which is instrument specific and can
be calculated using a calibration measurement with a single dye of known brightness (for
example, Alexa Fluor 488 or rhodamine 6G).
Distribution of photon counts, P(n) , arising from the observation volume carries
information about the specific brightness and concentration of all fluorescent species
present in the volume and is calculated according to the Mandel formula3,
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which is

expressed as
i 5

P (n)   
V i 1





m 0

ci dV m
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mq B(r )T  exp(mq B(r )T
exp(c dV ) 
n

i

i

count

n!

i

count

)

(Eqn. 12 )

where ci is the concentration of species with specific brightness of qi , Tcount is the length
of the counting period, i is the summation index representing the number of fluorescent
species, m is summation index representing total number of molecules inside the
observation volume, n is summation index representing the number of photon counts.
Equation 12 is a double Poissonian first part of which represent the Poisson distribution
of the number of molecules within small portion of the observation volume, dV , while
the second part of the equation represent the Poisson distribution of the number of photon
counts detected from the molecules inside the observation volume. It is stated by Kask et
al that FIDA can differentiate up to five various fluorescent species in a single
experiment.
In FIDA two major assumptions are used: (i) the coordinates of the molecules do
not change significantly during the counting period Tcount which means that the counting
period should be shorter than the average time a fluorophore spends inside the
observation volume (i.e. Tcount   D ); and (ii) brightness of each molecule can be
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expressed as the product of a spatial brightness function B(r ) and specific brightness q ,
which is characteristic to each fluorescent species. Example of FIDA for monomeric
fluorescently labeled BaxΔC and for fluorescently labeled BaxΔC bound to liposomes is
shown in Figure 3-9. Furthermore, use of FIDA to determine the oligomeric state of Bax
in detergent micelles is discussed in Chapter 4.
a

b

Figure 3-9. Fl-BAXΔC(G40C) bound to liposomes: FCS and FIDA results. a. Results of

the FIDA fitting for monomeric free fl-BAXΔC(G40C) in solution (squares) and the flBAXΔC(G40C)-liposome mixture (circles). According to the single-component FIDA
fitting the molecular brightness of free fl-BAXΔC(G40C) monomers in solution was
5.4±0.1 kHz, while two-component FIDA fitting for fl-BAXΔC(G40C)-liposome mixture
produced the values for the molecular brightness of 5.4 kHz (fixed component) and
51.7±10.7 kHz which correspond to 9.57±1.99 fl-BAXΔC(G40C) molecules bound per
LUV. FIDA analysis was done based on at least six 100 seconds measurements. b.
Autocorrelation curves (not fitted) for free fl-BAXΔC(G40C) in solution (  D =91.3±4.3
µsec) (filled squares) and for fl-BAXΔC(G40C)-LUV mixture (  D1 =91.3 µsec,

 D 2 =1.12±0.2 msec) (empty circles).
The general idea for analysis of the photon counts have been proposed by Qian
and Elson66, 67 in 1990, while the formalism and experimental implementation of FIDA
has been presented by Kask et al3 in 1999. Currently a number of variation of FIDA have
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been developed and they include two-dimensional FIDA (2D-FIDA)68, fluorescence
intensity and lifetime analysis (FILDA)69, fluorescence intensity multiple distributions
analysis (FIMDA)70. In contrast to FIDA, 2D-FIDA uses two detectors to differentiate
between the various dyes, while FILDA and FIMDA perform simultaneous determination
of the fluorescence brightness (as done by FIDA) together with fluorescence lifetime or
diffusion time respectively.

Assay of liposome permeability

Assay of liposome permeability is used to study the kinetics of the pore formation
by Bax and other pore-forming proteins and peptides71. For this assay large unilamellar
liposomes (100-200 nm in diameter) containing high concentration of a fluorescent dye
are prepared (See Appendix II for a detailed protocol). As a fluorescent dyes in this assay
carboxyfluorescein or calcein are most commonly used16,

72

. These dyes are self-

quenched and thus do not fluoresce at 20-50 mM concentration and become fluorescent
when diluted to µM concentration.
In a generic liposome permeability assay unilamellar liposomes with encapsulated
dye have very low background fluorescence signal ( F (0) ) (Fig. 3-10). When the pore
forming agent is added (for example, activated Bax), the dye molecules are released from
liposomes, becomes diluted and the increase in the fluorescence signal ( F (t ) ) is detected.
Maximum dye release from liposomes ( Fmax ) is achieved by the addition of detergent
(for example, 0.1% w/v Triton X-100) which results in the solubilization of all liposomes
present in the assay. The curve representing the kinetics of dye release from liposomes is
calculated as
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R (t ) 

F (t )  F (0)
Fmax  F (0)

(Eqn. 13)

In many instances the curve of dye release is exponential and can be used to gain
quantitative information about the kinetics of the release73, 74 by fitting to equation
R (t )  F (0)  A1  (1  exp( t

 release ))  m  t

(Eqn. 14)

where, A1 is the size of exponential component,  release is the time constant of the
exponential component, m is the slope of the linear component of the release curve
which is occasionally present in release experiments due to the background leakage of
dye from liposomes. Saito et al used equation 14 to calculate the  release values for the
various concentrations of activated Bax and then used these values in a Hill plot analysis
to determine the stoichiometry of the initial pores formed by Bax73. This analysis showed
that Bax forms dimer and then tetramer pores. However, due to the small size of the
encapsulated dye (0.5 kDa) the formation of higher in stoichiometry Bax pores has not
been detected. However, later experiment with liposomes encapsulating larger dye
molecules (for example 10 and 70 kDa dextran labeled with carboxyfluorescein) have
shown that Bax can form pores large enough to release these dyes75, 76.
In addition to using self-quenching effect of carboxyfluorescein and calcein in
some applications it is advantageous to encapsulate into liposomes dyes together with a
quencher. Examples of such quencher-dye pair are Tb/DPA and ANTS/DPX76-78.
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Figure 3-10. Principles of the assay of liposome permeability.

The assay of liposome permeabilization has a number of advantages over other
techniques measuring the pore formation in lipid membranes (for example, the
electrophysiology methods).

These advantages include relative ease of sample

preparation (liposomes can be prepared in 30 min and then used within 1 week), fast data
acquisition and analysis, and the ability to measure multiple samples at in one experiment
by using 96-well format in a fluoremeter. However, the major disadvantage of the
technique is that it measures the permeabilization of a population of liposomes and thus
doe not allow characterization of individual pores.
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CHAPTER 4
“Protein Bax is a Monomer in Detergent Micelles”
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Abstract*
BAX is a pro-apoptotic member of the BCL-2 protein family. At the onset of apoptosis,
monomeric, cytoplasmic BAX is activated and translocates to the outer mitochondrial
membrane, where it forms an oligomeric pore. The chemical mechanism of BAX
activation is controversial and several in vitro and in vivo methods of its activation are
known. One of the most commonly used in vitro methods is activation with detergents,
such as n-octylglucoside. During BAX activation with n-octylglucoside, it has been
shown that BAX forms high molecular weight complexes which are larger than combined
molecular weight of BAX monomer and one detergent micelle. These large complexes
have been ascribed to the oligomerization of BAX prior to its membrane insertion and
pore formation. This is in contrast with the in vivo studies which suggest that active BAX
inserts into the outer mitochondrial membrane as a monomer and then undergoes
oligomerization. Here, to simultaneously determine the molecular weight and the number
of BAX proteins per BAX-detergent micelle during detergent activation we have used an
approach which combines two single-molecule sensitivity techniques – fluorescence
correlation spectroscopy (FCS) and fluorescence-intensity distribution analysis (FIDA).
We have tested a range of detergents: n-octylglucoside, dodecylmaltoside, Triton X-100,
Tween 20, CHAPS and cholic acid. With these detergents we observe that BAX is a
monomer before, during and after interaction with micelles. We conclude that detergent
activation of BAX is not congruent with oligomerization and that in physiologic buffer
conditions BAX can assume two stable monomeric conformations: one inactive and one
active.
* This research was originally published in Journal of Biological Chemistry Ivashyna, O., A.J. GarciaSaez, J. Ries, E.T. Christenson, P. Schwille, and P.H. Schlesinger. 2009. Detergent activated BAX protein
is a monomer. 284(36):23935-23946. © the American Society for Biochemistry and Molecular Biology.
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Introduction
BAX is a pro-apoptotic member of the BCL-2 protein family. In a simplified
apoptosis model, monomeric inactive BAX is localized in the cytoplasm of healthy nondying cells1. During apoptosis BAX is activated, and translocates to the OMM2 where it
inserts as a monomer3, undergoes oligomerization4 and forms a pore through which
cytochrome c and other apoptotic factors are released into the cytoplasm. Once in the
cytoplasm, these apoptotic factors induce the activation of the effector caspases which
execute the cell death process. This mechanism, which is generally correct, requires that
soluble BAX becomes integrated into the mitochondrial membrane where it forms a
functional oligomeric pore capable of cytochrome c release. However, the molecular
mechanism of BAX activation remains controversial5, 6.
It has been understood for some time, but frequently ignored, that activity of the
BCL-2 family proteins are exhibited in cells when these proteins are associated with the
hydrophobic environment of membranes. Therefore, it has always seemed that attention
to the effect of hydrophobic environments on the BCL-2 family proteins would be
rewarding. It has been shown that BAX can be directly activated by treatment with nonionic detergents such as n-octylglucoside, dodecylmaltoside, and Triton X-1001, 7. During
activation by non-ionic detergents, in order to gain the ability to form pores in a bilayer
membrane, BAX needs to undergo a major conformational transition from a globular
protein with two pore-forming alpha-helices 5 and 6 hidden in the protein core8 to a
conformation in which these two helices are exposed and inserted into a lipid membrane3,
5, 9

. The nature of this active conformation of BAX is important for the understanding of

the death decision in cells. Most proposals suggest that in a cell this activated form of
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BAX protein is initiated and maintained by the interactions with other proteins, such as
tBID, or by BAX itself as a homo-oligomer7, 10.
Non-ionic detergents have been commonly used to activate BAX for in vitro
studies because they are reliably effective and simple to employ. However, little is known
about the detailed molecular mechanism of BAX activation by these detergents and its
comparability with in vivo activation of BAX. What is known is that concentrations of
detergent above their critical micelle concentration (CMC) are necessary for BAX
activation. This suggests that, in order to be activated, BAX needs to interact with
detergent micelles instead of monomeric detergent molecules. For example, in the case of
BAX activation by n-octylglucoside, it has been shown that n-octylglucoside
concentration should be 1 % (w/v)7, which is well above the CMC for this detergent (0.6
% w/v)11. In addition, it has also been shown that above their individual CMC
concentrations most BAX activating detergents produce a change in BAX conformation
which can be detected by a conformation-sensitive 6A7 antibody against BAX1, 12, 13. In
cellular experiments this feature of BAX reactivity to 6A7 antibody is commonly
associated with the onset of apoptosis14,

15

. However, CHAPS does not generate the

antibody detected conformational change or the activation of BAX. The small micelle
size of this detergent (10 kDa) suggests that perhaps BAX can not adopt an activated
state with this detergent. However, cholic acid with even smaller micelle size (4 kDa) can
partially activate BAX1.
Many important detergent properties are associated with micelles. The formation
of detergent micelles in solution is concentration dependent beginning at the CMC. The
CMC value for a detergent has a practical importance since in most cases only monomers
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of detergent can be removed by dialysis, and therefore, it is easier to remove detergent
monomers for a detergent with high CMC value than for a detergent with low CMC11.
For BAX this same consideration applies to its activation with n-octylglucoside
(CMC~23 mM) as compared to its activation with Triton X-100 (CMC~0.25 mM). The
ease of dialysis is why, in most cases, OG is used to activate BAX in vitro.
It has been shown by analytical gel filtration that, when incubated with noctylglucoside, BAX creates complexes with molecular weight larger than the combined
size of a BAX monomer (21 kDa) and an n-octylglucoside micelle (~26 kDa)7, 11. It has
also been shown that in defined liposomes BAX pore formation requires
oligomerization16. These data combined with the knowledge that oligomerization is
important for the biological function of BAX led to a hypothesis that BAX oligomerizes
during its detergent activation prior to membrane insertion7. However, it has been shown
that in vivo activated BAX inserts into the OMM as a monomer3 and in order to create a
pore, BAX undergoes oligomerization in this membrane4. This discrepancy between the
oligomeric state of active BAX prior to its insertion into a lipid membrane in vivo
(monomer) and in vitro (possibly hexamer or octamer) led us to study the oligomerization
state of BAX in detergent micelles. The important issue is whether BAX activation
requires protein oligomerization or whether active BAX conformation can be generated
from a single protein monomer. To solve this issue we used two single-molecule
sensitivity techniques: fluorescence correlation spectroscopy (FCS)17 and fluorescenceintensity distribution analysis (FIDA)18. Combined use of FCS and FIDA allows
simultaneous determination of the apparent molecular weight and the number of
fluorescently labeled BAX monomers per protein-detergent micelle. Our results are
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consistent with previously established results in which BAX forms high molecular weight
protein-detergent micelles with n-octylglucoside4 and show that BAX is present as a
monomer in these complexes. In addition, we determined the apparent molecular weight
and the number of BAX proteins bound per protein-detergent micelles formed by BAX
and micelles of five additional detergents (dodecylmaltoside, Triton X-100, Tween 20,
cholic acid and CHAPS). Our data show that BAX is a monomer before, during and after
interaction with the micelles of all tested detergents.

Results
Detergent-activated fluorescently labeled BAX∆C can release cytochrome c from
isolated mitochondria.
For the FCS and FIDA experiments, we prepared recombinant, fluorescentlylabeled, human BAX∆C containing a fluorophore at a single cysteine residue (Fig. 1.A,
B). Human BAX∆C contains two indigenous cysteines (C62 and C126) which we
considered inappropriate for fluorophore conjugation due to structural and functional
reasons8. Previously full-length BAX with G40C, C62A and C126A mutations has been
reported to be functional in vivo3. Therefore, we removed cysteines, C62 and C126, by
mutation to alanine and added an additional cysteine residue in place of glycine 40
creating BAX∆C(G40C) (Fig. 4-1.A). BAX∆C(G40C) labeled with Bodipy FL
maleimide fluorophore became fluor-BAX∆C.
To check the biological activity of the fluor-BAX∆C protein, we studied its
ability to release cytochrome c using mitochondria isolated from HeLa cells (Fig. 4-1.C).
Our results show that fluor-BAX∆C activated with 2% (w/v) n-octylglucoside releases
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Figure 4-1. A. Schematic structure of human BAXΔC(G40C). Introduced mutations and
their relative position with respect to the helices and BH domains are indicated with
arrows. B. SDS-PAGE of purified recombinant proteins: Protein standards with
molecular weight indicated (lane 1), human BAXΔC(G40C) (lane 2), human BAXΔC
(lane 3), human fluor-BAXΔC (lane 4). C. Cytochrome c release from mitochondria
isolated from HeLa cells. Mitochondria isolated from HeLa cells were incubated for 20
min at 37 °C with 100 nM of the indicated recombinant protein. Where indicated, protein
was activated by incubation with 2% (w/v) n-octylglucoside for 1 hour at 4°C after which
protein/detergent mixture was diluted to obtain final detergent concentration of 0.5%
(w/v) and the 100 nM protein concentration used in the assays. Cytochrome c content of
each fraction was normalized for the basal release of cytochrome c in mitochondria
samples with only detergent added and in mitochondria samples without detergent or
protein added. Error-bars were calculated based on three independent experiments.

87

cytochrome c from isolated mitochondria similar to BAXΔC but with slightly lower
efficiency. For both proteins significant cytochrome c release required detergent
activation, suggesting that the detergent activation of fluor-BAXΔC was comparable to
the detergent activation of the BAXΔC7, 12, 19. In each cytochrome c release experiment
final concentration of n-octylglucoside was 0.005% (w/v) or lower, which is well below
the CMC for this detergent (0.6% w/v)11, so that detergent micelles played no role in the
release of cytochrome c or the maintenance of the active BAXΔC conformation during
the assay.

Surface plasmon resonance studies of membrane binding and integration by
BAX∆C and fluor-BAX∆C.
Direct analysis of the membrane binding and integration by detergent activated
fluor-BAXΔC was compared to that of BAXΔC using surface plasmon resonance (SPR)
as previously described20 (Fig. 4-2). SPR has been applied to the study of membrane
binding and integration of a number of pore forming proteins and peptides21, 22 including
BAX20. Using this technique it is not necessary to label or chemically modify the protein
under study. Therefore, we could use this method to determine the effect of the mutations
and the added fluorophore on fluor-BAXΔC membrane binding and integration by
comparison with the same properties of BAXΔC.
These SPR experiments were done using cardiolipin-containing liposomes
(DOPC:DOPA:cardiolipin 70:20:10 mol%) immobilized on the SPR-chip surface and the
protein of interest were injected over this surface. Both BAXΔC and fluor-BAXΔC
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required n-octylglucoside activation to generate significant interaction with liposomes
membrane (Fig. 4-2.A, B).
To determine the concentration-dependence of BAX integration into the liposome
membranes, we sequentially injected increasing concentrations of BAX over the same
liposome-covered surface and determined the amount of BAX integrated into the lipid
membrane based on sensorgram response after 300 seconds of washing. Our results show
that, when activated with n-octylglucoside, fluor-BAXΔC and BAXΔC have comparable
integration into the liposome membrane (Fig. 4-2.C). This similarity in membrane
integration suggests that the slight decrease in cytochrome c release by fluor-BAXΔC
(Fig. 4-1.C) is not the result of reduced membrane retention of the labeled protein, but
possibly a result of reduced stability of the in-membrane open pore conformation.
However, despite a possible reduction in the stability of fluor-BAXΔC pores, the
cytochrome c release experiments (Fig 4-1.C) together with the SPR binding data (Fig. 42) suggest that both BAXΔC and fluor-BAXΔC, when activated with n-octylglucoside,
follow a similar mechanism of membrane interaction and pore formation.

Analytical gel filtration of BAX∆C(G40C) with n-octylglucoside or CHAPS present.
To show that fluor-BAXΔC interacts with detergent micelles of n-octylglucoside and
CHAPS comparably to BAXΔC, we performed analytical gel filtration following a
procedure of Antonsson et al.7 We carried out our analytical gel filtration studies using
BAX∆C(G40C) incubated with either 2% (w/v) of n-octylglucoside or CHAPS (Fig. 43). The obtained results show that in the absence of detergents BAX∆C(G40C) eluted as
a monomer with molecular weight of slightly less than 25 kDa (Fig. 4-3.A), while in the
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presence of 2% (w/v) n-octylglucoside, protein eluted at a molecular weight slightly
below 440 kDa (Fig. 4-3.C). In contrast, when BAX∆C(G40C) was incubated with and
eluted in the presence of 2% (w/v) CHAPS in the column, protein eluted mostly (73%) as
a monomer in a broad peak (Fig. 4-3.B). These results are consistent with previously
reported analytical gel filtration of BAX∆C (7) and show that mutant BAX∆C(G40C)
interacts with micelles of n-octylglucoside and CHAPS similarly as BAX∆C.

Figure 4-2. Surface plasmon resonance data of fluor-BAXΔC and BAXΔC binding to
cardiolipin-containing liposomes (200 nm in diameter; DOPC:DOPA:CL 70:20:10
mol%). Increasing concentrations of protein activated with 2% (w/v) n-octylglucoside
was flowed over immobilized on surface liposomes A. Data for fluor-BAXΔC binding.
B. Data for BAXΔC binding. C. Results of concentration-dependence analysis of protein
integration into liposomes for BAXΔC (squares) and fluor-BAXΔC (triangles).
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Figure 4-3. Analytical gel filtration of BAXΔC(G40C) incubated with indicated
detergents. BAXΔC(G40C) was incubated with 2% (w/v) of indicated detergent for 1
hour at 4 °C. BAXΔC(G40C) incubated with detergent was passed through a Superdex200 column equilibrated with 10 mM HEPES/KOH, pH 7.0, 300 mM KCl buffer
containing 2% (w/v) of the same detergent in which BAX was incubated. The Superdex200 column was calibrated with two protein standards. A. BAXΔC(G40C) without
detergents. B. BAXΔC(G40C) + 2% (w/v) CHAPS. C. BAXΔC(G40C) + 2% (w/v) noctylglucoside. D. Standards (chymotrypsinogen, 25 kDa, and ferritin, 438.7 kDa).
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Activation of BAX with non-ionic detergents.
Compared to the amount of protein required for the analytical gel filtration
studies, the amount of fluor-BAXΔC required for the FCS and FIDA analyses is at least
100 times lower. Therefore, we decided to extend the range of the detergents used in our
study. We chose n-octylglucoside, CHAPS, Triton X-100, dodecylmaltoside and Tween
20 since these detergents have specific and known effects on BAX∆C activity7, 19. We
also chose cholic acid due to its similarity in structure to CHAPS, because it is a
physiologic detergent and because it can activate BAX1. In all cases the 2% (w/v)
concentration of the detergent was well above the CMC11.
Before proceeding to the FCS and FIDA studies, we first tested the ability of all
chosen detergents to activate BAXΔC using an assay of carboxyfluorescein release from
liposomes (Fig. 4.A)20. For these experiments we used recombinant human BAXΔC
purified from E. coli cells without detergent. This BAXΔC protein was monomeric (23 ±
4 kDa as determined by dynamic light scattering) and had very low (<10%)
carboxyfluorescein release activity. Upon 1 hour incubation at 4°C with selected nonioninc detergents (n-octylglucoside, dodecylmaltoside, Triton X-100 and Tween 20)
BAXΔC released carboxyfluorescein from liposomes (Fig. 4-4.A), indicating that protein
became activated. Incubation with cholic acid, an ionic detergent, also resulted in
activation of BAXΔC. However, upon similar 1 hour incubation at 4°C with CHAPS
(detergent known for its inability to activate BAX) no significant carboxyfluorescein
release was observed. Similar carboxyfluorescein release results were obtained for
BAXΔC(G40C) incubated with all six detergents (Fig. 4-4.B). Comparison of the
maximum carboxyfluorescein release values for both proteins after 90 min presents two
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instructive observations (Fig. 4-4.C). First, upon incubation with all detergents BAXΔC
has almost 20% higher carboxyfluorescein releasing activity than its mutant,
BAXΔC(G40C). Second, for both proteins incubation with Triton X-100 resulted in the
most activated form of BAX followed by n-octylglucoside, dodecylmaltoside, cholic acid
and Tween 20, while CHAPS failed to activated either of the two proteins.

CD spectroscopy on BAXΔC in detergent micelles.
Circular dichroism measurements were performed to determine whether any
significant secondary structure changes occur in BAXΔC during interaction with
detergent micelles. BAXΔC without detergent produced CD spectra with strong α-helical
pattern (Fig. 4-5). In the presence of micelles of Triton X-100, Tween 20 or cholic acid
no significant changes in the BAXΔC spectra were observed. However, in the presence of
micelles of n-octylglucoside or dodecylmaltoside slight increase in the alpha-helical
content of BAXΔC CD spectra was observed. The CD spectra of BAXΔC in the presence
of CHAPS were not collected because of high CD signal from CHAPS (due to presence
of amide bond in CHAPS structure).
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Figure 4-4. Release of carboxyfluorescein (CF) from liposomes by the detergent
activated BAXΔC and BAXΔC(G40C). A. Monomeric inactive BAXΔC was incubated
for 1 hour at 4°C with 2% (w/v) n-octylglucoside (OG), 0.6% (w/v) dodecylmaltoside
(DM), 0.076% (w/v) Triton X-100 (TX), 0.038% (w/v) Tween 20 (Tw), 2% (w/v)
CHAPS, or 2% (w/v) cholic acid (ChA). During this incubation the concentration of each
detergent was above the CMC while protein concentration was 70 µM. Before addition to
liposomes protein was diluted to 50 nM. Total lipid mass in each assay was 175 µg.
Liposomes composition was DOPC:DOPA 70:30 mol%. Final detergent concentration in
the release assays was below the CMC for each detergent. Releases were normalized to
carboxyfluorescein release by 20% Triton X-100 and corrected for basal
carboxyfluorescein release by each detergent. Each release curve represents an average of
at least three independent experiments. B. Release of carboxyfluorescein from liposomes
by detergent activated BAXΔC(G40C). Protein was treated the same way as BAXΔC in
panel A. C. Single point comparison of the carboxyfluorescein release values at 90
minutes for BAXΔC and BAXΔC(G40C) activated with indicated detergents.
Representative error bars are shown for each release curve.
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Figure 4-5. CD spectroscopy of BAXΔC in the presence of detergent micelles in 10 mM
HEPES, pH 7.0, 100 mM KCl. A. Comparison of the CD spectra for BAXΔC alone and
in the presence of either 0.08% Triton X-100 (TX), or 0.04% Tween 20 (Tw), or 2%
cholic acid (ChA). B. Comparison of the CD spectra for BAXΔC alone and in the
presence of either 2% n-octylglucoside (OG), or 0.6% dodecylmaltoside (DM).

FCS detection volume is not affected by the presence of detergents.
The maintenance of consistent detection volume is critical for accurate
comparison of FCS characteristics of different particles. Size and shape of the FCS
detection volume depend on a number of parameters, one of which is the refractive index
of solution23, 24. The latter can be affected by the presence of detergents leading to the
distortion of the FCS detection volume.
Commonly AlexaFluor 488 dye is used for calibration of the FCS detection
volume24,

25

. During this calibration procedure the diffusion time (  D ) of the dye

molecules and the structure parameter of the FCS detection volume (  ) are obtained by
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fitting the measured autocorrelation curve using Equation 1. Using such analysis for
AlexaFluor 488 diffusing freely in solution in the absence of detergent we get following
values:  D =22.7±0.9 µsec,  =5.5±0.8. To determine whether presence of detergent has
an effect on our FCS measurements we determined  D and  values for AlexaFluor 488
in solution containing increasing concentrations of n-octylglucoside detergent (Fig. 4-6).
The results of these experiments show that over the range of 0% to 5% (w/v) of noctylglucoside the diffusion time of the dye and the structure parameter of the detection
volume do not change indicating that the FCS detection volume is not affected by the
detergent presence. Similar experiments were done with the rest of the detergents and
they yielded analogous results (data not shown).

Figure 4-6. Effect of detergent on the shape and size of the FCS detection volume.
Measurement of the diffusion time (  D ) of Alexa Fluor 488 and the structure parameter
of the detection volume (  ) at various detergent concentrations. N-octylglucoside was
used as a detergent of choice, while buffer composition was 10 mM HEPES, pH 7.2, 100
mM KCl. Error bars were calculated based on nine 10 sec measurements. For some data
points error bars are smaller than the symbol.
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FCS characterization of fluor-BAX∆C in detergent micelles.
We used fluorescence correlation spectroscopy to confirm the detergent
dependent change in the apparent molecular weight of BAXΔC protein as seen by
analytical gel filtration. The diffusion characteristics of fluor-BAXΔC were studied in the
absence and in the presence of 2% (w/v) of selected detergents (Fig. 4-7, Table 4-1). The
FCS diffusion times were obtained by fitting the autocorrelation curves (Fig. 4-7) and are
shown in Table 1. Fluor-BAX∆C incubated with 2% (w/v) of either n-octylglucoside,
dodecylmaltoside, Triton X-100 or Tween 20 had a significant increase in diffusion time,

 D , compared with the diffusion time of fluor-BAX∆C monomer in the absence of
detergent. In contrast, the diffusion time of fluor-BAX∆C in the presence of 2% (w/v)
CHAPS or cholic acid did not increase significantly (Table 4-1).
Using Equation 6 and the diffusion time of the fluorescent particles we calculated
the apparent molecular weight (MW) of the BAXΔC-detergent micelle complexes for
each detergent (Table 4-1). The apparent MW of fluor-BAXΔC in the presence of noctylglucoside and CHAPS calculated from the FCS data are the same as the MW
obtained by analytical gel filtration of BAX in the presence of these detergents (Fig. 4-3).
The large MW complexes of BAX generated in the presence of n-octylglucoside,
dodecylmaltoside and Triton X-100 detergents were significantly larger than the sum of
BAX and micelle of the respective detergents.

97

Figure 4-7. Normalized FCS autocorrelation curves of fluor-BAXΔC incubated with
various detergents, as indicated (OG - n-octylglucoside, DM – dodecylmaltoside, TX-100
– Triton X-100). For each autocorrelation experiment protein was incubated in 10 mM
HEPES/KOH, pH 7.2, 100 mM KCl, with 2% (w/v) of indicated detergent at 4 °C for 1
hour. In each graph: normalized autocorrelation curve for fluor-BAXΔC in the absence
of detergent (dashed line), normalized autocorrelation curve for fluor-BAXΔC incubated
with 2% (w/v) of the indicated detergent (solid line), and normalized autocorrelation
curve for fluor-BAXΔC after detergent was diluted to the concentration below its CMC
(dotted line). Raw data for each autocorrelation curve are shown with thin jagged line.
See Table 1 for the numerical results of the analysis of these autocorrelation curves.

98

To determine the size of fluor-BAX∆C after interaction with detergent micelles
we removed micelles by diluting detergent concentration below CMC. In most cases this
resulted in dissociation of the protein-detergent micelles as well as of the detergent
micelles in solution. Each measurement of fluor-BAXΔC size after detergent dilution was
done at least one hour after dilution to allow dissociation of the detergent micelles bound
to the protein. In all cases the diffusion time of fluor-BAXΔC decreased significantly
upon detergent dilution (Table 4-1, Fig. 4-7). For all detergents, except Triton X-100, the
diffusion time decreased close to that of fluor-BAXΔC monomer. These observations
indicate that upon detergent dilution the molecular weight of the protein-detergent
micelle complexes is reduced, and for most of the detergents this molecular weight is
reduced to that of a fluor-BAXΔC monomer. In addition, it should be mentioned that noctylglucoside treated fluor-BAX∆C used in the FCS dilution experiments was used with
similar dilution as in the cytochrome c release experiments (Fig. 4-1.C).

Table 4-1. Results of the FCS studies with fluor-BAX∆C-detergent micelles.
The molecular weight of the fluor-BAX∆C-detergent micelles was calculated using Equation 6.

Detergent concentration 2%
(w/v)
Sample:
fluor-BAXΔC+

 D , µsec

no detergent
n-octylglucoside
Triton X-100
dodecylmaltoside
CHAPS
cholic acid
Tween 20

91 ± 4
223 ± 5
366 ± 8
262 ± 21
115 ± 4
124 ± 5
161 ± 12

Molecular
weight, kDa

280 ± 12
1236 ± 223
453 ± 31
38 ± 1
48 ± 1
105 ±2
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After detergent dilution
Detergent
concentration,
% (w/v)

 D , µsec

0
0.003
0.003
0.003
0.004
0.003
0.003

91 ± 4
100 ± 5
158 ± 4
90 ± 4
87 ± 3
86 ± 2
112 ± 3

Molecular
weight, kDa

25±1
99±2
18±1
17±1
17±1
35±1

Fluorescence intensity distribution analysis of fluor-BAX∆C in detergent micelles.
Analysis of the distribution of the photon counts in the FCS data sets was used to
determine the number of fluor-BAX∆C molecules per protein-detergent micelle formed
with micelles of all tested detergents. This analysis used the FIDA algorithm developed
by Kask et al.26 Using FIDA we determined fluorescence brightness of BAX molecules
before, during and after interaction with detergent micelles. Comparison of these
fluorescence brightness values shows that BAX is a monomer in all cases (Table 4-2).
However, in case of dodecylmaltoside and Triton X-100 the calculated values of
fluorescence brightness per protein-detergent micelle were 90% higher than the
fluorescence brightness of the fluor-BAXΔC monomer. It is possible that BAX is
dimerized in micelles of these detergents. Interestingly, in the presence of cholic acid or
Tween 20 protein fluorescence brightness decreased by 36% and 15% respectively, while
in the presence of the rest of the detergents protein fluorescence brightness increased or
stayed the same as in the absence of detergents. Therefore, since protein fluorescence
brightness was clearly affected by the detergent we studied this effect directly.
For three detergents where micelle size was significantly increased by the
addition of BAX (n-octylglucoside, dodecylmaltoside and Triton X-100) we varied the
degree of protein to detergent ratio while holding either detergent or protein
concentration constant. First, we varied the concentration of the fluor-BAXΔC from 25
µM to 3 µM while keeping detergent concentration constant at 2% (w/v). We reasoned
that, if fluor-BAXΔC forms oligomers in micelles, then decrease in protein concentration
while keeping detergent concentration constant would lead to a change, e.g. reduction, of
the oligomeric state of protein in detergent micelles. Such change in the oligomeric state
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of protein with increasing detergent concentration has been previously demonstrated for
some transmembrane peptides in detergent micelles27. In this case there was no
significant change in the fluorescence brightness of the fluor-BAXΔC-detergent micelles
(Table 4-2).

Table 4-2. Analysis of the fluorescence-intensity distribution of the fluor-BAX∆C
protein detergent-micelle complexes. Protein (at concentration indicated in the table)
was preincubated with detergent for 1 hour at 4 °C. Upon incubation with detergent, the
protein was diluted below 0.5 µM into a solution containing identical detergent
concentration as during activation. The measurements were done immediately upon this
dilution. Mean and standard deviations of the brightness values were calculated based on
9 measurements 50 seconds each.

Detergent concentration 2% (w/v)
Sample:
fluor-BAXΔC+
no detergent
n-octylglucoside
Triton X-100
dodecylmaltoside
CHAPS
cholic acid
Tween-20

Fluorescence
brightness for 25
µM BAX, kHz
7.4 ±0.2
10.5 ± 0.1
8.5 ± 0.1
5.9 ± 0.1
3.49 ± 0.06
4.70 ± 0.24

Fluorescence
brightness for 3
µM BAX, kHz
7.2 ±0.3
10.4 ± 0.1
10 ± 0.1
5.8 ± 0.1
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After detergent dilution
Detergent
concentration,
% (w/v)

Fluorescence
brightness,
kHz

0
0.003
0.003
0.003
0.004
0.003
0.003

5.5 ± 0.1
4.7 ± 0.2
7.1 ± 0.1
5.0 ± 0.1
5.6 ± 0.1
4.71 ± 0.09
5.41 ± 0.06

Second, we measured the effect of increasing detergent concentration on the
fluorescence brightness of fluor-BAXΔC at constant protein concentration. If protein
fluorescence brightness increases due to the presence of detergent, then the total
fluorescence intensity of the sample containing constant protein concentration will
increase with increasing detergent concentration. As shown in Fig. 4-8.A (empty circles),
for constant protein concentration in the presence of increasing n-octylglucoside
concentrations total fluorescence intensity increases. Furthermore, fluorescence
brightness per particle of protein-detergent micelles determined by single-component
fitting of resulting FCS auto-correlation curves also increased (Fig. 4-8.A. filled squares).
The ratio of the total fluorescence intensity to the fluorescence brightness per particle
(a.k.a. cpp) represents average number of particles in the FCS observation volume. As
expected, this number stayed constant for all n-octylglucoside concentrations clearly
showing that increase in n-octylglucoside concentration leads to increase in protein
fluorescence brightness. For n-octylglucoside the FCS and FIDA yield similar protein
fluorescence brightness values (Table 4-2, Fig. 4-8). Such an agreement between FCS
and FIDA results further shows that fluor-BAXΔC is present as a monomer in noctylglucoside micelles.
Analogous detergent titration experiments were performed for the rest of the
detergents giving the same result that protein fluorescence brightness of the fluorBAXΔC is changing with increasing concentration of detergent (Fig 4-8.C). In addition,
in the n-octylglucoside titration experiment gradual increase in the protein diffusion time
was observed together with increase in protein fluorescence brightness. This observation
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suggests that with increasing n-octylglucoside concentration protein-detergent micelles
grow in size (Fig 4-8.B).

Figure 4-8. Enhancement of the fluor-BAXΔC fluorescence intensity upon interaction
with detergents. A. Constant concentration (3 µM) of fluor-BAXΔC was incubated with
increasing concentrations of n-octylglucoside for 1 hour at 4 °C. The fluorescence
intensity of the protein samples incubated with detergent was measured using ConfoCor 3
(Zeiss, Germany). For each measurement the protein incubated with detergent was
diluted to a final concentration of 24 nM in EB buffer containing the same detergent
concentration as in the protein sample. All measurements were done at 22 °C. Counts per
particle (cpp) values were determined using single-component fit of the FCS
autocorrelation curves. B. Increase in the apparent molecular weight of BAXΔC upon
interaction with micelles of n-octylglucoside. MW values were calculated using Equation
6. C. Change in the cpp value of fluor-BAXΔC with increasing detergent concentration.
Samples were prepared and measurements were done similar to the Fig. 6.A. Detergent
abbreviations are similar to Fig. 5.
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For all tested detergents after micelle removal by dilution the fluorescence
brightness of the fluor-BAXΔC returned to that of a protein monomer. However, upon
removal of Triton X-100 protein fluorescence brightness decreased but was still 29%
higher than that for the protein monomer in the absence of the detergent. This result
suggests incomplete dissociation of the Triton X-100 molecules from BAX and is in
accordance with the FCS diffusion time which shows that upon Triton X-100 dilution
below CMC, the apparent MW of the fluor-BAXΔC was higher than that of a protein
monomer.

FCCS analysis of BAXΔC in detergent micelles.
To show the absence of BAX oligomerization in detergent micelles fluorescence
cross-correlation (FCCS) analysis was used. FCCS is a variation of the FCS which allows
determination of the degree of interaction between two fluorescent molecules or
macromolecular assemblies. In these experiments we used two types of fluorescently
labeled BAX: fluor-BAXΔC and Bodipy 630/650 maleimide-BAXΔC. The degree of
interaction between these two proteins in detergent micelles is proportional to the crosscorrelation value which is determined by FCCS analysis. The results of these FCCS
experiments show low cross-correlation values between two fluorescent forms of
BAXΔC compared to the theoretically predicted cross-correlation value of BAXΔC
dimer. These FCCS results suggest absence of interaction between the two fluorescent
variants of BAXΔC in detergent micelles of all tested detergents (Fig. 4-9).
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Figure 4-9. Results of the FCCS experiments with fluor-BAXΔC (50% labeled) and
Bodipy 630/650 maleimid-BAXΔC (80% labeled) in the presence of indicated
detergents: lane 1 - cross correlation standard (double-stranded RNA with Alexa Fluor
488, Cy5 labels); lane 2 - no detergent present; lane 3 - + 2% n-octylglucoside; lane; 4 - +
2% Triton X-100; lane 5 - + 2% CHAPS; lane 6 - + 2% Cholic acid; lane 7- + 2% Tween
20; lane 8 - + 2% dodecylmaltoside; lane 9 – maximum expected cross-correlation value
for a formation of protein dimer from a mix of 50 % and 80 % labeled protein.
Experiments were done in 10 mM HEPES, pH 7.2, 100 mM KCl buffer at 22 °C. All
detergent concentrations are given in % of w/v.

Discussion
Fluorescently labeled BAXΔC is active.
In order to apply FCS to the study of BAX we generated a soluble form of the
protein. We employed the BAXΔC in these solution studies of the protein activity and
oligomerization because we found that it remained in solution and could be activated by
detergent throughout all the manipulations that were used in these studies. In order to
label this protein with a fluorophore we substituted endogenous cysteines with alanine
(C62A, C126A) and converted glycine 40 in an unstructured region of BAX to a cysteine.
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The position of these changes in the BAXΔC protein are shown not to interfere with the
function of the full-length BAX in vivo3 and the resulting protein was well expressed by
bacteria. The added cysteine was exposed in the engineered protein and formed disulfide
cross linked BAXΔC(G40C) dimers at high concentrations (data not shown). After
substitution with the fluorescent probe the disulfide formation did not occur. Therefore,
further characterization of the activity of the engineered protein was performed on the
fluor-BAXΔC.
To assess the functional capability of fluor-BAXΔC we tested its ability to
promote cytochrome c release from isolated mitochondria as compared to that of
BAXΔC. Since our engineered BAXΔC was based upon the human protein we used
mitochondria isolated from HeLa cells to study cytochrome c release28. In these
experiments we observed that activated with n-octylglucoside fluor-BAXΔC releases
71±15 % of the mitochondrial cytochrome c while BAXΔC releases 100±30 % (Fig. 4-1).
Based on this result we conclude that mutation and fluorophore labeling of BAXΔC alter
pore forming activity of this protein but only in a minor way. In addition, to these
experiments we also studied the ability of various detergents to activate BAXΔC and its
mutant in liposomes (Fig. 4-4). Again we saw a reduction in pore activation by the
mutant protein. However, it is clear that the reduction is consistent across the range of
tested detergents (Fig 4-4.C). Finally, we compared the integration of BAXΔC and its
mutant into lipid membranes using SPR. We have recently developed methods to
quantitatively study binding and integration of BAX to membranes using SPR20. In those
studies protein integration into lipid membranes was critical for pore formation and only
occurred after protein incubation with n-octylglucoside. In the SPR comparison mutant of
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BAXΔC, BAXΔC(G40C), was fully functional and integrated into lipid membranes as
well as BAXΔC (Fig. 4-2). Taken together these studies indicate that BAXΔC(G40C) is
fully functional but its specific activity for pore formation is slightly lessened by the
introduced mutations, possibly due to lower oligomerization rate or changed pore
topology.
Fluor-BAXΔC forms high MW protein-detergent micelles with most activating
detergents. BAXΔC has been shown to form high molecular weight complexes with noctylglucoside but not with CHAPS7. To show that our mutated BAX, BAXΔC(G40C),
can form high molecular weight complexes with n-octylglucoside and not with CHAPS
we performed analytical gel filtration studies similar to those in reference 7. The results
of these analytical gel filtration experiments show that in the presence of 2% (w/v) of noctylglucoside BAXΔC(G40C) elutes at molecular weight slightly below 440 kDa , while
in the presence of 2% (w/v) CHAPS this protein elutes mostly as a monomer (73%).
These results are similar to the previously published results for BAXΔC (7) indicating
that mutations introduced into BAXΔC do not interfere with formation of high molecular
weight complexes of this protein with n-octylglucoside.
Next we proceeded to measure the molecular weight of fluor-BAXΔC in the
presence of n-octylglucoside and CHAPS using FCS. In the FCS experiments we
measured the diffusion time,  D , of fluor-BAXΔC molecules in the presence of 2% (w/v)
of these detergents. Then using Equation 6 we calculated the molecular weight of the
fluor-BAXΔC protein-detergent micelle complexes (Table 4-1). The molecular weight of
BAXΔC protein-detergent micelle complexes determined by FCS and analytical gel
filtration were fairly similar, further demonstrating that mutagenesis and fluorescent
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labeling of BAXΔC does not affect the interactions of this protein with n-octylglucoside
and CHAPS. This result also shows that FCS can be used to determine apparent
molecular weight BAXΔC with other detergents. Therefore, we extended the range of
detergents used in our study to dodecylmaltoside, Triton X-10, Tween 20 and cholic acid.
As a result of these FCS studies we determined that fluor-BAXΔC forms high molecular
weight complexes in the presence of activating non-ionic detergents (n-octylglucoside,
dodecylmaltoside, Triton X-100, Tween 20). However, in the presence of cholic acid,
activating ionic detergent, fluor-BAXΔC does not form high molecular weight
complexes. Fluor-BAXΔC also did not form high molecular weight complexes with
CHAPS, a zwitter-ionic detergent known for its inability to activate BAXΔC. In addition,
all of the tested activating detergents did not induce significant secondary structure
changes in the BAXΔC protein (Fig. 4-5).
For the studies of BAXΔC pore-formation in lipid membranes it is desirable that
detergent is removed after BAXΔC activation since detergent at concentrations above the
CMC can alter the integrity of lipid membranes. Therefore, it is important to know the
molecular weight of BAXΔC after interaction with detergent micelles. To determine the
latter, excess detergent was removed from fluor-BAXΔC by dilution below the CMC.
After removal of detergent micelles the molecular weight of fluor-BAXΔC decreased to
that of the fluor-BAXΔC monomer for the most of the detergents (Table 4-1). The results
for fluor-BAXΔC treated with Triton X-100 were an exception. Upon Triton X-100
dilution the molecular weight of fluor-BAXΔC was five times larger than that of fluorBAXΔC monomer. There are two possible explanations of this result. The first
explanation is based on incomplete dissociation of Triton-X-100 molecules bound to
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fluor-BAXΔC upon detergent dilution, while the second explanation is possible
formation of fluor-BAXΔC homo-oligomers. To differentiate between these two
explanations and to determine the stoichiometry of fluor-BAXΔC before, during and after
interactions with detergent micelles we performed FIDA.

BAXΔC is present as a monomer in protein-detergent micelles.
To further investigate the stoichiometry of the fluor-BAXΔC-detergent micelles
we performed FIDA on the FCS data (Table 4-2). The fluorescence brightness of the
individual protein-detergent micelles varied approximately 90% as a function of the
detergent used, but all of them contained one BAX protein molecule. The reason for such
variation of the fluorescence brightness of the protein monomer in various detergents was
due to the enhancement or quenching of the Bodipy FL fluorophore brightness upon
transfer into hydrophobic environment of a detergent micelle. Similar effect of the
fluorophore brightness enhancement were reported previously for the fluorescentlylabeled diphtheria toxin T-domain interacting with detergent micelles29. In our case there
appears to be an enhancement of the fluorescence brightness of fluor-BAXΔC in the
presence of n-octylglucoside, dodecylmaltoside, Triton X-100 detergents and decrease in
protein fluorescence brightness in the presence of cholic acid and Tween 20. Studies of
detergent titration into constant protein concentration show that this effect is due to the
enhancement of the fluorophore brightness and not due to protein oligomerization (Fig.
4-8). In addition, detergent dilution studies show that upon detergent dilution, which
leads to the dissolution of the fluor-BAXΔC-detergent micelles, the fluorophore
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brightness of the protein returns to that of the protein monomer prior to the interaction
with detergent micelles (Table 4-2).
The FIDA results mean clearly that before, during, and after interaction with
detergent micelles the fluor-BAXΔC protein is a monomer. This observation suggests
that BAXΔC interaction with micelles is fundamentally different from the interaction
which it establishes in bilayer membranes. In a bilayer membrane BAXΔC assumes
conformation which allows assembly of homo-oligomers resulting in pore formation. In
contrast, in a detergent micelle BAXΔC assumes conformation which in case of nonionic detergents leads to a dramatic enlargement of resulting protein-detergent micelle
without necessary protein homo-oligomerization (Table 4-1, Fig. 4-3). Since this increase
in size can no longer be attributed to additional BAX molecules per micelle, it must be
due to the incorporation of additional detergent.
To study the interaction of the fluor-BAXΔC with detergent micelles we used
detergents at 2% (w/v) concentration which is well above the CMC for all tested
detergents. If expressed in molar units, this detergent concentration will be on the order
of mM for all tested detergents (n-octylglucoside – 68 mM, Triton X-100 – 32 mM,
CHAPS – 33 mM; dodecylmaltoside – 40 mM). In contrast, in all of the experiments the
concentration of fluor-BAXΔC during incubation with detergent was 20-30 µM. Solution
containing 20-30 µM protein and >30 mM detergent has an excess of detergent micelles
over the number of protein molecules. Fleming et al. have shown that an excess of
detergent micelles moves the protein to a more dissociated state27. Fleming et al. also
show that for a glycophorin A transmembrane α-helix, 40% of dimers of this α-helix are
detected for a 40 times lower mole ratio of protein to detergent than was used in our
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experiments. This demonstrates that if fluor-BAXΔC is forming oligomers in detergent
micelles, then we would not have been prevented from detecting them. The above
outlined argument together with the FCCS results (Fig. 4-9) lead us to a conclusion that
fluor-BAXΔC is present as a monomer in detergent micelles.
The outcome of this conclusion is that during and after detergent activation
BAXΔC is a monomer. Therefore this protein has two stable monomeric conformations
in physiological buffer conditions: one inactive and one active. Second this implies that
the detergent-activated species of BAX is a monomeric protein and the large molecular
weight in the presence of the micelles of non-ionic detergents is a result of the detergent
component of the complex.

Consequences for the physiological activation of BAX.
These studies suggest that detergent activation of BAX is not merely a mimicry of
the physiologic BAX activation. The characteristics of the detergent activation indicate
two intriguing characteristics which may concern in vivo activation of BAX. First, since
BAX remains active after we effectively remove the detergent substrate upon which it
has activated, there must be two stable conformations of monomeric solution BAX, one
active and the other inactive. Since this activation requires a large template and is distinct
from the oligomer-competent conformation which BAX assumes in membranes, we can
consider the possibility that BAX is activated as a soluble protein and then integrates into
the membrane. Second, the existence of a soluble active form of BAX suggests that this
process can be reversed which is a potential therapeutic approach.
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Conclusion
In this work we studied in detail the process of BAXΔC activation by non-ioninc
detergents. Based on the results of our study we conclude that BAXΔC is a monomer
before, during and after interaction with detergent micelles. In this study we used
fluorescently labeled analogue of BAXΔC in combination with two single-molecule
sensitivity techniques (FCS and FIDA). Since the determination of the oligomeric state of
proteins in detergent micelles is important for structural and functional studies of integral
membrane proteins30, 31, we are hopeful that the method presented here can be used for
other proteins.

Experimentals
All chemicals used in this paper were from Sigma-Aldrich, St. Louis, USA, unless
otherwise stated. All lipids were obtained from Avanti Polar Lipids, USA. Fluorescent
dyes for protein labeling were purchased from Molecular Probes, USA.

Protein constructs, protein purification and protein labeling.
The cDNA for human BAX with 19 amino acid truncation on the C-terminus (BAXΔC)
was fused to the C-terminal intein/chitin-binding domain of pTYB1 vector (New England
BioLabs, USA)8. Three mutations (G40C, C62A, C126A) were introduced into each of
the DNA plasmids using a QuikChange mutagenesis kit (Stratagene) and presence of
mutations was confirmed by sequencing. Resulting construct and purified protein was
dubbed as BAXΔC(G40C). All proteins (human BAXΔC and human BAXΔC(G40C))
were purified from BL21(DE3) E. coli cells without detergent. Briefly, bacterial cultures
were grown at 37 °C in Terrific Broth32 to an OD600 of 1.5-2.0, then the cultures were
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induced with 0.1 mM IPTG (RPI, Illinois, USA) and the temperature was dropped to 25
°C. After 12-15 hours, bacteria were collected via centrifugation, the resulting pellet
resuspended in lysis buffer (PBS, pH 7.2, 1mM EDTA, 0.25 mM PMSF), and cells
broken by four passages through a Microfluidizer (Microfluidics, USA) at 1000 bar.
Lysate was clarified by centrifugation and the supernatant containing BAX incubated
with chitin affinity resin (New England BioLabs, USA) overnight at 4°C on a rocker.
Resin was subjected to a high salt wash then equilibrated in cleavage buffer (10 mM
HEPES/NaOH, pH 8.0, 100 mM NaCl, 50 mM DTT) and incubated for 48 hours at 4ºC.
The purity of the proteins were assessed by SDS-PAGE. BAXΔC(G40C) was labeled
with Bodipy FL c5-maleimide (Molecular Probes, USA) according to the manufacturer’s
protocol. Labeled protein was separated from the free dye using a Sephadex G-25
column. The degree of protein labeling was determined using a NanoDrop
spectrophotometer (Thermo Scientific) by measuring absorbance at 280 nm (for protein
concentration) and 504 nm (for Bodipy FL concentration). Resulting protein was ~ 80 %
labeled and was stored in EB buffer (10 mM HEPES/KOH, pH 7.2, 100 mM KCl) at 4ºC.

Incubation of BAX with detergent micelles.
Prior to FCS studies, cytochrome c and carboxyfluorescein release experiments,
fluorescently labeled BAXΔC(G40C) or BAXΔC (20-30 µM) were incubated with 2%
(w/v) of indicated detergent in EB buffer for 1 hour at 4 °C. For FCS studies of the fluorBAX∆C in detergent micelles, after incubation with detergent, protein was diluted to a
concentration below 0.5 µM in a solution containing the same detergent concentration as
the activated protein. This dilution was done to insure that the fluorescent signal emitted
by the protein sample is within the dynamic range of the detector in the ConFocor 3
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(Zeiss, Germany). To remove detergent micelles for the cytochrome c release and for the
FCS studies of post-micelle-activated fluor-BAX∆C, the BAX-detergent mixture was
diluted below the CMC of each particular detergent. The disappearance of micelles
occurred at different rates (< 1 minute for OG and longer but <60 minutes for TX-100)
but was allowed to finish before further studies on the sample (cytochrome c release or
FCS) proceeded.

Cytochrome c release assay.
Mitochondria from HeLa cells were isolated using previously published procedure33.
Isolated mitochondria were resuspended in 10 mM HEPES/KOH, pH 7.4, 100 mM KCl,
1 mM EGTA, 200 mM sucrose. For the cytochrome c release assay isolated mitochondria
were incubated with 100 nM of protein that was detergent activated but micelle diluted as
described in the preceding section or inactive protein at 37 °C for 20 min. After the
incubation with BAX protein or detergent control solutions, mitochondria were spun
down at 10,000 g for 10 min at 4 °C, then pellet and supernatant fractions were collected
and stored at -20 °C. For the cytochrome c release assay we used 0.5 µg of mitochondria
in 30 µl volume. Protein concentration in the preparation of isolated mitochondria was
determined by Bio-Rad Protein Assay (Bio-Rad Laboratories, USA). Cytochrome c
content in the pellet and supernatant fractions was determined using TiterZyme EAI
human cytochrome c Enzyme Immunimetric Assay Kit (Assay Designs, USA) in
combination with Synergy HT plate reader (Bio-Tek Instruments, Inc., USA).
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Surface plasmon resonance studies of BAX binding to liposomes.
These studies were done using Biacore X instrument (Biacore Division of GE Healthcare,
Sweden) at ambient temperature of 25 °C. Liposome with lipid composition of
DOPC:DOPA: bovine heart cardiolipin (70:20:10 mol %) were prepared using the
reverse-phase evaporation method34 following procedure described in detail in20. The
buffer was EB unless otherwise noted. The rest of the experimental conditions,
experimental protocol and data analysis were the same as described in (20).

Analytical gel filtration.
Analytical gel filtration experiments were performed on a Superdex 200 HR 10/30
column (GE Healthcare, UK) equilibrated with 20mM Hepes/KOH pH 7.5, 300mM KCl,
0.2mM dithiothreitol. In the corresponding samples, 2% (w/v) of the indicated detergent
was included in the equilibration buffer. Prior to loading the sample on the column 2.5
nmol of BAX∆C(G40C) were incubated in 2% (w/v) of the corresponding detergent for
1h at 4° C. Then, samples were loaded into the column and run at 0.5 ml/min.
BAX∆C(G40C) elution was detected by light absorption at 280 nm.

Carboxyfluorescein release assay.
Liposomes containing 50 mM carboxyfluorescein (CF) were prepared following
procedure described in (20). Incubation with detergents protein was diluted into wells in a
black bottom 96 well-plate (NUNC, Denmark) using EB buffer. Liposomes (200 nm in
diameter, DOPC:DOPA 70:30 mol%) were added to the wells last. Immediately upon
addition of liposomes measurement of CF fluorescence was done using Synergy HT plate
reader (Bio-Tek Instruments, Inc., USA). CF releases for all protein samples containing
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detergent were corrected for the baseline CF release in the presence of detergents without
protein. Data were analyzed in Origin 6.1 (OriginLab Corp. USA).

Circular dichroism spectroscopy.
Samples for circular dichroism (CD) spectroscopy were prepared at 5 µM protein
concentration in 10 mM potassium phosphate buffer, pH 7.0. Detergents (noctylglucoside (2% w/v), dodecylmaltoside (0.6% w/v), Triton X-100 (0.08%), Tween 20
(0.04% w/v), cholic acid (2% w/v)) were added to protein samples 1 hour prior to
measurements and stored at 4 °C. Samples were measured at 20 °C on Jasco J-715
spectrapolarimeter using a 1 mm path-length cell. Data were collected every 0.1 nm at 50
nm/min scan speed from 260 to 200 nm, and results were averaged from five scans. Due
to high CD signal from Triton X-100 at 200 nm for samples containing this detergent
data were collected from 240 to 205 nm. Spectra for all protein samples containing
detergent were corrected for the baseline of detergents in the absence of protein.

FCS, FCCS and FIDA analyses: instrumentation and measurements.
LSM 510 ConfoCor 3 system coupled with Zeiss Axiovert 200M inverted microscope
(Zeiss, Germany) was used for FCS and FIDA experiments. A water immersion CApochromat 40x objective (Zeiss, Germany) focused the excitation light to a diffractionlimited spot. The pinhole size was set to 70 µm for 488 nm excitation laser light. The
excitation light of a 25 mW 488 nm Argon laser was set at 1% of the acusto-optical
tunable transmission. Laser power in the sample was 7 µW. In front of the detector LP
530 nm filter was used. For the FCS and FIDA analyses each sample was measured at
least nine times for 50 seconds. The detection volume was previously calibrated with free
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Bodipy FL maleimide in solution (diffusion time 22.6 ± 0.5 µsec, structure parameter 5.0
± 0.4).

FCS analysis.
FCS measurements provide three characteristic parameters for interpretation:  D - the
diffusion time of a fluorescent particle (i.e. the average time a particle spends in the
detection volume), N - the number of fluorescent particles in the detection volume, and
the counts per particle (cpp) or the average fluorescent intensity per particle. These
parameters are extracted by performing a fit of FCS auto-correlation data to one
component diffusion model which takes into account photophysical dynamics of
fluorophores


1  T exp( /  T )  
G( )   1 
  1 
1T
N 
  D






1

1
1    2 D

(Eq.1)

In this formula G ( ) is auto-correlation function, τ is the lag time, T is the fraction of
molecules in the triplet state,  T triplet decay time,  is the structure parameter (aspect
ratio) of the Gaussian detection volume. Fitting of the FCS auto-correlation curves was
done using Equation 1 with software written in MATLAB (Mathworks, NA) using a
weighted non-linear least squares fitting algorithm.
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Calculation of protein-detergent micelle molecular weight based on FCS diffusion
time.
For a particle in solution the diffusion time is inversely proportional to the diffusion
coefficient

2

D 

4D

(Eq. 2)

In general protein molecules diffusing in solution are assumed to approximate a
spherical shape permitting the Einstein-Stokes relationship to be used in evaluating the
diffusion constant
D

k BT
6R

(Eq. 3)

where, k B is the Boltzmann constant, T is temperature in degrees Kelvin,  is viscosity
of solution in which particle is diffusing, and R is the radius of the spherical particle. The
radius of diffusing particle depends on the molecular weight of the particle
( R  MW 

1/ 3

). Under these conditions a relationship can be established between the

FCS diffusion time of a particle and its molecular weight
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(Eq. 5)

In case of BAXΔC, we know diffusion time of a BAXΔC monomer,
molecular weight,

 D,monomer

, and its

MWmonomer = 19 kDa. We also know the diffusion time of BAXΔC
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protein-detergent micelle,

 D,oligomer

. Using Equation 5 we can determine the apparent

molecular weight of the BAXΔC protein-detergent micelle

MWoligomer

  D ,oligomer
 MWmonomer 
  D ,monomer






3

(Eq. 6)

FCCS analysis. Fluorescence cross-correlation spectroscopy (FCCS) employing BAX
labeled with dyes having non-overlaping fluorescence spectra and two channel collection
of data, was used to determine the presence or absence of BAX homo-oligomers in
detergent micelles (23,24). Using Bodipy FL maleimide-BAXΔC and Bodipy 630/650
maleimid-BAXΔC we studied cross-correlation in micelle associated protein. The crosscorrelation value, a ratio of the number of the fluorescent complexes containing both
proteins of interest to the number of the fluorescent species of one of the proteins, was
used to estimate the micelles with more than one BAX molecule. As a positive control
and as a calibration sample the 21 base pair long double-stranded RNA labeled with
Alexa Fluor 488 and Cy5 on each 3'-end was used35.

Fluorescence intensity distribution analysis, FIDA.
Analysis of the fluorescence brightness of a particle can provide an additional measure of
the number of fluorescent proteins associated with a detergent micelle. The particle
fluorescence brightness determined by FIDA is extracted by fitting the distribution of the
number of photon counts and is similar to the cpp value determined by FCS for a
monodisperse fluorophore solution. Determination of the particle brightness of the BAXdetergent micelle and comparison with particle brightness of monomeric BAX molecules
estimates the number of BAX molecules in detergent micelles. FIDA was performed
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according to Kask et al.18. The raw data of photon arrival times was binned to 20 µs and
photon counting histograms were constructed. Parameters describing the detection
volume were determined in a solution of fluor-BAXΔC in absence of detergent. As
indicated, histograms were fitted to model functions for one or two components,
described in Kask et al.18 subtracting a background of 310 Hz for the buffer solution.
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CHAPTER 5
“Effect of Bax onto the Morphology of GUVs: Imaging Study”
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Abstract
This Chapter provides an overview of the various effects of Bax onto GUV
morphology, permeabilization and collapse as studied by the confocal microscopy with
the use of fluorescently labeled Bax. In addition, to establishing the effects of Bax
binding and pore formation in GUVs, the confocal microscopy experiments described in
this chapter establish a time frame for the FCCS measurements on Bax presented in
Chapter 7. Furthermore, using the confocal microscopy we compare the ability of Bax to
transform the morphology of GUVs to the similar ability of detergents, thus establishing
that Bax has a detergent-like effect onto the morphology of GUVs. In this chapter, we
also show that the fluorescently labeled full-length Bax used in this and the following two
chapters is functional.
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Introduction
Upon binding and pore formation, Bax changes the physical properties of lipid
membranes such as line tension and surface tension1-3, which in place would lead to
changes in the morphology of lipid bilayers. Therefore, before proceeding to the FCCS
studies of Bax diffusion and self-assembly in GUV membranes we used confocal
microscopy to characterize the morphological changes in GUVs upon, during and after
Bax binding and pore formation. These confocal microscopy studies allow us to establish
the time frame for the FCCS experiments which is defined by the span of time during
which there is sufficient amount of the fluorescently labeled Bax in a GUV membrane
and the GUV is not deformed. As a result of these studies, we determined the optimal
concentration of Bax for the FCCS experiments and the time frame for the FCCS
experiments. We also have found that the ability of Bax to transform the morphology of
GUVs is similar to that of detergent n-octylglucoside suggesting that Bax and noctylglucoside disrupt lipid bilayer coupling in a similar fashion.
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Results and Discussion
Fluorescently labelled Bax is active
FCCS is a fluorescence-correlation technique with the sensitivity to detect the codiffusion of single molecules which need to be labeled with distinct fluorophores4. For
our FCCS and imaging experiments human full-length Bax with a single cysteine residue
engineered at position 4 and the two endogenous cysteines, C62 and C126, mutated to
serine and alanine respectively was produced in E. coli without use of detergent as
described in Appendix V. This protein was labeled with Alexa Fluor 488 dye (Bax-G) or
with Atto 655 dye (Bax-R). The activity of both fluorescently labeled proteins was
checked using assay of carboxyfluorescein release from liposomes5, 6 (also described in
Chapter 3). In this assay cBid was used to activate the pore formation by Bax. However,
without the addition of cBid, Bax produced a slow release of carboxyfluorescein from
liposomes (Fig 5-1). Interestingly, addition of Bcl-xL, an inhibitor of Bax pore formation,
inhibited only the cBid activation of Bax but not the auto-activation of Bax7 (Fig. 5-1b).
However, the auto-activation of Bax was inhibited by Bcl-xL when both proteins were
added simultaneously to liposomes.
Another check of the ability of the fluorescently labelled Bax to form pores was
done using GUVs (Fig. 5-2). In these experiments Bax-R (25 nM), Bax-G (25 nM), cBid
(4 nM) and free dye Alexa 546 (1 µM) were added to the GUVs and the time series of
images were taken to follow the GUV permeabilization. As a result Bax bound and
permeabilized GUVs (Fig 5-2). Bax binding to the GUVs can be seen from the timedependent increase in the fluorescence in the GUV membranes while permeabilization of
GUVs can be seen from the filling of GUV lumen with free dye and with Bax (Fig. 5-2).
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Figure 5-1. Assay of liposomes permeabilization by Bax. a. Kinetics of the
carboxyfluorescein release from the liposomes. Each release curve is normalized and
represents an average of three independent measurements. b. End point measurement of
the % release 60 minutes after addition of indicated proteins to liposomes filled with
carboxyfluorescein.

However, GUVs presented on Fig. 5-2 were not permeabilized simultaneously reflecting
the stochastic nature of the Bax pore formation. Nevertheless, all the GUVs in the well
were permeabilized by 45 min after addition of proteins to GUVs. Without activator
protein, cBid, fluorescently labeled Bax did bind to GUVs but much weaker than in the
presence of cBid (Fig. 5-3h). This result of low Bax-R and Bax-G binding to GUVs is
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consistent with an observation of slow release of carboxyfluorescein from liposomes (Fig
5-1) suggesting that the fluorescently labeled Bax has some intrinsic activity7.
We have also tested the effect of Bcl-xL on Bax binding and permeabilization of
GUVs (Fig. 5-3). In these experiments as expected Bcl-xL prevented pore formation by
Bax without inhibiting the ability of Bax to bind GUV membranes (Fig. 5-3f). However,
when liposomes were initially preincubated with Bcl-xL and cBid for one hour and then
Bax was added no Bax binding to GUVs was observed, suggesting that Bcl-xL when
present in a lipid membrane inhibits Bax binding to the membrane8. Taken together, these
results show that both fluorescently labelled Bax proteins can bind lipid membranes and
form pores in liposomes and thus behave similarly to the wild-type full length Bax.

Figure 5-2. GUV permeabilization by Bax-R and Bax-G activated with cBid. Alexa 546
was used as a small soluble 0.5 kDa dye to follow the GUV permeabilization. Time
stamps indicate time after protein addition to GUVs. Scale bar is 20 µm.
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Figure 5-3. f. Bax binding to GUVs in the presence of Bcl-xL (50 nM) and cBid (4 nM).
Bax-R and Bax-G total concentration is 50 nM. g. Bax does not bind GUVs preincubated
for 60 minutes with 50 nM Bcl-xL and 4 nM cBid. h. Bax-R and Bax-G binding to GUVs
in the absence of the activator cBid protein. In all images scale bar is 20 µm.

Bax changes morphology of GUVs
The ability of Bax to from pores in GUVs has been reported previously but not
with the fluorescent protein or with the intent to characterize the evolution of membrane
morphology upon prolonged interaction with Bax protein9,

10

. Here, we used confocal

microscopy to establish the effect of the fluorescently labeled Bax on GUVs and to
establish the time window for the FCCS measurements. We determined that incubation
with 50 nM Bax and 4 nM cBid allowed us to simultaneously observe the accumulation
of fluorescent Bax in the GUV membrane and permeabilization of this membrane (Fig. 52) and that the GUVs were stable for 7 to 8 hours allowing FCCS measurements.
However, after 24 hours this preparation became a mass of collapsed GUV remnants
reflecting the multiple effects of Bax on membrane structure.

After one hour of

incubation with this Bax concentration, 100 % of GUVs were permeabilized and had
homogeneous distribution of labelled Bax on the bilayer membrane. At the same time, in
these experiments, Bax did not bind to all GUVs equally producing variation in the
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fluorescence of Bax in GUV membranes representing a variation of Bax concentration in
these membranes (Fig. 5-5). We hypothesize that this heterogeneity of Bax binding to
GUVs results from the variation in cardiolipin content of the GUVs which is known to
affect the Bax and cBid binding11, 12 (See next section for discussion). After 3-4 hours of
incubation with Bax and cBid the heterogeneity of Bax binding to GUVs was no longer
visible suggesting Bax saturation in the lipid membrane of GUVs (Fig. 5-5a). Prolonged
incubation of GUVs with these concentrations of Bax and cBid leads to major
morphology changes in the GUVs (Fig. 5-3a-d). GUVs change their shape from spherical
to potato-like and tubule-like shape reflecting the Bax induced changes in the elastic
coupling to lipid bilayer forces in membranes. Additionally, we observed formation of
gigantic Bax mega-pores (See Chapter 6) and other large visible Bax aggregates in GUV
membranes (Fig. 5-4b). During incubation with Bax occasional GUVs rupture onto
smaller liposomes (Fig. 5-4e) and by the 24 hours of incubation with Bax almost no
GUVs are left in the observation chamber. This clearly defined the time period when
these GUVs could be studied by FCCS. The Bax binding to GUVs and consequent
deformation and rupture of GUVs is dependent upon the Bax concentrations
demonstrating that mass action and thermodynamics governs this process. Although all of
the GUVs were permeabilized by one hour, the membrane density of Bax particles was
not sufficient for the FCCS measurements until 30 to 40 minutes, and, therefore, the early
pore formation was not accessible to these studies.
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Figure 5-4. Bax binding to GUVs: confocal microscopy images. a. ….b. Aggregates of
Bax in GUV membranes. c. Agglomeration of GUVs after four hours of incubation with
Bax. d. Formation of tubule-like lipid membrane structures after 7-8 hours of incubation
with Bax. e. Rupture and collapse of GUVs upon Bax addition. Time steps represent the
time after Bax addition. In all images scale bar is 20 µm.

Heterogeneity of Bax binding to GUVs
For all the experiments presented in Chapters 5, 6 and 7 of this dissertation, the
lipid composition of GUV was DOPC:bovine heart cardiolipin (80:20 mol%). Assuming
homogeneous distribution of lipids among GUVs during electroformation we expected
homogeneous Bax binding to GUVs. However, we observed wide variation in the amount
of Bax binding to GUVs electroformed from the same lipid mixture (Fig. 5-5a). We
hypothesize that the heterogeneity of Bax binding to GUVs is based on the heterogeneity
of lipid distribution among GUVs during the electroformation (See Appendix IV for the
detailed description of the method). In particular, we hypothesize that the heterogeneity
comes from un-equal distribution of cardiolipin among the GUVs. Cardiolipin is known
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for its ability to promote non-lamellar lipid bilayer formation (i.e. lipid bilayers with high
curvature) and in our GUV preparations with 80:20 mol% of DOPC:cardiolipin we
observe formation of both unilamellar and multilamellar vesicles (Fig. 5-5b), with the
multilamellar vesicles showing high curvature regions. We hypothesize that these multilamellar vesicles contain higher concentration of cardiolipin than the rest of the vesicles
from the same GUV preparation. However, we do not have a direct way to measure the
cardiolipin concentration in these vesicles.

Figure 5-5. Heterogeneity of Bax binding to GUVs.

GUVs were prepared by

electroformation from DOPC:CL (80:20 mol%) and added to the solution containing
Bax-R (50 nM), Bax-G (50 nM) and cBID (10 nM). The confocal image was taken
approximately 30 minutes after mixing. The confocal image is an overlay of red and
green channels corresponding respectively to Bax-R and Bax-G. a. Confocal image of the
field view of multiple GUVs with the fluorescently labeled Bax bound. Scale bar is 50
µm. b. Confocal image of a giant multilamellar vesicle containing high concentration of
the bovine heart cardiolipin which resulted in the production of high curvature in the
portions of this vesicle.

Scale bar is 20 µm. Images a and b were taken in the same

chamber, indicating that these vesicles were from the same preparation and were exposed
to the same concentration of the fluorescent Bax and cBid.
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Bax and detergents produce similar morphological changes in GUVs.
In addition to permanent transformations of GUV morphology shown in Figure 54, we have observed transient changes in GUV morphology upon Bax binding (Fig. 5-6).
These transient morphological changes included endocytosis like events, where
thransforamtion of the GUV membrane resulted in the formation of smaller daughter
vesicles inside the original vesicle (Fig. 5-6a), and fission like events, where GUV
disintegrated into a number of smaller vesicles (Fig. 5-6b). Similar morphological
transformations have been observed when sub-CMC concentration of n-octylglucoside
detergent was added to GUVs (Fig. 5-7). This apparent similarity in the shape
transformation of GUVs in the presence of detergents and in the presence of Bax, which
have never been exposed to detergents, suggests that Bax acts as a detergent during
binding to lipid membranes. When detergents bind lipid membranes changes in the
mechano-elastic properties of membranes have been observed, thus we can stipulate that
Bax can change mechano-elastic properties of lipid membranes similar to detergents.
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Figure 5-6. Transformation of GUV shapes upon Bax binding.
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Figure 5-7. Transformation of GUV shapes upon the addition of n-octylglucoside
detergent. Time stamps indicate time since the beginning of the observation, which
occurred 10-15 sec upon the detergent addition.
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Conclusion
Described above confocal microscopy studies of the effects of Bax onto the
morphology of GUVs were undertaken with the goal of determining the feasibility and
the experimental conditions for the FCCS measurements of Bax diffusion and selfassembly in GUV membranes. As a result of these studies we determined that GUVs can
be used as a source of free-standing lipid membranes in the FCCS experiments and that
addition of 50 nM Bax and 4 nM cBid result in sufficient for the FCCS measurement
amount of Bax accumulated in GUV membranes. In addition, for these Bax and cBid
concentrations it was determined that GUVs maintain spherical shape and do not collapse
for a period of 4-7 hours which is suitable for FCCS measurements. In addition, the
functionality of the two forms of the fluorescently labelled Bax, Bax-R and Bax-G, have
been tested for their ability to form pores in LUVs and GUVs indicating that Bax-R and
Bax-G can form pores in liposomes similar to the wild-type Bax.

Experimentals
Protein preparation, labeling and functionality check. Human cDNA for Bax, Bid and
Bcl-xL were subcloned into pTYB1 vector (New England Biolabs). For production of the
fluorescently labeled Bax two endogenous cysteines of Bax were substituted (C62S,
C126A) and additional cysteine was engineered, S4C. All proteins were expressed in
BL21(DE3) E. coli, and purified as an intein/chitin-binding domain fusion protein
without use of detergents (See Appendix V for details). Purified proteins were estimated
to be > 95% pure by Coomassie staining SDS-PAGE gels and stored at 4 °C. Bid was cut
with recombinant caspase 8 to produce cBid. Mutant Bax with single cysteine was
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labeled according to the manufacturer’s protocol with Alexa Fluor 488 maleimide
(Invitrogen) and Atto 655 maleimide (AttoTech). Functional comparison of the
fluorescently labeled Bax to the wild-type Bax was done using carboxyfluorescein assay
from liposomes (See Chapter 3 for the method description).

Preparation of giant unilamellar vesicles. GUVs were prepared by the electroformation
method13 from a lipid mixture containing 80 mol% of 1,2-dioleoyl-sn-glycero-3phosphocholine (DOPC from Avanti Polar Lipids) and 20 mol% of bovine heart
cardiolipin (Avanti Polar Lipids). For the detailed protocol of GUV preparation see
Appendix IV. For the confocal microscopy observation 50 µl of solution containing
GUVs was transferred into a Lab-Tek observation chamber (Fisher Scientific) containing
450 µl of 10 mM HEPES, pH 7.2, 100 mM KCl and a mixture of Bax, cBid and Bcl-xL.

Confocal Microscopy was performed at 22 °C on a laser-scanning confocal microscope
Meta 510 system (Carl Zeiss) using 40× NA 1.2 UV-Vis-IR C Apochromat waterimmersion objective. For excitation the 488 nm line of an Argon-ion laser (25 µW) and
the 633 nm line of the HeNe laser (15 µW) were used. Collection and processing of
images was done using Zeiss software provided with the microscope (AIM, version 4.2).
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CHAPTER 6
“Bax Mega-Pore: Line Tension Measurement”
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Introduction
The size of the Bax pore has become a controversy in the field of apoptosis. In
fact, the Bax pore has not been observed in vivo by electron microscopy in mitochondria
of cells undergoing apoptosis, where Bax appears to aggregate at the fission sites on the
surface of the OMM1. Nonetheless, in vitro studies using electrophysiology and poresizing techniques have shown that Bax forms pores of 2-5 nm in diameter2-6, while
electron microscopy and AFM revealed the formation of 100-200 nm disruptions in
liposomes and supported lipid bilayers incubated with Bax7, 8. In light of this controversy
about the size of a Bax pore, the finding of the formation of 5-20 µm in diameter Bax
mega-pores support the hypothesis that Bax is able to form pores of various sizes9.
In addition to extremely large diameters, Bax mega-pores also exhibited
uncommonly long life times ranging from 10 min to hours. Based on the life time and
size, these Bax mega-pores are very similar to the giant pores formed in GUVs by
detergents or by the physical disruption of GUVs10-15. The latter two types of giant pores
can be differentiated on the basis of the magnitude of the force responsible for closing a
pore – the line tension10, 16. The line tension is the energy per unit length of the membrane
contour at the pore edge, and it arises due to the exposure to water of the hydrophobic
lipid tails in the rim of the pore. The line tension is the highest in the giant pores opened
by physical disruption (10-20 pN)10, 15, and it is two orders of magnitude lower in the
giant pores stabilized by detergents (0.2 pN)10. Therefore, in order to characterize the Bax
mega-pores with respect to the other two known types of giant pores, we used an
established microscopy technique to measure the line tension in the rim of the Bax megapore, which turned out to be two orders of magnitude lower than the line tension in the
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rim of a detergent stabilized giant pore. Furthermore, using this line tension measurement
together with other knowledge about the Bax interaction with lipid membranes, we
propose a model of the formation, existence and closure of the Bax mega-pores.

Results and Discussion
Bax forms longed lived mega-pores in GUVs
While using confocal microscopy to study Bax-R and Bax-G binding to GUVs in
the presence of cBid, we were intrigued by the formation of giant Bax pores which we
named Bax mega-pores (Fig. 6-1, 6-2). These pores ranged from 5-20 µm in diameter,
appeared within 10 minutes of Bax addition to GUVs, and were extremely stable, with
life times of 8 minutes up to many hours. Interestingly, all observed Bax mega-pores had
increased Bax concentration in the rim of the pore, which did not expand or led to GUV
collapse17. Although the mega-pores usually closed over the observation period of 1-2
hours, the presence of a simple obstacle in the pore closure path, e.g. another liposome,
was observed to arrest the closure process (Fig. 6-1c). For comparison, an impedimentary
lipid vesicle present in the closure path of a giant pore opened by the stimulation with
visible light was cut into two vesicles when the pore closed10. This observation shows
that Bax reduces the line tension in the pore rim, thus resulting in the arrest of the pore
closure by an impedimentary vesicle. Nonetheless, in GUVs where Bax mega-pore did
close, the fluorescent Bax concentrated at the rim of the pore dispersed over the GUV
surface producing a homogeneous Bax fluorescence signal. Additionally, GUVs which
have gone through the process of the mega-pore formation and closure did not have
another mega-pore open and appeared to be stable for hours afterwards.
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Figure 6-1. Bax mega-pore. a 3D reconstruction of the Bax mega-pore shown together
with the confocal images used to produce this reconstruction. Values in µm indicate
distance from the coverslip surface. b. Time series of opening, existence and closure of
the Bax mega-pore. Arrow in the first image indicates the position at which mega-pore
will open. Time stamps represent time since the opening of the pore. c. Other examples of
giant Bax mega-pores.
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Figure 6-2. Time series of the opening and closure of a Bax mega-pore. These
confocal images represent an overlay of three channels: red (Bax-R), green (Bax-G) and
pink (Alexa 546). Time stamps indicate time after protein addition to GUVs. Scale bar is
40µm.
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Size distribution of Bax mega-pores.
To determine whether there exists correlation between the size of a Bax megapore and the size of a GUV, we performed the Pearson’s correlation test. In this test we
compared the distribution of the diameters of the Bax mega-pores with the diameter of
corresponding GUVs (Fig. 6-3). As a result only weak correlation was found between
these two sets of values (with the Pearson correlation coefficient of 0.25). The maximum
value for the Pearson correlation coefficient is 1, and it corresponds to the direct positive
correlation between the two sets of values, i.e. increase in the value of one data set will
lead to linear increase in the values of the other data set.
a

b

Figure 6-3. Size distribution of Bax mega-pores. a. Bar plot of GUV diameter (gray)
and corresponding diameter of a Bax-mega pore (white). Data from 44 GUVs is
presented. b. Same data as in a but plotted as a distribution on Bax mega-pore diameter
versus the GUV diameter. As an additional evidence of weak correlation between the two
data sets the linear fit of this data shown as a line (R=0.25).
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Weak correlation between the diameter of a GUV and the diameter of a Bax
mega-pore present in this GUV suggest that the Bax mega-pore formation is a stochastic
process which most likely depends on the physical properties of the GUV membrane (i.e.
elasticity and bending rigidity etc.). These physical properties of GUV membranes
depend directly on the lipid composition of membranes. In Chapter 5 the heterogeneity of
cardiolipin distribution among GUVs during the electroformation was discussed, and
correlated with the heterogeneous binding of Bax to GUVs. Based on this, it can be
concluded, that one of the reasons for the weak correlation between the diameters of Bax
mega-pores and GUVs in which they occur is due to heterogeneous lipid distribution
among GUVs. We can also speculate, that the other reason for the weak correlation can
be the fact that Bax mega-pores formed in GUVs larger than 50µm in diameter
destabilize the GUV leading to its collapse (data not shown) which results in a skewed
distribution of the Bax mega-pore diameters with GUV diameter. Finally, we should
mention that the diameter values for this analysis were collected from a number of
confocal images corresponding to the various experiments where concentration of the
fluorescently labeled BAX was varied.

Analysis of the line tension in the rim of Bax mega-pore
Kinetics and thermodynamics of giant pores in GUVs can be explained by
theoretical models 10, 13 where the energy E r of a pore of radius r can be described as

E r  2r  r 2

(Eqn. 1)

where,  is the line tension while  is the surface tension. Interplay between line and
surface tension allows opening, existence and closure of giant pores in GUVs. Following
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model of Borchard-Wyart et al.14 the life of a pore in a GUV can be described in four
steps: (i) pore opens due to the increase of the membrane surface tension (  ) which can
be induced by application of an electrical field11, 18, or by insertion of molecules with
non-zero spontaneous curvature such as detergents10, or by the insertion of the Baxderived α5 peptide 19; (ii) while surface tension term in Equation 1 is larger than the line
tension term the pore expands to some critical radius ( rc ); (iii) while the surface tension
and line tension terms in the equation 1 are equal (i.e. pore energy  r  0 ) the pore exists
in unstable equilibrium state; (iv) when the line tension begins to increase the pore begins
to close. Using this theoretical framework the line tension in the rim of the pore during
the pore closing stage can be calculated using

k 

2
3

(Eqn. 2)

where, k is the slope of the R 2 ln(r ) versus time plot and  is the solution viscosity
(1.035×10-3 Pa·s for 30 mM sucrose solution), R is the radius of a GUV containing a
pore of radius r . Examples of the evolution of the radius ( r ) of Bax mega-pore for three
GUVs are shown in Figure 6-4. From these three plots we estimate the line tension in the
rim of the Bax mega-pore to be 3.7±1.7 fN which is four orders of magnitude lower than
the line tension of a pore opened by the intense illumination in a DOPC vesicle (  =
20.7±3.5 pN)10 and two orders of magnitude lower than the line tension of a detergent
stabilized giant pore (0.2 pN).
The ability of the Bax to reduce the line tension of artificial lipid membranes have
been reported previously but without a direct measurement of the line tension20. Here, we
measured the line tension in the rim of the Bax mega-pore to be 3.7±1.7 fN which is two
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to four orders of magnitude lower than the line tension in the rim of detergent stabilized
or mechanically opened pores respectively. It is hypothesized, that the reason for the
ability of the cone-shaped detergents to reduce the line tension in giant lipid pores is
based on their propensity to partition to the high curvature regions in the edge a pore10, 16
(Karatekin, May 2000 others). Therefore, the ability of Bax to reduce the line tension
lower than that of detergents indicates that Bax is a remarkable protein designed by
evolution to stabilize edges of lipid membranes.
Interestingly, the line tension generated by the full length Bax proteins is three
orders of magnitude lower than the line tension generated by the pore-forming α5 peptide
of Bax in a supported lipid bilayer (  = 3.8±0.4 pN)19. The lower line tension value
measured in the presence of the full length Bax protein indicates that the full length
protein is able to stabilize the pore edge more efficiently than a single alpha helix of Bax
indicating an additional role for the non-pore forming alpha helices of Bax. Previously
the non-pore forming helices of Bax were given two major roles in the function of Bax:
first, to prevent the pore-forming helices of Bax (α5 and α 6) from harming the cell by
forming pores in various membranes; and second, to facilitate the communication
between Bax and other proteins involved in the apoptosis decision such as BH3 domain
interactions etc.

The life time of Bax mega-pore
The life time of a lipid pore in DOPC vesicle immersed in water solution is
estimated to be 10-200 msec, and it can be extended by increasing the viscosity of
solution13. Therefore, 66 % glycerol solution which has 30 times higher solution viscosity
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a

b

c

Figure 6-4. Plots of the evolution of the radius of Bax mega-pore with time. GUVs
were mixed with 30 nM Bax-G, 25 nM Bax-R and 4 nM cBid. Movies of the Bax-R and
Bax-G binding to GUVs as well as transformation of GUVs were taken immediately
upon mixing. a. GUV initial radius was 40 µm while the slope of the R 2 ln(r ) during the
pore closing is k = -22.8±2.5 µm2/sec. The opening and closing of a pore for this
particular GUV is shown in Supp. Movie 1. b. GUV initial radius was 20 µm while the
slope of the R 2 ln(r ) during the pore closing is k = -0.57±0.19 µm2/sec. c. GUV initial
radius was 20 µm, while the slope of the R 2 ln(r ) during the pore closing is k = 0.93±0.14 µm2/sec.
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than water is commonly used to measure the life time of giant lipid pores10, 12, 14. The
reported life time of giant pores in glycerol ranges from seconds for the lipid pores
opened by a physical method to minutes for lipid pores stabilized with detergent10 while
the life time of Bax mega-pores is measured in water solution and ranges from 8 min to
many hours. Hence, if the life time of all tree types of giant pores is compared in the
same solution, the Bax mega-pore will have the longest life time, which is explained by
the extremely low line tension measured in the rim of this pore.

Proposed model of the Bax mega-pore formation, existence and closure
We propose the following mechanism for Bax mega-pore opening, existence, and
closure based on a GUV shown in Figures 6-1b and 6-2. In this mechanism Bax inserts
into a lipid membrane from the outside of a GUV and transforms from a globular soluble
protein21 to a membrane integrated protein with proposed extended structure shallowly
inserted into the membrane22 (Fig. 6-5a). This produces a dramatic area increase in the
outer membrane leaflet while the area of the inner leaflet remains unchanged (Fig. 6-5b).
The localized area difference of the two membrane leaflets induces curvature frustration
and increase in the surface tension of the membrane23, 24 (Δσ>0). When surface tension
increases to a critical value the membrane structure ruptures and the mega-pore is
formed. Once the pore is formed its line tension provides a force for reclosure of the
mega-pore which counteracts the surface energy such that GUV continues to exist and
does not collapse (See also Eqn. 1). However, now through the open mega-pore soluble
Bax is able to accumulate in the lumen of the GUV and insert into the inner leaflet of the
GUV membrane. This results in the area increase of the inner leaflet leading to the
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increase in surface tension in this leaflet. Meanwhile, membrane Bax has accumulated in
the rim of the pore, reducing line tension and decreasing the rate of pore closure as
surface energy of the inner and outer leaflets equilibrate (Fig. 6-2b). As a result the Bax

Figure 6-5. Model of Bax interaction with lipid membranes. a. Schematic of Bax
binding, integration and oligomerization in a lipid membrane. b. Proposed mechanism of
the Bax mega-pore opening and closure.
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mega-pore closes very slowly over tens of minutes even though the surface energy of the
two leaflets is the same. After the pore closure Bax in the form of monomers or small
oligomers diffuses away from the position where the membrane resealed such that within
seconds after pore closure no heterogeneities are observed on the GUV surface.

Bax mega-pore: connection to physiology
It is clear that the Bax mega-pore structures we observed in GUVs can not occur

in vivo simply due to their size (5-20 µm) versus the size of mitochondria (0.2-1 µm).
Furthermore Bax mega-pores scaled for the smaller size of mitochondria would also need
to be scaled for the reported localization of Bax to the fission sites1. Finally, the simple
lipid composition of GUVs (DOPC:cardiolipin, 80:20 mol %) compared to the
complexity of mitochondrial outer membrane and the heterogeneous distribution of lipids
and proteins on the mitochondrial surface all limit the space available for Bax pore
formation to a submicroscopic size. Therefore, on the mitochondrial surface Bax has a
limited membrane area to form a protein-membrane complex, while on the surface of
GUV membrane the area available to Bax is many times greater and can generate the
mega-pores that we observed.

Conclusion
The existence of microscopic Bax mega-pores further supports the hypothesis that
Bax can form a variety of pore sizes in artificial lipid membranes and that the Bax pore is
a lipidic pore stabilized by the presence of the Bax protein in the pore rim5,
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20

. The

accumulation of Bax in the pore rim not only reduces the line tension to extremely low
values but it also leads to the increase of the pore life time.
Bax is not the first protein which is reported to form giant pores in GUVs. For
example, protein talin and other FERM domain containing proteins have been shown to
stabilize the edges of giant pores in GUVs but only in conditions of zero salt25, 26. At
physiological salt concentrations these proteins do not promote the formation of giant
pores. Furthermore, the physiological relevance of this pore stabilization ability of talin
and other FERM domain containing proteins is not clear. In vivo the function of these
proteins is to connect actin filaments to the cell membrane. In contrary to these proteins,
Bax forms giant pores in physiologic salt conditions and is a bona fide pore-forming
protein, whose pore forming activity is directly linked to its function in vivo, thus making
the discovery of the ability of Bax to form mega-pores more significant.

Experimentals
Protein purification and labeling was done as described in Chapter 5 and Appendix V.
Line tension analysis. Analysis of the line tension in the rim of a Bax mega-pore was
done according to Karatekin et al.10 using time-lapse movies of the pore opening and
closure collected using laser-scanning microscope Meta 510 system (Carl Zeiss).
Diameter of an open Bax mega-pore together with the diameter of a GUV was measured
using Zeiss LSM image browser software. Time dependent evolution plots of the pore
diameter were fitted using linear square fit analysis in Origin 6.0 software (OriginLab
Corp.). The value for the slope of this linear fit was used to calculate the line tension as
described in Supplementary Information.
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CHAPTER 7
“FCCS Study of Bax Self-Assembly in Lipid Membranes”
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Abstract
It is widely accepted that during apoptosis, permeabilization of the outer mitochondrial
membrane by the pore-forming members of the Bcl-2 protein family is a critical point
after which the cell cannot be resuscitated. However, without

direct evidence of how

they interact in bilayers the molecular mechanism of the mitochondrial permeabilization
remains controversial. Here we have reconstituted the pore formation by protein Bax in
giant vesicles and show that in this environment Bax can form a heterogeneous
distribution of coexisting pore sizes ranging from 1 nm to 20 µm in diameter. Evidence is
provided by directly examining oligomerization and mobility change of Bax molecules in
GUVs by fluorescence cross-correlation spectroscopy and by studying the large
complexes by confocal microscopy. We show that in the presence of Bcl-xL, an inhibitor
of Bax pore formation, membrane bound Bax was primarily monomeric. We also show
that, in the large length scale format of a GUV, Bax form structures that reveal its affinity
for highly curved membranes, and that it dramatically reduces line tension while
stabilizing its lipidic pores. Finally, our results demonstrate that Bax forms pores by
increasing membrane surface energy and changing curvature of lipid membranes, thus
manifesting an ability to sculpt lipid bilayers.
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Introduction
Bax is a pro-apoptotic member of the BCL-2 protein family and its paramount
function is to permeabilize the OMM during apoptosis1, 2. Upon apoptotic stimulation
Bax translocates to the OMM where it changes conformation, inserts as a monomer, and
then undergoes in-membrane homo-oligomerization to form a pore. Once the Bax pore is
formed, cytochrome c and other mitochondria-resident proteins escape into the cytoplasm
where they activate the cascade of caspases that dismantle the cell. To date the structure
of the inactive, cytoplasm-resident, form of Bax is known3; however, the structure of the
active, membrane-integrated, form of Bax remains unsolved. The absence of a membrane
structure for this protein has lead to a vigorous debate about: the nature of the Bax pore
(lipidic versus barrel-stave)4-6, the number of Bax monomers participating in the pore
formation7-10, the possible molecular interactions formed among them in a pore11, 12, and
the progression and variety of pores formed by Bax (i.e. dimer, tetramer and higher order
polymers)5,

6, 13, 14

. To address these questions we used two-focus two-color scanning

FCCS15-17 to non-intrusively measure the mobility and self-association of the
fluorescently-labeled Bax in a hydrated lipid membrane of GUVs for 5-7 hours after Bax
insertion into the lipid membrane (See Chapter 5 for the confocal microscopy analysis of
the fluorescent Bax binding to GUV). In these FCCS experiments the microscope output
was multiplexed for simultaneous determination of the membrane diffusion coefficients
and concentrations of Bax-R, Bax-G and Bax-RG complexes, and the analysis of the Bax
pore activation. Using the membrane diffusion coefficients for the monomeric Bax-R and
Bax-G proteins and for the Bax-RG complexes we estimated the hydrodynamic radius of
these complexes in lipid membranes which is comparable to values reported in literature.
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Furthermore, using the values for the membrane diffusion coefficient of Bax we were
able to clearly differentiate between two monomeric species of Bax in lipid membranes –
membrane associated and membrane integrated Bax. In support of this analysis we used
cBid to activate Bax and Bcl-xL to inhibit the membrane integration and self-association
of Bax.

Results and Discussion
Bax is monomeric in solution and oligomerizes only in lipid membranes
It has been shown by a FRET study that Bax does not oligomerize prior to
membrane binding14. Using FCCS we observe similar result that Bax-R and Bax-G in
the presence of cBid are monomeric and do not oligomerize in solution (Fig. 7-1b). In
solution, diffusion coefficient for Bax-G is 114±6 µm2/sec (mean±s.e., n=3) and for BaxR it is 134±12 µm2/sec (mean±s.e., n=3) which is similar to that of monomeric tBid and
Bcl-xL17. We observe oligomerization of Bax-R and Bax-G only in the environment of a
lipid membrane as shown by the increased cross correlation in Fig. 7-1c (blue line).

In a lipid membrane Bax forms a population of varying in size oligomers
Two-color two-focus scanning FCCS allows simultaneous measurement of the
fluorescent protein concentration, diffusion coefficient and self-association in a lipid
membrane15-18. To study Bax self-association in a lipid membrane we used Bax-R and
Bax-G proteins (50 nM total concentration) activated with 4 nM cBid (as was determined
by the confocal microscopy experiments described in Chapter 5).
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Figure 7-1. FCCS on Bax in solution and in a lipid membrane. b. Normalized autocorrelation curves and cross-correlation curve (blue) for Bax-R and Bax-G in solution in
the presence of cBid. c. Normalized auto-correlation curves and cross-correlation curve
(blue) for Bax-R and Bax-G in a lipid membrane in the presence of cBid.

Figure 7-2. Confocal microscopy images of Bax binding to a GUV. Bax-R (25 nM),
Bax-G (25 nM) and cBid (4 nM) were added to GUVs upon which collection of the timeseries of images was initiated. Time stamps represent the time after protein addition to
GUVs.
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After the establishment of sufficient fluorescent signal of Bax in GUV
membranes (as shown in Fig. 7-2), the FCCS measurements were done on a population of
GUVs (10 min measurement time per GUV) (Fig. 7-3 d, e). The FCCS analysis of
membrane Bax produced a clear result that Bax protein complexes increased in size with
time, as can be seen from the decrease in the average mobility of these Bax-RG
containing complexes (Fig. 7-3 e, blue squares). At the same time, the number of
membrane Bax particles (which include monomers and oligomers) was increasing, so it
was clear that for the >6 hours of these experiments Bax was continuing to accumulate in
the membrane. Each time point on the Figure 7-3 d and 7-3 e represents an independent
GUV measurement such that amount of Bax in the membrane and the average diffusion
coefficient of the Bax particles is not uniform and reflects the variation in the vesicle
lipid composition (See Chapters 2 and 5 for discussion).
The average diffusion coefficient of Bax-RG complexes in GUV membranes
incubated for five hours with 50 nM of the fluorescent Bax and 4 nM cBid is 2.0±0.4
µm2/sec (mean±s.d., n=21). This diffusion coefficient is slower than the membrane
diffusion coefficient of monomeric tBid and Bcl-xLΔC measured by the same technique
(5 µm2/sec)17, suggesting formation of a bulky slowly-diffusing Bax-RG complex in a
lipid membrane (Table 7-1). Since the diffusion coefficient of a particle in a lipid
membrane depends on the in-membrane hydrodynamic diameter of the particle, we can
use the value for the diffusion coefficient of Bax-RG complexes to determine their
approximate in-membrane hydrodynamic diameter using a modified Saffman-Delbruck
formula19 but for this the membrane diffusion coefficient of a Bax monomer should be
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Figure 7-3. Two-color two-focus scanning FCCS experiments on Bax. a and b
represent FCCS results of Bax-R/Bax-G cross-correlation (50 nM total Bax
concentration) in the presence of 50 nM Bcl-xL and 4 nM cBid, while d and e represent
similar results but in the absence of Bcl-xL. c. Schematic of various diffusion species of
Bax in a lipid membrane.
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known. The value for the diffusion coefficient of a Bax monomer will be used to ensure
the accuracy of calculations.

Bcl-xL prevents the self-assembly of Bax in lipid membranes.
To determine the membrane diffusion coefficient of a Bax monomer, Bax selfassembly and pore formation in a lipid membrane should be inhibited. This was
accomplished by using full length human Bcl-xL protein, which is an anti-apoptotic
member of the Bcl-2 family that inhibits Bax pore formation20. When GUVs were
preincubated with Bcl-xL (50 nM) and cBid (4 nM) for one hour and then Bax (50 nM)
was added, no binding of Bax to GUV membranes was observed (Fig. 5-3, Chapter 5),
which does not allow for the FCCS measurements. However, this observation reflects the
ability of Bcl-xL to sequester cBid in an inactive complex which is unable to activate and
promote membrane integration of Bax14,

17, 20

. Simultaneous addition to GUVs of

Bax, cBid and Bcl-xL at these same concentrations resulted in sufficient membrane
binding of Bax for the FCCS measurements but did not result in GUV permeabilization
(Fig. 5-3, Chapter 5). Comparison of the fluorescence intensity of Bax-R accumulation in
the GUV membranes in the presence and absence of Bcl-xL shows that in the presence of
Bcl-xL the amount of Bax binding to the GUV membranes is lower than in the absence of
Bcl-xL (Fig. 7-4).
Based on the results of the FCCS experiments shown in Figures 7-3 a-c, in the
presence of Bcl-xL the membrane concentration of Bax increased over 7 hours and its
diffusion coefficient decreased from 8.3±1.0 µm2/sec (mean±s.d, n=6) to 5.2±0.7 µm2/sec
(mean±s.d., n=26). The latter diffusion coefficient value is typical of a transmembrane
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Figure 7-4. Comparison of Bax-R binding to GUV membranes in the presence and
absence of Bcl-xL. a. Map of fluorescence intensity changes in a line scan through the
GUV membrane (vertical direction) with time (horizontal direction). This membrane
trace comes from a GUV exposed only to Bax-R protein and cBid. b. Change in
cumulative fluorescence intensity in membranes of GUVs exposed to Bax-R and cBid in
the absence and presence of Bcl-xL. The trace for the last point in each measurement is
shown in a and c. c. Map of fluorescence intensity changes in a GUV exposed to Bax-R,
cBid and Bcl-xL. In these experiments following protein and lipid concentrations were
used: 25 nM Bax-R, 25 nM Bax-G, 50 nM Bcl-xL, 4 nM cBid, and 5 µM total lipid.
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alpha-helical peptide21 and it is also similar to the in-membrane diffusion coefficient of
monomeric membrane integrated tBid or C-terminal truncated Bcl-xL described by the
Saffman-Delbruck model of membrane protein diffusion (Table 7-1)17, 22. In addition, we
observed no cross-correlation between Bax-R and Bax-G at this concentration of Bcl-xL
(Fig. 7-3b). Based on these results we conclude that the diffusion coefficient of a
membrane integrated Bax monomers is 5.2±0.7 µm2/sec.
Furthermore, we propose that the gradual decrease in the membrane diffusion
coefficient of Bax in the presence of inhibiting concentrations of Bcl-xL represents the
transition of Bax from being a monomeric membrane-associated protein sliding on the
membrane surface with fast diffusion to becoming a monomeric membrane-integrated
protein with appropriately slower diffusion (Fig. 7-3c). However, we do not discount the

Table 7-1. Comparison of the various diffusion coefficients of Bax with the diffusion
coefficient of lipids.
Type of molecule

Diffusion
coefficient, µm2/sec

in solution:
monomeric inactive Bax
monomeric tBid17
monomeric Bcl-xLΔC17
in a lipid membrane:
lipids
monomeric membrane associated Bax
monomeric membrane integrated Bax
monomeric tBid17
monomeric Bcl-xLΔC17
Bax pore complex
(at 50 nM total Bax concentration )

in-membrane
diameter,
nm
-

114±5
143±9
78±10
10.0±0.5
8.3±1.0
5.2±0.7
5.0±0.3
4.8±0.7
2.0±0.4
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1
~1
53±12

possibility that the monomeric integrated Bax forms hetero-dimers with Bcl-xL in lipid
membranes20. In the Saffman-Delbruck theory scaling of the diffusion coefficient with
the in-membrane diameter of the protein is logarithmic implying that integrated
monomeric Bax would have membrane diffusion coefficient similar to that of a Bax/BclxL hetero-dimer.

Calculation of the Bax pore complex diameter
Traditionally the Saffman-Delbruck equation is used to calculate the
hydrodynamic radius of a membrane inclusion from its diffusion coefficient21-25 (See
Eqn. 1 in the Experimentals section). It has been shown, that Saffman-Delbruck equation
faithfully describes diffusion of membrane inclusions traversing both leaflets of a lipid
membrane in the case of small proteins, however, in the case of larger membrane
inclusions (for example, such as lipid rafts) this theory underestimates the diameter of
membrane inclusions. As a consequence of this, a modified version of a SaffmanDelbruck equation has been developed by Petrov and Schwille for the description of the
diffusion of large membrane inclusions19 (See Eqn. 2 in the Experimentals section).
In the case of Bax diffusion in lipid membranes, the diffusion coefficient of a Bax
monomer (5.2±0.7 µm2/sec) is consistent with the Saffman-Delbruck theory, however,
the diffusion coefficient of Bax-RG protein complex is two times slower than the
diffusion of a Bax monomer, and thus according Petrov and Schwille the in-membrane
hydrodynamic diameter of this complex should be calculated according to the modified
Saffman-Delbruck formula. As a result the diameter of the Bax-RG protein complex
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diffusing with diffusion coefficient of 2.0±0.4 µm2/sec is 53±12 nm. This value is one
order of magnitude larger than the size of a Bax pore measured by the dextran blocking
of a pore and by the electrophysiology methods13, 26. However, this value is consistent
with the electron microscopy imaging of a Bax pore in liposomes and the AFM
measurement of the Bax pores in supported lipid bilayers5, 27, where it has been shown
that the diameter of a Bax pore can be 100-200 nm.
It is worth noting here that the calculated hydrodynamic radius of a Bax-RG
complex does not necessarily represent the size of a pore formed by this complex. In spite
of the obvious connection between the calculated diameter of a Bax-RG complex and the
electron microscopy and AFM experiments, it is still possible that the size of the pore is
smaller than 53 nm and the rest of the size of the pore is occupied by the lipids trapped in
the concerted motion of a lipidic pore.

Titration of Bax in lipid membranes: mass action law
We next asked a question, whether by increasing the amount of Bax in a lipid
membrane we can control for the size and the concentration of Bax-RG complexes. For
this purpose various amounts of total soluble Bax-R and Bax-G proteins were added to
the constant concentration of GUVs, and the FCCS measurements were done on these
GUV populations. In each case, Bax binding to GUVs was activated by the addition of 4
nM cBid. As a result of these experiments we find that with the increasing concentration
of total Bax added to the system the higher concentration of Bax particles is found in a
lipid membrane (Fig 7-4, grey bars). It is important to note that these Bax particles
include monomers and oligomers of Bax. Additionally, with increasing concentration of
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Figure 7-5. Titration of Bax. Bax-R and Bax-G were added to GUVs (5µM total lipid
concentration) in the presence of cBid. FCCS measurements were done on a population
of no less than 10 GUVs upon 1-2 hours after protein addition to GUVs.

Table 7-2. FCCS results of the titration of Bax. Experimental conditions were the same
as described in the legend to Figure 7-5. The hydrodynamic diameter was calculated
using modified Saffman-Delbruck formula19.
Total Bax

Bax-RG

measured diffusion

calculated in-membrane

concentration,

complexes,

coefficient, µm2/sec

hydrodynamic diameter,

nM

particles/µm2

50

7.9

2.0±0.4

53.2

83

8.8

1.5±0.4

102.2

100

9.6

1.4±0.3

120

nm
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Bax particles in a lipid membrane, the greater number of the Bax-RG complexes was
observed (Fig. 7-5, black bars). Analysis of the diffusion coefficients for the Bax-RG
complexes formed at different total concentrations of Bax also showed an increase in the
average size of these complexes (Table 7-2). Such correlation between the size and
concentration of Bax-RG complexes with the total concentration of Bax in a system
shows that Bax pore formation follows the mass action law.

Moderating the activity of Bax with cBid
To study the effects of increasing concentrations of cBid onto the distribution of
Bax particles in a lipid membrane, we varied cBid concentrations in our FCCS
experiments while keeping Bax and total lipid concentration constant. As a result, we
observed correlation between the increase of cBid concentration and the resulting
concentration of Bax particles in the lipid membrane (Fig. 7-6). However, the
concentration of Bax-RG complexes did not follow this correlation pattern.

Figure 7-6. Effects of cBid titration on the distribution of the membrane forms of
Bax. Results were obtained using two-color two-focus scanning FCCS analysis.
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The concentration of Bax-RG complexes in a lipid membrane remained constant (within
the margin of error) for all cBid concentrations (Fig. 7-6, blue bars). This observation
indicates that cBid must be affecting only the kinetics of Bax integration into the lipid
membranes without a significant effect on the resulting concentration of the Bax
oligomers.

Interactions among Bax, cBid, and Bcl-xL: rheostat model
In Figure 7-3 we have shown that Bcl-xL inhibits oligomerization of Bax in a lipid
membrane. However, we were intrigues to know whether the inhibitory effect of Bcl-xL
on Bax can be rescued by the addition of excess cBid. According to the rheostat model
proposed by Korsmeyer et al. the apoptosis decision in cells depends on the relative
concentrations of pro- and anti-apoptotic proteins28. Therefore, in our minimal in vitro
system we expect to observe an increase in the oligomerization of Bax in a lipid
membrane containing Bcl-xL when cBid concentration is increased, due to the
competition for cBid between Bax and Bcl-xL29.
Simultaneous addition to GUVs of 50 nM Bax and Bcl-xL at 1:1 protein to protein
ratio with 4 nM cBid resulted in complete inhibition of Bax oligomerization as can be
seen from the absence of Bax-RG complex formation, while in the absence of Bcl-xL the
same concentrations of Bax and cBid resulted in the formation of 16% of Bax-RG
complexes (normalized to the total concentration of Bax particles in the membrane) (Fig.
7-7). However, when excess of cBid is added, with 1:1:1 stoichiometry of Bax, Bcl-xL
and cBid in the system, there is sufficient cBid for the interaction with both Bax and BclxL, and as a result we observe rescue of the Bax-RG complex formation (Fig. 7-7). These
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observations are consistent with the rheostat model where cBid can interact with both
Bax and Bcl-xL while having higher affinity for the interaction with Bcl-xL14, 17, 29 and
thus when Bcl-xL is present majority of the cBid molecules is sequestered in the
interaction with Bcl-xL (assuming 1:1 stoichiometry of protein binding) leaving few cBid
molecules for the interaction with Bax. Therefore, using minimal in vitro system we were
able to show that the outcome of the interaction among Bax, cBid and Bcl-xL can be
described by the rationale of the rheostat model.

Figure 7-7. Bax, cBid and Bcl-xL: rheostat model. Results were obtained using twocolor two-focus scanning FCCS analysis.

Discussion
For use with two-color two-focus FCCS we produced two forms of the
fluorescently labeled full length Bax protein, Bax-R and Bax-G. These fluorescently
labeled Bax proteins have been shown to have the pore formation activity similar to that
of the recombinant wild type Bax (See Chapter 5 for details). Furthermore, we show that
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these two fluorescent forms of Bax are monomeric in solution and oligomerize only in
lipid membranes (Fig. 7-1).

Bax binding to lipid membranes: associated versus integrated Bax
Using two-color two-focus scanning FCCS we show that prior to oligomerization
in a lipid membrane monomeric Bax associates with the lipid membrane, and then
becomes membrane integrated. The transition between the membrane associated and
integrated forms of Bax most likely occurs via a conformational change, which is aided
by cBid protein already present in the membrane. We differentiate between these two
monomeric forms of Bax based on their diffusion coefficient: membrane associate
monomeric Bax, due to incomplete insertion into a lipid bilayer, has faster diffusion
coefficient (8 µm2/sec) than the monomeric membrane integrated Bax (5 µm2/sec). It is
important to note, that this transition from associated to integrated Bax could only be
observed by scanning FCCS in the presence of Bcl-xL protein in GUV membranes. BclxL slows down membrane binding of Bax, and thus allowed us to observe this transition
process. Bcl-xL have been proposed to inhibit the pore formation by Bax in three ways:
by directly binding monomeric integrated Bax, by binding cBid protein and thus
eliminating it as an activator of Bax, and by preventing Bax binding to a lipid
membrane20,

30

. However, the mechanism of a letter inhibition pathway is not clear.

Therefore, Bcl-xL inhibition of Bax binding, oligomerization and pore formation in lipid
membranes, which were observed in our experiments, agree with literature.
In the absence of Bcl-xL in the membrane, the association and integration of Bax
is rapid, and can not be resolved by the scanning FCCS. In this case we observe the
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decrease in the average diffusion coefficient of Bax from 5 µm2/sec to 2 µm2/sec, which
is likely represents the transition form monomeric integrated Bax to a proteo-lipidic
complex containing multiple Bax monomers. Furthermore, the time frame of the Bax
transition from the associated to integrated protein in the presence of Bcl-xL is longer
than the time frame of the transition from the monomeric membrane integrated protein to
the proteo-lipid complex in the absence of Bcl-xL (Fig. 7-3 b and e), thus supporting our
proposal that Bcl-xL slows down the process of Bax integration in a lipid membrane. Our
observation of the transition from membrane integrated to membrane associated forms of
Bax can be further supported by the SPR studies31 and by the studies of the conformation
of Bax loosely associated with the lipid membrane of LUVs32.

Self-assembly of Bax in lipid membranes
It has been shown that in order to form a pore in artificial lipid membranes, Bax
need to undergo self-assembly in the lipid membrane environment5, 10, 13, 14, 33, while in
vivo, during apoptosis, Bax has also been shown to form large aggregates10,

34, 35

.

Therefore, our observation of the Bax-RG complex formation was expected. However,
what was unexpected, is the progressive decrease in the diffusion coefficient of Bax upon
membrane integration. According to the Saffman-Delbruck formula, diffusion of a
membrane protein is primarily affected by the in-membrane hydrodynamic diameter of
the protein. Therefore, dimerization and even tetramerization of a protein in a lipid
bilayer would not result in a significant change in the diffusion coefficient of the resulting
complex, compared to that of a monomer36,

37

. Therefore, our observation of the

significant decrease in the diffusion coefficient of Bax-RG complex compared to that of a
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Bax monomer, indicates that Bax is not simply oligomerizing, but most likely is forming
lipidic pores4, 5, 38. These lipidic pores involve lipids which contribute to the size of the
in-membrane hydrodynamic diameter of a complex (See Fig. 7-3 c for a proposed model
of a Bax lipidic pore). Therefore, our estimation of the diameter of these slowly diffusing
Bax-RG proteo-lipidic complexes most likely over-estimates the size of pores formed by
these complexes in a lipid bilayer. However, we do not have direct experimental evidence
for the presence of pores in these complexes. The reason for our assumption, that these
Bax-RG proteo-lipidic complexes contain a pore, is based on the transmission electron
microsocopy and AFM measurement of the Bax pore diameters, which show that Bax is
capable of forming pores with the diameter of 100-200 nm. Calculated in-membrane
diameter of a Bax-RG complex falls into this range.

Rheostat model: connection to physiology
The finding that pro- and anti-apoptotic proteins of the Bcl-2 family can
heterodimerize, and that their relative concentrations to each other affects the decision
whether a cell should undergo apoptosis, have lead to the proposal of the rheostat model
by Korshmeyer et al28.

The results obtained using our model system of Bax pore

formation in GUVs support this hypothesis (Fig. 7-7). These results show that, when
equimollar concentrations of Bax and Bcl-xL are present in a lipid membrane together
with low concentration of cBid, there is no oligomerization and pore formation by Bax.
However, when cBid is added, such that there is approximately one cBid molecule for
each Bax and Bcl-xL molecule, then oligomerization and pore formation by Bax is
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rescued. Similarly, in the presence of low cBid concentration and the complete absence
of Bcl-xL, Bax is able to oligomerize and form pores.
The results of scanning FCCS shown that Bax, cBid and Bcl-xL obey the law of
mass action (Fig. 7-5, 7-6, 7-7). These results show that increase in the concentration of
soluble protein leads to the concentration increase of the membrane bound protein, with a
certain saturation limit. Results of the titration experiments with Bax-R and Bax-G show
that not only the total concentration of membrane bound Bax monomers increases, but
also that the distribution of Bax-RG proteo-lipidic complexes changes, resulting in the
larger mean diameter of complexes (Table 7-2).

Conclusions
The work presented in this chapter represents the first example of the application
of two-color two-focus scanning FCCS to study oligomerization and pore formation by
Bax in lipid membranes of GUVs. The results of this study provide an insight into the
mechanism of Bax pore formation in lipid membranes and the regulation of this
mechanism by the pro-apoptotic BH3-only protein cBid and anti-apoptotic protein BclxL. These results show that Bax binds lipid membranes containing cBid as a monomer, by
first associating with the lipid membrane, likely via electrostatic interaction, and then
undergoing conformational transition to become a membrane integrated protein, likely
due to the interaction with cBid. Once in lipid membrane, integrated Bax monomers
initiate self-association which leads to the formation of pores. Formation of pores reduces
the concentration of monomeric Bax monomers in the lipid membrane, thus allowing for
the integration of additional Bax proteins. This continual insertion of Bax monomers into

175

the lipid membrane leads to increase in the average Bax pore size resulting in the
heterogeneous distribution of Bax pores. Increase in the number of Bax pores in the lipid
membrane leads to the disruption of elastic forces of the lipid membrane, thus leading to
the deformation and destruction of GUVs.

Experimentals
Protein purification and labeling was done as described in Chapter 5 and Appendix V.
Sample preparation for the FCCS experiments.
For the FCCS experiments GUVs were prepared from a lipid mixture of
DOPC:bovine heart cardiolipin (80:20 mol%) using the electroformation method
described in Appendix IV. After the preparation 50 µl of GUVs were transferred to an
observation well containing 450 µl of 1xEB buffer (10 mM Hepes, pH 7.2, 100 mM KCl)
and a mixture of proteins (Bax, cBid, Bcl-xL) depending on the experiment. For all
experiments observation chambers (8 well LabTak, Nunc) were treated for at least one
hour with a solution containing 4 mg/ml BSA. BSA treatment was done with the purpose
to prevent protein adsorption to the plastic walls of the observations chamber. All FCCS
measurements were performed at room temperature (22 °C) in a dark room.

Fluorescence cross-correlation spectroscopy.
FCCS measurements were performed on a laser-scanning microscope Meta 510
system (Carl Zeiss) using 40× NA 1.2 UV-Vis-IR C Apochromat water-immersion
objective. For excitation the 488 nm line of an Argon-ion laser (25 µW) and the 633 nm
line of the HeNe laser (15 µW) were used, while detection was done using a home-built
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detection unit at the fiber output channel. A dichroic mirror and band-pass filters (D555,
HQ520/40 and HQ700/75; AHF Analyze Technik) were used behind a collimating
achromat to split the emission for the dual-color detection and to reject residual laser and
background light. We then used achromats (LINOS Photonics) to image the internal
pinhole onto the apertures of the fibers connected to the avalanche photodiodes (APD,
PerkinElmer). The photon arrival times were recorded in the photon mode of the
hardware correlator Flex 02-01D (http://correlator.com).
For scanning FCCS, the detection volume was repeatedly scanned perpendicularly
through the equator of a GUV. We controlled its movement directly with the Zeiss LSM
operation software. We used the frame mode with Nx2 pixels to scan the two parallel
lines. We measured their distance d by repeatedly scanning over a film of dried
fluorophores and measuring the distance between the bleached traces in a high-resolution
LSM image.
Data analysis was performed with software written in MATLAB (MathWorks).
For scanning FCCS, we binned the photon stream in bins of 2 µs and arranged it as a
matrix such that every row corresponded to one line scan. Corrected for movements of
the membrane was done by calculating the position of the maximum of a running average
over several hundred line scans and shifting it to the same column. We fitted an average
over all rows with a Gaussian and we added only the elements of each row between -2.5σ
and 2.5σ to construct the intensity trace. We computed the auto- and cross-correlation
curves of the resulting intensity traces with a multiple tau correlation algorithm and fitted
them with a nonlinear least-squares fitting algorithm. In all FCCS data processing, we
excluded from further analysis irregular curves resulting from major instabilities
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identified by distortions of the curves and a systematic change in the intensity trace. For
details of data fitting see Supplementary information.

Calculation of the diameter for the Bax pore complex.
According to the Saffman-Delbruck theory of the diffusion of particles in lipid
membranes translational diffusion coefficient ( D ) of the particle depends on the radius
( R ) of the particle in the following way

D

  mem h

 ln
  
4 mem h   sol R

k BT

(Eqn.1)

where  mem is membrane viscosity,  sol is solution viscosity, h is membrane thickness,

T temperature, k B is Boltzmann constant, and 

is Euler's constant (0.5772)22.

Schematic representation of a diffusing particle in a lipid membrane is shown in Figure 78.

Figure 7-8. Schematic representation of the hydrodynamic model of a particle diffusing
in a lipid membrane described by the Saffman-Delbruck equation (Eqn. 1).
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As was mentioned previously that Saffman-Delbruck formula describes well
diffusion of small proteins is a lipid membrane, but it fails to describe the membrane
diffusion of larger complexes such as lipid rafts19. Since Bax-RG proteo-lipidic
complexes have diffusion coefficient two times smaller that the diffusion coefficient of a
Bax monomer we used modified Saffman-Delbruck formula19 to determine the inmembrane hydrodynamic radius of these complexes. In our analysis we made
assumptions that membrane viscosity is 0.7 cP15, membrane thickness is 5 nm. The
expression for the modified Saffman-Delbruck formula is following
 2
4   2   2  
 ln    
   ln  
  

k BT
 2    

D ( ) 
4 mem h    3   2  c  b1

1    ln   1

b2 
     
(1  c 2  ) 
  

(Eqn. 2)

where,  is the reduced radius,   2 R sol  mem , while c1 , c 2 , b1 , and b2 are constant
( c1  0.73761 , c 2  0.52119 , b1  2.74819 , b2  0.61465 ).
To calculate the error for this value we used the fact that membrane viscosity is
not very well defined and according to Ramadurai et al.15 it varies for a lipid membrane
composed of DOPC/DOPG mixture from 0.6 cP to 0.8 cP. Using this uncertainty in the
actual value for the membrane viscosity together with the fact that lipid composition used
in our work has similar viscosity as the one used in Ramadurai et al. based on the
measurements of translational lipid diffusion (see Appendix VI) we estimated that
standard error for the diameter of the Bax pore complex is 12 nm. Therefore, we estimate
that the diameter of the Bax pore complex in a lipid membrane is 53±12 nm.
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CHAPTER 8
“Conclusions and Future Directions”
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Conclusions
Protein Bax, a member of the Bcl-2 family, participates in the apoptosis decision
by forming pores in the mitochondrial outer membrane. In non dying cells, Bax is found
in the cytoplasm, therefore, in order to form pores in the mitochondrial outer membrane it
needs to undergo a conformational change, which is associated with the activation of
Bax. The molecular mechanism of Bax activation is one of the major unanswered
questions in the field of apoptosis. In addition to this question, there are other questions
about the pore formation mechanism of Bax, which remain unanswered due to the
absence of the structure for membrane integrated active Bax, the form of Bax involved in
the formation of pores. These questions include (i) the molecular mechanism of Bax
integration into a lipid membrane; (ii) the details of molecular interactions between Bax
monomers, leading to the formation of a pore; (iii) the progression, oligomeric state and
the size of pores formed Bax; (iv) the nature of a Bax pore – lipidic versus barrel-stave;
(v) the molecular interactions among monomers in a pore. To answer some of these
questions we developed and used approaches to study fluorescently labeled Bax in three
model in vitro systems –detergent micelles, LUVs and GUVs – using single-molecule
sensitivity fluorescence techniques based on FCS. These single-molecule sensitivity
techniques provide us with a non-invasive method to study the mechanism of Bax pore
formation in lipid membranes.

Determination of the oligomeric state of Bax in micelles of activating detergents
It has been observed that Bax can be activated via interaction with detergent
micelles. Additional biochemical analysis of the complexes formed by Bax and detergent
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micelles revealed that these proteo-micellar complexes have a hydrodynamic volume
larger than the combined volumes of a Bax monomer and a single detergent micelle. Due
to the propensity of Bax to oligomerize in the hydrophobic environment of a lipid
membrane during pore formation, it was hypothesized that Bax oligomerizes in detergent
micelles, and that this oligomerization leads to the activation of Bax. Additionally, it was
proposed that the oligomer of detergent activated Bax (consisting of up to 8 monomers)
binds lipid membranes and then leads to the formation of a pore. This is in contrast to the
in vitro studies where it was shown that Bax binds the mitochondrial outer membrane as
a monomer, and then undergoes oligomerization culminating in the formation of a pore.
Using a truncated version of Bax, BaxΔC, labeled with a single fluorophore per
protein monomer, we determined the oligomeric state of Bax in the micelles of several
activating detergents using the fluorescence intensity distribution analysis (FIDA). To
show that the fluorescently labeled BaxΔC used in our study has similar pore forming
ability to that of BaxΔC used in the preceding studies where it was shown to enlarge the
size of detergent micelles, we compared the pore forming ability of the two proteins
using the assay of dye release from liposomes. The results of this assay showed that the
fluorescently labeled BaxΔC has similar but slightly reduced pore forming ability
compared to unlabeled BaxΔC. We attribute this slight reduction in the pore forming
activity of fluorescently labeled BaxΔC to the presence of the fluorescent label on this
protein.
The detergents used in this study were n-octylglucoside, dodecylmaltocide, Triton
X-100, Tween 20, and cholic acid, and the results of FIDA for all of these detergents
showed that BaxΔC does enlarge the hydrodynamic volume of detergent micelles, but
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there is only one protein monomer per detergent micelle. Cholic acid was an exception to
the first part of this statement, since Bax did not enlarge the size of micelles of cholic
acid. We ascribe the absence of enlargement of the micelles of cholic acid upon
interaction with Bax to the fact that cholic acid is an ionic detergent, and it naturally
forms extremely small micelles of 4 kDa (in comparison the size of Bax is 21 kDa while
the size of Triton X-100 detergent micelles is 70-100 kDa).
The result, showing that BaxΔC is present as a monomer in the proteo-micellar
complexes, provides a connection between the detergent activation of Bax in vitro and
the physiologic pattern of Bax activation observed in vivo, showing that active Bax is a
monomer prior to membrane binding, and oligomerizes only in the environment of a lipid
membrane to form a pore. However, independent reviewers of our study pointed out that
the use of the truncated version of Bax, BaxΔC, might be a problem. Furthermore, two
recently published studies used micelles of Triton X-100 to study the homooligomerization of full length Bax using cross-linking. The comment of the authors of
these studies on our study was that the reason for difference in the observed results is the
use of BaxΔC, which might have different oligomerization propensity than full length
Bax.
BaxΔC has 19 amino acids truncated at the C-terminus, and thus lacks helix 9
which is implicated in binding lipid membranes. When expressed in vivo, BaxΔC can
release cytochrome c from mitochondria, thus showing that it has pore forming activity
comparable to that of full length Bax. The reason why we chose to use BaxΔC in our
studies is because the full length Bax in our hands forms visible by eye precipitates upon
incubation with activating detergents, thus rendering it unusable in FIDA analysis.
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However, we do agree that repeating FIDA with the full length fluorescently labeled Bax
is one of the future experiments which need to be done.

Imaging studies with fluorescently labeled Bax
Before continuing to the two-color two-focus scanning FCCS experiments on the
fluorescently labeled full length Bax in lipid membranes, we performed confocal
microscopy characterization of the interaction of fluorescent Bax with GUVs. In these
confocal microscopy experiments we used cBid to promote Bax binding to GUVs, and
we have made a number of informative observations: (i) permeabilization of GUVs by
Bax is a stochastic process, i.e. GUVs exposed to the same concentration of solution Bax
are not permeabilized simultaneously; (ii) after the initial permeabilization of a GUV,
Bax continues to bind the GUV membrane until it saturates; (iii) shortly after the addition
of Bax to GUVs, Bax is able to open stable giant pores in GUVs, which we named Bax
mega-pores; (iv) Bax binding was not homogenous among the GUVs, i.e. some GUVs
accumulated high membrane Bax concentrations than others, suggesting heterogeneity in
the lipid composition of GUVs; (v) after prolonged incubation with GUVs Bax causes
morphological changes in GUV structure, GUVs may form tubule-like structures, or have
a potato-like shape, GUVs can form agglomerates or disintegrate; (vi) large, visible by
confocal microscopy aggregates of Bax were observed in GUV membranes after
prolonged incubation with Bax; (vii) the inhibitor of Bax pore formation, protein Bcl-xL,
does not completely inhibit Bax binding to GUV membranes but it does inhibit
permeabilization of GUVs by Bax; (viii) within 24 hours of Bax addition, the majority of
GUVs are disintegrated and are unfit for FCCS measurements, while GUVs which were

187

not treated with Bax maintain their spherical shape and remained present in the
observation chamber after 24 hours. The results of these confocal imaging studies not
only allowed us to determine the optimal experimental conditions and the time frame for
performing scanning FCCS measurement on Bax in GUV membranes, but also they
showed that Bax binding changes the morphology of GUVs.

Bax mega-pore
It has been observed that Bax forms a wide variety of pores in artificial lipid
membranes and in isolated mitochondria, with the largest size of a Bax pore ranging
between 100-200 nm in diameter. In contrast to these studies, we observed the formation
of Bax mega-pores with diameters of 5-20 µm. All of these pores had fluorescent Bax
concentrated at the rim of the pore which allowed us to perform 3D reconstructions of
these pores.
These Bax mega-pores spent an unusually long time in an open state ranging from
10 minutes to hours. Giant pores of similar diameter can be opened in GUVs by
application of detergents or by mechanical disruption, however, these only have a life
time on the order of seconds and microseconds respectively. By analyzing the closure
kinetics of Bax mega-pores, we have determined that the reason for such long lifetime of
these pores compared to the other giant pores is explained by the extremely low line
tension in the rim of the pore (3.7±1.7 fN), which is caused by the presence of Bax in the
pore rim. Furthermore, the line tension in the rim of a Bax mega-pore formed by full
length Bax is three orders of magnitude lower than that formed by the pore forming helix
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5 of Bax, thus suggesting that the non-pore forming helices of Bax participate in the
stabilization of a pore.
The existence of Bax mega-pores shows that Bax can form pores spanning four
orders of magnitude in size. However, it is not clear whether all of these Bax pores have
similar molecular interactions among Bax monomers in the pore rim, suggesting for the
need to further explore the formation mechanism of various Bax-containing pores.

FCCS studies with Bax
For FCCS studies, we have produced two fluorescently labeled forms of Bax. One
is labeled with Alexa Fluor 488 (Bax-G) and the other is labeled with Atto 655 (Bax-R).
The pore forming activity of these proteins was identical to that of the wild-type full
length Bax. Furthermore, these proteins behaved as monomers in solution and did not
associate in solution in the absence of lipid membranes. Association of Bax-R and Bax-G
resulted in the formation of a stable Bax-RG complex, and was observed only in GUV
membranes using two-color two-focus scanning FCCS. Using this scanning FCCS
technique, we have also observed that the diffusion of Bax-RG complexes decreases with
time, suggesting a time dependent enlargement in the hydrodynamic in-membrane size of
the complexes.

The size of these Bax-RG complexes ranged from 50-120 nm in

diameter, which is consistent with the size of the Bax pores observed in LUVs by
transmission electron microscopy (with maximal size of 10-200 nm

in diameter).

However, it is important to mention that the in-membrane size of the Bax-RG complexes
may not be the same as the size of pores possibly formed inside these complexes, since if
the Bax pore is a lipidic pore, then lipids would be participating in the formation of the

189

pore, and their contribution to the diffusion of the Bax-RG complex would lead to a
decrease in the overall diffusion coefficient of the complex, and thus lead to higher
values in the estimation of the hydrodynamic diameter of the complex.
In the presence of Bcl-xL protein the oligomerization of Bax was inhibited and the
amount of Bax binding to the lipid membrane was decreased. We have also found that the
diffusion coefficient of Bax was changing with time from 8 µm2/sec to 5 µm2/sec. This
change in the diffusion coefficient of monomeric Bax is consistent with the hypothesis
that, during membrane integration, Bax transitions from being a membrane associated
protein to being a membrane integrated protein, where the membrane associated Bax
monomer would have fast diffusion coefficient, comparable to that of lipids (~10
µm2/sec), while the membrane integrated Bax monomer would have a slow diffusion
coefficient, similar to that of transmembrane monomeric proteins (~5 µm2/sec). This
change in the diffusion coefficient of Bax in the presence of Bcl-xL occurred over two
hours after protein addition to GUVs, while in the absence of Bcl-xL, Bax became
oligomeric and reduced its diffusion coefficient to 3-4 µm2/sec after 40 min of addition to
GUVs, thus indicating that Bcl-xL prevents pore formation by Bax not only by keeping it
monomeric but by also keeping Bax mostly in the membrane associated state preventing
the membrane integration of Bax.
Overall the results of scanning FCCS studies on Bax in GUV membranes provide
direct observation that Bax binds lipid membranes as a monomer (membrane associated
monomeric Bax), undergoes membrane insertion (membrane integrated monomeric Bax)
and then undergoes in-membrane oligomerization and self-assembly into large complexes
50-120 nm in diameter which we feel are proteo-lipid pores.
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Future Directions
Scanning FCCS can be used to study hetero-oligomerization among proteins of the
Bcl-2 family
To the best of our knowledge, the approach, implementation and data analysis
presented in this dissertation of using single-molecule sensitivity fluorescence techniques
to study the mechanism of pore formation by Bax, and in fact by any other pore forming
protein, is the first of its kind. Therefore, we foresee further studies utilizing this
approach to study other pore forming proteins and peptides, and in particular, Bax. Our
scanning FCCS studies provided an initial characterization of the diffusion coefficients of
various Bax species in a lipid membrane. However, since in vivo Bax is kept in check by
other members of the Bcl-2 protein family, it is important to investigate in future
experiments the effect of other Bcl-2 members on Bax. This can be done by studying not
the homo-oligomeirzation of Bax, as was done in this dissertation, but the heterooligomerization of Bax with other Bcl-2 family members. This type of heterooligomerization studies by scanning FCCS in lipid membranes can, for example, provide
information about the affinity of the interaction among various Bcl-2 family members,
and in particular help to determine whether activator and de-repressor BH3-only proteins
interact with Bax in the environment of a lipid membrane. Another set of heterooligomerization experiments can address the question whether the major mechanism of
inhibition of Bax pore formation by the anti-apoptotic proteins is by directly binding Bax
in the lipid membrane or not. Our preliminary evidence suggests that Bax and Bcl-xL do
not form a stable complex in a lipid membrane; however, Bcl-xL did inhibit the pore
formation by Bax in these experiments. Information obtained in the described above
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experiments about the mechanisms of interaction among the Bcl-2 family members in
lipid membranes can potentially be used to develop small molecules which can help
modulate these Bcl-2 family interactions and thus can be used in cancer treatment of
prevention of cell death after trauma or cardiac infarction.

Cholic acid can be used to determine the structure of active Bax
Our FCS studies with the micelles of Bax activating detergents have shown that
the majority of activating detergents form large proteo-micellar complexes with Bax. The
large hydrodynamic size of these complexes prohibits NMR determination of the
structure of active Bax contained inside these complexes. However, we have shown that
cholic acid activates Bax without the formation of large hydrodynamic volume
complexes, in fact, the size of Bax-cholic acid complexes is almost identical to the size of
an inactive Bax monomer whose structure have been successfully determined by NMR.
Therefore, we predict that cholic acid can be used to determine the structure of active Bax
by NMR.

Single-molecule TIRF can be used to study the sequence of interactions among
proteins of the Bcl-2 family
Single-molecule TIRF microscopy allow to study interactions among individual
molecules near a surface. Supported lipid bilayers can form such a surface, and thus they
have been used in single-molecule TIRF experiments. We hypothesize that singlemolecule TIRF can be used to study homo- and heterotypic interactions among proteins
of the Bcl-2 family, provided that these proteins are fluorescently labeled. These types of
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studies would provide information about the sequence of interactions among the proteins
of the Bcl-2 family, since such information can not be easily obtained using scanning
FCCS technique used in this dissertation.
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Appendix I
Structural information on human α Bax protein
Amino acid sequence:
MDGSGEQPRG

GGPTSSEQIM

KTGALLLQGF

IQDRAGRMGG

EAPELALDPV

PQDASTKKLS

70
ECLKRIGDEL

80
DSNMELQRMI

90
AAVDTDSPRE

100
VFFRVAADMF

110
SDGNFNWGRV

120
VALFYFASKL

130
VLKALCTKVP

140
ELIRTIMGWT

150
LDFLRERLLG

160
WIQDQGGWDG

170
LLSYFGTPTW

180
QTVTIFVAGV

190
LTASLTIWKK MG

Number of amino acids: 192
Molecular weight: 21184.4
Theoretical pI: 5.08
Amino Acid composition:
Ala (A) 14
7.3%
Arg (R) 11
5.7%
Asn (N) 3 1.6%
Asp (D) 13
6.8%
Cys (C) 2 1.0%
Gln (Q) 9 4.7%
Glu (E) 10 5.2%
Gly (G) 21
10.9%
His (H) 0 0.0%
Ile (I) 9
4.7%
Leu (L) 22
11.5%
Lys (K) 9 4.7%
Met (M) 8
4.2%
Phe (F) 10 5.2%
Pro (P) 8 4.2%
Ser (S) 11 5.7%
Thr (T) 13
6.8%
Trp (W) 6
3.1%
Tyr (Y) 2
1.0%
Val (V) 11
5.7%
Total number of negatively charged residues (Asp + Glu): 23
Total number of positively charged residues (Arg + Lys): 20
Extinction coefficients:
Ext. coefficient 35980 M-1 cm-1, at 280 nm measured in water.
Abs 0.1% (=1 g/l) 1.698, assuming all Cys residues are reduced
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Appendix II
Protocol for the preparation of large unilamellar vesicles

For my thesis I have used the reverse phase method of LUV preparation (ref). The other
existing method for the LUV preparation is the freeze-thaw method (ref). Using either of
these methods it is possible to prepare LUVs in various aqueous buffer solutions. In my
thesis research I mainly prepared two types of LUV: filled with quenched concentration
of carboxyfluorescein or filled with buffer solution. In order to prepare LUVs by either
method lipids have to be dried in a glass vial/tube.
Drying lipids:
1. Deposit lipids dissolved in chloroform into a glass tube (1x10 cm, diameter x
height). The total amount of lipids per tube can be from 0.5 – 10 mg.
2. Dry lipids using a stream of nitrogen gas. Dried lipids are extremely vulnerable to
oxidation by the oxygen in the atmosphere, therefore, care must be taken to keep
the dry lipids either under 100% nitrogen or 100% argon atmosphere.
3. To remove the chloroform from lipids completely the liophilization vacuum
system is used for 2 hours.
4. At this points glass tubes with dried lipids can be stored at -20 °C under 100%
nitrogen or 100% argon atmosphere. For convenience 50 ml disposable plastic
conical tubes can be used. In this form lipids can be stored for 1-2 months.
LUV preparation by reverse phase method:
1. Defrost a container containing the glass tube/tubes with dried lipids by leaving it
on a bench at room temperature for 5-10 minutes.
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2. Return the rest of the glass tubes to -20 °C.
3. To the glass tube with dried lipids add 1 ml of diethyl ether to dissolve the lipids.
Make sure that all lipids are dissolved by checking for the white residue of dry
lipids on the sides of a glass tube. (Note, a bottle of diethyl ether which is over 1
year old is dangerous since it can be explosive due to the formation of diethyl
ether hydroperoxide).
4. Next, add 0.5 ml of buffer which will be incorporated into the interior of the
liposomes (for example, 1x EB* or 50 mM rarboxyfluorescein in 1x EB). At this
point the ether and water phases will be separated with ether phase being on top
of the water phase.
5. Sonicate the water-ether solution using a table top, water bath sonicator for 10-30
seconds. At this point the solution in the glass tube should become homogeneous
and milky. If the solution is not homogeneous repeat the sonication cycle.
6. The milky solution in a tube is an emulsion of aqueous buffer in ether.
7. Transfer the emulsion to a bulb-like vial and connect it to a rotary evaporator to
evaporate the ether from the emulsion. Slow evaporation of ether forces lipids in
solution to organize into lipid bilayers of liposomes. At this point liposomes
would be non-unilamellar (i.e. there would be daughter liposomes inside of a
larger mother liposome) and would have diameters anywhere between 600 nm
and 50-30 nm.
8. To form unilamellar liposomes of a 200 nm to 100 nm in diameter the liposomes
from the Step 7 should be extruded 7-21 times through a membrane with pore of a
specified diameter.
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9. At this point dynamic light scattering can be used to asses the quality of the
extrusion process.
10. Depending on the lipid composition resulting extruded LUVs can be stored for 1
month. For example, extruded LUVs made with lipids containing tow oleoyl
carbon tails can be store at room temperature for 1 month.

Preparation of LUVs filled with quenched carboxyfluorescein:
1. Prepare a 50 mM carboxyfluorescein solution in a buffer of choice. Keep 7.0 pH.
2. Follow steps 1-3 of the above LUV preparation protocol.
3. Add 0.5 ml of 50 mM carboxyfluoresceine in 1x EB to the glass tube containing
lipids dissolved in ether. Separation of the aqueous and ether pahses would be
clearly visible.
4. Sonicate the buffer-ether solution using a table top, water bath sonicator for 10-30
seconds. At this point the solution in the glass tube should become homogeneous
and milky. If the solution is not homogeneous repeat the sonication cycle.
5. The milky solution in a tube is an emulsion of aqueous buffer in ether.
6. Transfer the emulsion to a bulb-like vial and connect it to a rotary evaporator to
evaporate the ether from the emulsion. Slow evaporation of ether forces lipids in
solution to organize into lipid bilayers of liposomes. At this point liposomes
would be non-unilamellar (i.e. there would be daughter liposomes inside of a
larger mother liposome) and would have diameters anywhere between 600 nm
and 50-30 nm.
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7. To form unilamellar liposomes of a 200 nm to 100 nm in diameter the liposomes
from the Step 7 should be extruded 7-21 times through a membrane with pore of a
specified diameter.
8. To separate the extruded LUVs filled with the carboxyfluoresceien from the
carboxyfluoresceine present outside the LUVs use a Sephadex G-25 column. The
appropriate dimentions of such Sephadex G-25 column should be 1 cm x 30 cm
(diameter versus length) to enshure clear separation of the liposomes filled with
the carboxyfluorescein from free carboxyfluoresceine in solution.
9. After the gel filtration thotuhg the Spehadex G-25 column perform dynamic light
scattering on the sample of LUVs to ensure the correct size.
10. To ensure that the liposomes are filled with quenched carboxyfluorescein use a
small sample of liposomes (5-10 µl) in a clear ependorf tube (note the brightness
of the sample) then add 5 µl of 20% Triton X-100 to the sample. Triton X-100 is a
detergent which when added to the liposomes would solubilize the liposomes
releasing their content into solution. If the sample changes brightness this would
mean that the liposomes are filled with qunenched carboxyfluoresceien and are
ready for use. The same type of control can be sone using a plate reader or a
conventional fluorimeter.
11. Liposomes filled with quenched carboxyfluoresceine and filtered throught he
Sphadex G-25 column can be used only over a 5 day period due to the gradual
leakage of carboxyfluoresceine from liposomes.

* 1x EB – equilibration buffer containing 10 mM HEPES pH 7.2, 100 mM KCl
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Appendix III
Protocol for preparation of giant unilamellar vesicles
Giant unilamellar vesicles (GUVs) used in all experiments described in this dissertation
were prepared by the electroformation method2, 3. In this method chloroform mixture of
lipids (1-2 mg/ml of total lipid) is deposited onto the surface of two parallel platimun
wires (5 µl of mixture per wire). Deposition of lipid mixture onto the platinum wires is
done using a plastic gel-loading pipette tip. Lipids are allowed to dry on the surface of the
wires after which the wires are immersed into the di-ionized water solution of 300 mM
sucrose. The platinum wires and the sucrose solution are contained in a Teflon chamber
(Fig. A1a). Next, wires are connected to an AC function generator set to sine waveshaped output of AC current with 10 Hz, 2V for 1-2 hours (Fig. A1b, A1c). During this
1-2 hour time period GUVs are formed on the surface of the platinum wires (like grapes
on a wine). After that the frequency of the AC current is changed to 2 Hz for another 30
min to 1 hour. This leads to detachment of GUVs from the platinum wires into the
sucrose solution resulting in GUVs ready for use in an experiment. While pipetting the
GUVs care must be taken not to rupture them by cutting the tip of 200 µl pipette tip (this
increases the diameter of the pipette opening and results in a smaller shear forces
experienced by GUVs while passing through the opening during pipetting).
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a

b

c

Figure A1. Illustrations to the method of GUV electroformation. a. Electroformation
chamber made of Teflon with two platinum wires. b. Function generator; this figure
shows for function generators. c. Assembled electroformation chambers connected to the
function generator.
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Appendix IV
Protocol of protein purification and labeling.
Human full length Bax, BaxΔC, BaxΔC(G40C), Bid, Bcl-xL, and mutant Bax_S4C were
expressed in BL21(DE3) E. coli, and purified as an intein/chitin-binding domain fusion
protein without use of detergents. Briefly, bacterial cultures were grown at 37 °C in
Terrific Broth4 to an A600 of 1.5–2.0, and then the cultures were induced with 0.1 mM
isopropyl 1-thio-D-galactopyranoside (Research Products International. Corp.), and the
temperature was changed to 25 °C. After 12–15 h, bacteria were collected via
centrifugation; the resulting pellet was resuspended in lysis buffer (phosphate-buffered
saline, pH 7.2, 1mM EDTA, 0.25 mM phenylmethylsulfonyl fluoride), and cells were
broken by four passages through a microfluidizer (Microfluidics) at the pressure of 1000
bar. Lysate was clarified by centrifugation, and the supernatant containing protein of
interest was incubated with chitin affinity resin (New England Biolabs) overnight at 4 °C
on a rocker. Resin was subjected to a high salt wash and then equilibrated in cleavage
buffer (10 mM HEPES/NaOH, pH 8.0, 100 mM NaCl, 50mM dithiothreitol) and
incubated for 48 h at 4 °C. The purity of the proteins was assessed by SDS-PAGE.
Bax_S4C was labeled with either Alexa Flupr 488 maleimide (Invitrogen) or Atto 655
maleimide (AttoTech) according to the manufacturer’s protocol. Labeled protein was
separated from the free dye using a Sephadex G-25 column. The degree of protein
labeling was determined using a Nano-Drop spectrophotometer (Thermo Scientific) by
measuring absorbance at 280 nm (for protein concentration) and 488 nm (for Alexa Fluor
488 concentration) and 655 nm (for Atto 655 concentration). Resulting proteins Bax-R
and Bax-G were 80% and 100% labeled respectively and were stored in EB buffer (10
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mM HEPES/KOH, pH 7.2, 100 mM KCl) at 4 °C. Proteins were used within one month
of purification and labeling.
Bid was cut with recombinant caspase 8 to produce cBid.

Protein functionality check: fluorescently labeled Bax is functional. To determine
whether fluorescent labeling and mutagenesis of the human full length Bax protein
(Figure 1B) interferes with the capacity of Bax to form pores the experiments of
carboxyfluorescein release from liposomes

5, 6

were performed. In these experiments the

ability to form pores in liposomes of the wild-type Bax and the two forms of the
fluorescently labeled Bax (Bax-G labeled with Alexa 488 and Bax-R labeled with Atto
655) were compared. As a result, identical kinetics of carboxyfluorescein release was
observed for the wild-type Bax and for Bax-R and Bax-G which implies that fluorescent
labeling and mutagenesis of Bax did not interfere with its pore forming ability. In these
experiments 100 nM Bax was activated by the activator protein cBid (20 nM). To show
that the wild-type Bax as well as Bax-R and Bax-G can be inhibited by the full-length
Bcl-xL we also performed carboxyfluorescein releases in the presence of 100 nM Bcl-xL
(Supplementary Fig. 2b-d). For these experiments liposomes were prepared from the lipid
mixture of DOPC and bovine heart cardiolipin (80:20 mol%). Lipids were purchased
from Avanti Polar Lipids.
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Appendix V
Lipid diffusion in DOPC versus DOPC:CL (80:20 mol%) lipid bilayer.
To determine whether lipid diffusion and viscosity of a lipid membrane is
affected by the presence of cardiolipin in a lipid bilayer we have measured the lipid
diffusion in GUVs formed from DOPC or DOPC:CL (80:20 mol%) lipid mixtures. We
have also compared the results using dual-focus scanning FCS versus static volume FCS
which is normally done in a fixed position at the top a GUV (See Chapter 3 for the
description of FCS in lipid membranes). The results of our analysis show no difference in
diffusion of classic lipidic probes (DiO and DiD) in DOPC versus DOPC:CL lipid
membranes (Table A1) indicating the presence of cardiolipin does not affect lipid
diffusion and the viscosity of a lipid membrane.

Table A1. Comparison of lipid diffusion in GUVs prepared from lipid mixture of DOPC
and DOPC:CL (80:20 mol%). The lipid probe used was DiO or DiD (Invitrogen,
Molecular Probes). Comparison was also done with regard to the dual focus scanning
FCS versus static volume FCS7 which was done using Zeiss Confocor 2 instrument.
Membrane
composition

Probe

D,
µm2/sec

DOPC:CL (80:20
mol%)
DOPC

DiO,
DiD
DiD

10.0±0.5

Number
of GUVs
measured
9

10.9±1.9

12

DOPC:CL (80:20
mol%)

DiO

10.6±2.9

10
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Method
dual focus scanning FCS
static volume FCS (single
point measurement at the top
of a GUV)
static volume FCS (single
point measurement at the top
of a GUV)
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